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ABSTRACT 
Insulin-like growth factor 2 (IGF2) is a maternally imprinted growth factor that is thought 
to primarily promote prenatal skeletal muscle growth.  A SNP within intron 3 of IGF2 identified 
as IGF2-intron3-G3072A has a considerable impact on lean yield as a result of increased 
postnatal IGF2 expression.  Our first objective was to characterize carcass cutting yields of pigs 
with paternal A alleles (A
Pat
) and paternal G alleles (G
Pat
) and determine how the mutation 
affects fresh meat quality and bacon processing.  A single heterozygote (AG) boar was bred to 
homozygous (AA) commercial Yorkshire-cross sows producing F1 barrows and gilts with either 
G
Pat
 or A
Pat 
alleles.  Loin eye area was 10% greater (P = 0.01) and back fat was reduced (P = 
0.01) 15% in A
Pat
 pigs compared with G
Pat
 pigs.  Consequently, boneless carcass cutting yield 
was increased (P < 0.01) 2.34 percentage units in A
Pat
 pigs compared with G
Pat
 pigs.  Mutations 
that improve carcass lean yield are often associated with reduced meat quality; however, fresh 
LM quality was minimally affected by the genotype, as 24-hour pH, drip loss and shear force 
was not different (P ≥ 0.27) between APat pigs and GPat pigs. Despite the reduced subcutaneous 
fat accumulation, LM intramuscular extractable lipid was 0.64 percentage units greater (P = 
0.02) in A
Pat
 pigs compared with G
Pat
 pigs.  While not statistically different (P = 0.30), the 
magnitude of difference in slicing yield as a percentage of green weight was 1.57 percentage 
units between bellies from A
Pat
 pigs (85.83%) and bellies from G
Pat
 pigs (87.40%).  Therefore, 
while A
Pat
 pigs yielded a greater amount of lean product, this may have been at the expense of 
reduced bacon slicing yields.  Our next objectives were to determine the contributions of 
hyperplasia and hypertrophy to increased muscle mass and delineate the effect of the IGF2 
mutation on the expression of myogenic genes during prenatal and postnatal growth.  While 
postnatal IGF2 expression is known to be greater in A
Pat
 pigs compared with G
Pat
 pigs there is 
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little data that characterize how the mutation alters prenatal myogenesis. In addition to the 
expected postnatal increase (P ≤ 0.02) in IGF2 expression, IGF2 expression was also increased 
(P ≤ 0.06) 1.4-1.5 fold at d90 of gestation and at birth in APat pigs compared with GPat pigs.  
Additionally, skeletal muscle fiber number within the semitendinosus (ST) tended to be greater 
(P = 0.10) in A
Pat
 pigs compared with G
Pat
 pigs, possibly as a result of the elevated prenatal IGF2 
expression.  Together, these data suggest that A
Pat
 pigs are later maturing than G
Pat
 pigs and 
therefore, may be marketed at heavier weights but with similar subcutaneous fat depth.  
Furthermore, the elevated IGF2 expression did not affect (P ≥ 0.12) expression of other growth 
factors such as IGF1 and myostatin.  The final objective was to determine how IGF1 and IGF2 
cooperate with myostatin to regulate skeletal muscle growth. Therefore, we quantified IGF 
family member expression in myostatin null (MN) and wild type mice.  Skeletal muscle IGF1 
expression was surprisingly less (P ≤ 0.04) in skeletal muscle of 7d and 21d old MN mice 
compared with WT mice.  Additionally, IGF2 expression was 1.9 to 2.9-fold greater (P < 0.01) 
in 21d, 42d, and 70d old MN mice compared with WT mice.  Likewise, a similar increase (P < 
0.01) was observed in three known Igf2 transcript variants at 21d and 70d in skeletal muscle of 
MN mice compared with WT mice.  Hepatic Igf1 and Igf2 levels were minimally affected by 
genotype; with an exception at 21d when IGF1 was reduced 1.4-fold (P = 0.04) and IGF2 tended 
to be 1.3-fold greater (P = 0.06) in MN mice compared with WT mice.  Together this implies 
that during postnatal development, myostatin may repress IGF2 expression in WT mice reducing 
skeletal muscle growth.  Overall, these studies provide evidence that IGF2 is a key factor in 
regulating both prenatal and postnatal skeletal muscle growth.  
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Chapter 1 
REVIEW OF LITERATURE 
 
INTRODUCTION 
 As the world population continues to increase, the agriculture industry must develop and 
improve technologies that maximize yields while minimizing inputs, environmental impact, and 
cost.  For the livestock industry, development of new technologies that improve efficiency of 
livestock production while maintaining an affordable, safe, high quality protein source for 
consumers is vital.  Understanding endogenous growth factor signaling cascades and their 
interactions can lead to development of these new technologies.  Two principal growth factor 
families that govern both pre-natal and postnatal growth are insulin-like growth factor (IGF) 
family and transforming growth factor-β (TGF- β) superfamily.  The IGF family primarily has a 
positive influence on growth while the TGF-β family negatively influences growth.  Mutations 
that alter protein functionality or gene expression of these growth factor families can have a 
dramatic impact on skeletal muscle growth.  A greater understanding of how these growth 
factors interact to regulate growth could potentially lead to new technologies to improve the 
efficiency of livestock production.   
INSULIN-LIKE GROWTH FACTORS 
Insulin-like growth factors are a family of hormones controlling hyperplasia and 
differentiation throughout the body.  The IGF family consists of two hormone ligands: insulin-
like growth factor-1 (IGF1) and insulin-like growth factor-2 (IGF2) (Liu et al., 1993).  There are 
two IGF cell surface receptors: IGF-Type 1 Receptor (IGF1R) and IGF-Type 2 receptor (IGF2R, 
also known as mannose-6-phosphate receptor) (Florini et al., 1996).  The IGF1R binds IGF1 
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with an increased affinity compared to IGF2; whereas, IGF2 is bound at an approximately 10-
fold decreased affinity.  The IGF2R binds IGF2 with an increased affinity compared to IGF1.  
Insulin binds to IGF1R at an affinity approximately 100 fold less than IGF1 and is unable to bind 
IGF2R (Table 1.1) (Florini et al., 1996).   
Insulin-like growth factors have sequences and conformation similar to insulin, and are 
therefore able to bind insulin receptors.  There are two insulin receptor isoforms: IR-A and IR-B.  
Insulin binds to either isoform at approximately the same affinity.  IGF2 also has a high affinity 
for IR-A, while IGF1 binds IR-B with decreased affinity compared to insulin (Table 1.1) 
(Belfiore et al., 2009).  IR-A is expressed at greater levels during gestational development and 
may be crucial for embryonic growth (Belfiore et al., 2009; Siddle, 2011).  It is currently 
believed that prenatal growth stimulatory effects by IGF2 are carried out through both IGF1R 
and IR-A (Siddle, 2011).    
IGF1 and IGF2 loss of function mutations 
Both IGF1 and IGF2 are important for both prenatal and postnatal growth.  Mice lacking 
functional IGF1 are approximately 40% smaller than controls at birth (Baker et al., 1993).  Some 
of these mice are not viable and die within 6 hours of birth, while some mice survive until 
adulthood.  An IGF2 loss-of-function mutation was also introduced into a mouse model.  
Analysis of inheritance indicated heterozygous mice that received a paternally derived IGF2 
mutated allele were approximately 60% smaller (dwarfed) than both wild-type mice and those 
heterozygous mice that received a maternally derived IGF2 mutated allele (DeChiara et al., 
1990; DeChiara et al., 1991).  Mice dwarfed in size were viable, fertile and had similar postnatal 
growth rates compared to both wild-type and maternally derived heterozygotes (DeChiara et al., 
1991).  This indicated that IGF2 is subject to parental imprinting and is particularly important 
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during prenatal growth and development (DeChiara et al., 1991).  Because IGF1 and IGF2 null 
mutants result in distinct phenotypes, a hypothesis can be drawn that these growth factors either 
stimulate separate signaling pathways or their expression is differentially expressed over time.   
Given that IGF1 and IGF2 both act through IGF1R, the current hypothesis is that IGF1 
and IGF2 are differentially expressed over time.  Regulating prenatal growth is the primary 
function of IGF2, while IGF1 is primarily responsible for growth after birth.  Skeletal muscle 
mRNA expression analysis would concur as IGF2 expression dramatically decreases after birth 
(Van Laere et al., 2003), while IGF1 expression increases after birth (Dupont and Holzenberger, 
2003).  However, because IGF1 and IGF2 activate the same receptor (IGF1R), and IGF1 and 
IGF2 null mice are occasionally viable, the growth factors may have some overlapping 
redundant growth regulating responsibilities.   
IGF1R and IGF2R 
Mice lacking a functional IGF1R are approximately 45% smaller than controls and die 
within minutes of birth due to asphyxiation (Liu et al., 1993). Interestingly, IGF2R, similar to 
IGF2, is imprinted, however the maternally derived allele is expressed (Barlow et al., 1991).  
Downstream pathways activated by IGF2R are not well defined.  Instead of a traditional 
signaling cascade, the proposed function of IGF2R is to bind and degrade IGF2.  Once IGF2 
binds to IGF2R, the ligand is internalized and degraded, decreasing circulating IGF2 (Jones and 
Clemmons, 1995; Florini et al., 1996).  Mice lacking functional IGF2R are larger at birth (140% 
of wild type weight) but usually perish perinatally (Ludwig et al., 1996). Simultaneous deletion 
of IGF2 and IGF2R restores viability, however, mice are born smaller than controls (Table 1.2) 
(73.8% of wild type weight) (Filson et al., 1993; Jones and Clemmons, 1995; Ludwig et al., 
1996).  This suggests that excess IGF2 resulting from the lack of IGF2R is fatal.  Increases in 
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fetal weight and perinatal death in the IGF2R mutants is believed to be an effect of IGF2 over 
activating IGF1R.  The IGF2R mutants are also rescued through a simultaneous induction of a 
loss of function IGF1R mutation.  Mice lacking both IGF1R and IGF2R have similar birth 
weights as wild type mice (Ludwig et al., 1996).  Triple IGF2, IGF2R and IGF1R loss of 
function mutants, however, are much smaller at birth (Table 1.2) (34.4% of wild type weight), 
but similar to double IGF1R/IGF2 mutants (33.6% of wild type weight) (Ludwig et al., 1996).  
Because, mice lacking IGF1R and IGF2R have birth weights similar to wild type mice and mice 
lacking IGF1R and IGF2 are significantly smaller, a conclusion can be drawn that IGF2 interacts 
with another receptor, such as an insulin receptor isoform, to promote growth.  Additionally, 
IGF1R can be activated by another ligand; however, when IGF1R and IGF2 are both absent at 
birth weight is reduced.   
Overexpression of IGF2 also results in abnormalities.  Beckwith-Wiedemann syndrome, 
a human disease, has been attributed to loss of imprinting in the IGF2 gene and results in a 10% 
increase in birth weight (Grandjean et al., 2000).  In contrast to IGF2R knock-out that also 
results in increased IGF2, Beckwith-Wiedemann syndrome is not lethal.  This decreased lethality 
is attributed to the more moderate increase in IGF2 compared to the increase in IGF2 after 
deletion of IGF2R or transgenic overexpression of IGF2.  Beckwith-Weidmann syndrome, 
however, is not without symptoms as patients often have growth defects, predisposition to 
tumors and abnormal body wall closure (Grandjean et al., 2000). In contrast, postnatal IGF2 
overexpression results in increased growth and prolonged increases have been associated with 
tumor formation (Pravtcheva and Wise, 2008).  
Actions of IGF2R independent of IGF2 degradation have also been noted.  Activation of 
IGF2R has also been linked to induction of motility in Rhabdomyosarcoma cells (Minniti et al., 
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1992).  Therefore, IGF2R may also be involved in migration of myoblasts or satellite cells 
during myogenesis and regeneration, respectively.  However, to date, no research has been 
completed focusing on this function of IGF2R. 
Insulin-like Growth Factor Binding Proteins 
 Various cell types secrete binding proteins (BP) that interact with IGF1 and IGF2 to alter 
IGF affinity to IGF1R and IGF2R and protect the growth factors from degradation in circulation.  
There are six known IGFBP numbered 1 through 6.  Each binding protein has a unique binding 
affinity for IGF1 and IGF2 (Wong et al., 1999) (Table 1.3).  Seventy-five percent of circulating 
IGF1 is bound to IGFBP-3 and glycoprotein acid-liable subunit (Jones and Clemmons, 1995; 
Firth and Baxter, 2002).  The second most abundant binding protein bound to circulating IGF1 is 
IGFBP-2, while other BP are found at a lesser concentration in serum (Jones and Clemmons, 
1995).  In vitro studies using L6A1 myoblasts indicated, IGFBP-4 may be expressed at greater 
levels during myoblast proliferation, while IGFBP-5 may be expressed at greater levels during 
muscle differentiation, and IGFBP-6 is greatest during quiescence (Florini et al., 1996).   
Furthermore, some IGF binding proteins act autonomously from IGF1 and IGF2, and 
elicit a cellular response.  Binding proteins such as, IGFBP-3 and IGFBP-5 can act as negative 
regulators of skeletal muscle growth independently of IGF (Baxter, 2001).  While very few 
studies have been completed using muscle cells, some in vitro studies imply that IGFBP-3 can 
mediate activation of TGF-β superfamily receptors to elicit an inhibitory growth response 
(Fanayan et al., 2002; Huang et al., 2004).  Although the precise molecular mechanism is still not 
known, IGFBP-3 is believed to mediate the activation of the typeV TGF-β receptor (Huang et al., 
2004), which dephosphorylates insulin-receptor substrate and inhibits IGF1R signaling cascade.  
Additionally, IGFBP-3 increased SMAD signaling pathway activation via a mechanism 
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dependent upon TGF-β receptor type II in breast cancer cell lines (Fanayan et al., 2002).  
Therefore, IGFBP may play a large role in regulating growth by altering IGF signaling and 
mediating other growth factor signaling cascades.  However, further studies are needed to fully 
understand how IGFBP are regulating the growth of skeletal muscle cells independently of IGF1 
and IGF2.  
IGF Mechanism of Action 
Activation of IGF1R leads to the activation of two primary signaling cascades: 
PI3K/AKT and MAPK/ERK.  These two pathways are believed to be responsible for opposing 
processes: proliferation and differentiation.  Upon ligand binding, IGF1R changes conformation, 
autophosphorylates, and ultimately interacts with Src homology containing protein (Shc), insulin 
receptor substrate (IRS-1), and other intermediate signaling proteins.  Three separate proteins 
comprise Shc (p46, p52, and p66), and upon interacting with activated IGF1R, tyrosine residues 
on the p52 component become heavily phosphorylated (Giorgino and Smith, 1995).  
Phosphorylated Shc interacts with the SH2 domain of growth factor receptor bound-2 (Grb2) 
(Skolnik et al., 1993).  Activated Shc/GRB2 protein complex binds to Son of Sevenless (Sos) at 
the SH3 domain on Grb2 (Skolnik et al., 1993; Egan et al., 1993).  The catalytic domain of Sos 
converts Ras-GDP (inactive form) to Ras-GTP (active) (Egan et al., 1993).  Conversion of 
inactive to active Ras begins the Ras signaling pathway (Figure 1.1). 
 Once activated, the Ras signaling pathway activates other growth promoting pathways. 
Ras recruits and activates Raf (serine/threonine kinase) that activates MAPK kinase (MEK1) by 
phosphorylation (Siddle, 2011).  MEK1 then phosphorylates inactive extracellular signal related 
kinase 1/2 (ERK1/2) protein, found in cytoplasm bound to MEK1.  Once activated ERK1/2 
disassociates from MEK1 and translocates to the nucleus (Siddle, 2011).  ERK1/2 then 
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phosphorylates and activates many growth promoting transcription factors, (ex. c-Myc, NF-IL6, 
ATF-2) (Davis, 1993).   
 Similar to Shc, IRS-1 interacts with proteins containing SH2 domains after being 
phosphorylated by the activated IGF1R receptor (Giorgino and Smith, 1995). IRS-1 can interact 
simultaneously with many SH2 domain-containing proteins such as Grb2, Nck, c-Crk, Syp, and 
PI3-kinase (Florini et al., 1996).  Activation of PI3-Kinase leads to activation of AKT (also 
known as Protein Kinase B) (Bodine et al., 2001).  Activation of AKT increases growth by 
increasing protein synthesis and decreasing protein degradation. (Figure 1.1) 
In vitro studies with satellite cells determined the MAPK/ERK pathway is primarily 
responsible for proliferation and initial activation of satellite cells (Coolican et al., 1997; Ge et 
al., 2013).  The MAPK/ERK pathway is responsible for increases in expression of c-fos, a 
transcription factor and marker of satellite cell differentiation (Coolican et al., 1997).   However, 
considerable cross-talk between the pathways exist as both PI3K/AKT and MAPK/ERK 
pathways are essential for increased cell cycle regulator, cyclinD2 (Engert et al., 1996; Ge et al., 
2013) that is required for entry into S-phase of the cell cycle.   
The PI3K/AKT pathway initiates satellite cell differentiation after prolonged exposure to 
IGF1 in vitro.   Myogenin and myogenic regulatory factor 4 (MRF4) are both myogenic markers 
for satellite cell differentiation.  Inhibitors of PI3K reduce myogenin and MRF4 expression in 
vitro (Engert et al., 1996; Coolican et al., 1997).  Together PI3K/AKT and MAPK/ERK 
signaling results in increased myonuclei by increasing fusion and maintaining the quiescent pool 
of satellite cells.  Increased myonuclei provide the DNA to increase transcription, translation and 
protein accumulation.  It should be noted that aforementioned satellite cell proliferation and 
differentiation studies are completed in vitro.  Therefore, satellite cells behave more like 
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embryonic myoblast cells and differentiate into myotubes.  Satellite cells in vivo differentiate and 
fuse with a neighboring muscle fiber.  Mechanisms of satellite cell differentiation and fusion are 
believed to be very similar, and therefore in vitro studies are crucial for understanding 
mechanisms behind satellite cell proliferation and differentiation; however, results should be 
interpreted with caution.        
 IGF1R can also be activated directly on the surface of muscle fibers increasing 
hypertrophy independent of satellite cell activation (Blaauw et al., 2009).  Similar to satellite 
cells, IGF1R activates both PI3K/AKT and MAPK/ERK pathways in muscle fibers.  These two 
pathways converge and promote mammalian target of rapamycin complex 1 (mTORC1) to 
increase protein synthesis.  Kinase activity of mTORC1 is inhibited by a tuberous sclerosis 
complex (TSC1 and TSC2).  Active AKT positively regulates mTORC1 activity by 
phosphorylating TSC2 which results in deterioration of the TSC1/2 complex and ubiquitination 
of free TSC2 protein (Figure 1.1) (Inoki et al., 2002).  Activation of mTORC1 leads to activation 
of P30S6K1 and inhibition of eukaryotic translation initiation factor 4E-binding protein 1 
(4EBP-1) (Inoki et al., 2002).  
This in turn leads to activation of a series of eukaryotic initiation factors, which promote protein 
translation as reviewed by Ma and Blenis (2009).  Briefly, activation of P30S6K1 promotes 
recruitment and assembly of eukaryotic translation initiation factors (eIF).  This complex 
contains eIF4E, eIF4G and eIF4A.  First, eIF4E binds the 5’ untranslated region of a targeted 
mRNA strand (Figure 1.2).  The subunit 4E-BP1 is phosphorylated and dissociates from eIF4E, 
thereby allowing eIF4E and eIF4G to bind and form the complete eIF4F complex.  This complex 
recruits eIF4A and 40S ribosomal subunit to initiate translation.   Active P30S6K1 can also 
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activate eIF4B, which is needed to enhance helicase activity of eIF4A.  After the binding of these 
factors, the elongation process of protein synthesis begins. 
 Activation of IGF1R also decreases protein degradation.  Activation of AKT inhibits the 
forkhead box (FoxO) family of transcription factors (Ge et al., 2013) that are responsible for 
transcription of myogenic ubiquitin ligases: atrogin-1 and muscle ring finger protein 1 (MuRF1) 
(Sacheck et al., 2004).  Therefore, IGF ultimately decreases ubiquitin-proteasome degradation 
which increases protein accumulation and therefore, increases hypertrophy.  
Persistent IGF1 overexpression in skeletal muscle results in increased body weight due to 
increased muscle size.  In mice, IGF1 overexpression increased both body weight and fat-free 
mass by approximately 3 g  (approximately 10% increase body weight and 13% increase in fat-
free mass compared to wild type) (Fiorotto et al., 2003)  In swine, IGF1 overexpression resulted 
in an approximately 2 percentage unit increase in lean percentage at 60kg body weight and 4 
percentage unit increase at 120kg body weight (Pursel et al., 2004).  At market weight, this 
increase in lean percentage would increase lean yield by approximately 4.8 kg.  Multiplied across 
the total number of pigs slaughtered in the United States yearly, the result would be 
approximately 537,600,000 kg of additional lean pork.   Therefore, technologies that exploit the 
IGF mechanism could have large positive effects on skeletal muscle growth and swine 
production.     
MYOSTATIN 
 Myostatin, also known as growth differentiation factor-8, is a negative regulator of 
myogenesis and a member of the TGF-ß superfamily (McPherron et al., 1997).  Myostatin is 
secreted as a 52kDa propeptide (Thomas et al., 2000) and contains three segments common 
among TGF-ß superfamily members: a hydrophobic core of amino acids needed for secretion, a 
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carboxyl terminal region, and a proteolytic processing site that is cleaved to produce the 26kDa 
mature myostatin peptide (McPherron et al., 1997; Thomas et al., 2000).  Myostatin expression is 
first detected in the myotome compartment of developing somites and expression continues in 
muscle throughout life (Lee and McPherron, 1999).  Mice without a functional copy of the 
myostatin gene are two to three times larger than control mice, have approximately 87% more 
skeletal muscle fibers and have larger skeletal muscle fibers (McPherron et al., 1997). Natural 
mutations have been identified in other species such as cattle (Grobet et al., 1998), dogs (Mosher 
et al., 2007), humans (Schuelke et al., 2004), and sheep (Clop et al., 2006) that cause non-
functional or decreased levels of myostatin.  Subjects that do not possess functional myostatin 
alleles or have decreased myostatin levels exhibit increased skeletal muscle mass and decreased 
fat accumulation.   
 Myostatin is secreted by myoblasts or muscle fibers and acts upon local myogenic cells 
as a paracrine growth factor.  Myostatin binds to isoforms of type II activin receptors (ActR-IIA 
or ActR-IIB) (Kollias and McDermott, 2008).  Upon binding, ActR-II forms a heterotetrameric 
complex by binding to a nearby type I receptor (TßRI/ALK-5 or ALK-4).  The type I receptor is 
then phosphorylated by ActR-II on serine and threonine residues, activating type-I kinase that 
leads to Smad path way activation (Kollias and McDermott, 2008).  Type-1 receptors 
phosphorylate either Smad2 or Smad3 (R-Smads) (Philip et al., 2005; Kollias and McDermott, 
2008).  An R-Smad protein oligomerizes with Smad4, translocates to the nucleus, interacts with 
a binding partner and regulates transcription (Attisano et al., 2001; Kollias and McDermott, 
2008; Huang et al., 2011).  However, this process is also impeded by inhibitory Smad (I-Smad) 
proteins, Smad6 and Smad7, and E3 ubiquitin-ligases known as Smurfs.    
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 Myostatin also regulates transcription in a Smad independent manner.  Myostatin binds to 
ActR-II that also activates multiple MAPK pathways (Philip et al., 2005; Yang et al., 2006; 
Huang et al., 2007; Huang et al., 2011).  Myostatin activates Ras (Yang et al., 2006) or TAK1 
(Huang et al., 2007).  Ras activation leads to activation of MEK1 and Erk1/2 (Yang et al., 2006), 
whereas the TAK1 cascade leads to activation of JNK and p38 MAPK (Philip et al., 2005; 
Huang et al., 2007; Huang et al., 2011).  Activation of TAK1, JNK, or p38 MAPK promotes 
their transport to the nucleus where these kinase molecules further activate downstream 
molecules and transcription factors.  Each molecule’s strength of inhibition is not precisely 
known, however, cross-talk between pathways is very important for overall growth and 
myogenic hypertrophy inhibition (Yang et al., 2006).  Furthermore, state of cells seems to play a 
large role in determining the overall effect of myostatin.  Addition of myostatin to proliferating 
cells stops proliferation, whereas myostatin inhibits differentiation when administered to 
differentiating cells.  
MYOSTATIN AND IGF INTERACTION 
 The signaling interactions between myostatin and IGF may play a significant role in 
skeletal muscle development.  The FoxO family of transcription factors are an example of 
proteins that are regulated by both myostatin and the IGF/AKT axis.  The FoxO proteins are 
inactive when phosphorylated and confined to the cytoplasm (Braun and Gautel, 2011).  
Dephosphorylated FoxO proteins translocate to the nucleus and initiate transcription of genes 
that primarily promote protein degradation, such as Murf and Mafbx1 (Sandri et al., 2004).  In 
muscle, active AKT directly phosphorylates FoxO3 and FoxO1 (Ge et al., 2013), the two 
primary FoxO family members expressed in skeletal muscle (Braun and Gautel, 2011).  On the 
other hand, myostatin inhibits FoxO phosphorylation and promotes its expression, therefore 
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increasing active FoxO family members in a Smad dependent mechanism (McFarlane et al., 
2006; Trendelenburg et al., 2009).  With this evidence, it is apparent that myostatin and 
IGF/AKT differentially regulate FoxO3 and FoxO1 in skeletal muscle to control skeletal muscle 
protein turnover.  However, it is unclear if myostatin signaling upstream of AKT decreases AKT 
activity that in turn increases FoxO transcriptional activity, or if myostatin regulates FoxO in an 
AKT-independent mechanism (Figure 1.3).  
 Myostatin may also be responsible for mediating the transcription of IGF2 and IGF1.  
Exogenous myostatin decreases IGF2 but not IGF1 levels in cell culture of bovine longissimus 
dorsi primary myoblasts (Miyake et al., 2010).  However, in vivo studies imply that myostatin 
regulation of IGF2 is fiber type specific.  Expression of IGF2 was increased in soleus muscle of 
myostatin null mice, while IGF2 was unaltered by loss of myostatin in both the gastrocnemius 
and pectoralis.  (Table 1.4) (Kocamis et al., 2002).  Williams et al. also indicated that there was 
no difference in IGF1 expression between wild-type and myostatin null mice in the pectoralis 
major muscle; however, expression of IGF1 was decreased in gastrocnemius muscle of 
myostatin null mice (Table 1.4) (Williams et al., 2011a). Other studies also reported decreased 
IGF1 expression in myostatin-null mice (Gilson et al., 2007).  This decreased expression was 
thought to result from a compensatory increase in IGF2 expression, as IGF1 and IGF2 both elicit 
an effect by interacting with IGF1R; however, IGF2 was not assessed by Williams et al. in adult 
muscles of myostatin knockout mice.   
Myostatin is hypothesized to act upstream of the IGF/AKT axis.  When exogenous TGF-
ß was added to C2 myoblast cultures, proliferation was reduced; proliferation was restored with 
the addition of exogenous IGF2 (Gardner et al., 2011).  Increased myostatin expression in 
proliferating rat L6 myoblasts reduced proliferation and decreased IGF2 expression, while IGF2 
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supplementation partially restored growth (Jin et al., 2006).   This supports the hypothesis that 
myostatin is acting upstream of IGF/AKT signaling pathway, most likely by repressing the 
transcription of IGF2.  In contrast, an in vivo study indicated that IGF1-induced hypertrophy is 
blocked by myostatin overexpression and rescued when AKT is constitutively activated 
(Morissette et al., 2009) suggesting that myostatin inhibits activation of AKT to inhibit growth.  
Therefore the evidence that suggests myostatin regulates IGF2, is inconclusive.   
 Furthermore, myostatin may also regulate expression of IGFBP-3 and IGFBP-5.  Both 
IGFBP-3 and IGFBP-5 inhibit hypertrophy by sequestering IGF1 and IGF2, preventing them 
from binding and activating IGF1R.  Furthermore, IGFBP-3 and IGFBP-5 act autonomously 
from IGF1 and IGF2 and inhibit growth by stimulating an unknown receptor (Cobb et al., 2004).  
Exogenous myostatin and TGF-ß supplementation to porcine embryonic myoblast cultures 
increased IGFBP-3 and IGFBP-5 levels (Kamanga‐Sollo et al., 2003; Kamanga-Sollo et al., 
2005).  Furthermore, immunoneutralization of IGFBP-3 and IGFBP-5 prevented myostatin from 
inhibiting proliferation (Kamanga‐Sollo et al., 2003; Kamanga-Sollo et al., 2005), suggesting 
that myostatin mediates transcription of IGFBP-3 and IGFBP-5 either directly or indirectly by 
altering the expression of another factor such as IGF1 or IGF2 which consequently alters the 
expression of binding proteins.  Similar to IGF2 regulation, in vivo studies indicate that loss of 
myostatin alters IGFBP-3 and IGFBP-5 differentially among fiber types and maturity.  In 
myostatin-null neonates, IGFBP-3 was increased in skeletal muscle compared to wild type mice; 
however, IGFBP-5 was unaltered.  In contrast, in gastrocnemius muscle of 7-month old mice, 
IGFBP-5 was increased in myostatin null mice compared to wild type mice while IGFBP-3 was 
unaltered by loss of myostatin. In the pectoralis muscle of 7-month old mice, IGFBP-3 was 
reduced in myostatin null mice while IGFBP-5 was unaltered (Table3) (Williams et al., 2011).  
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Therefore, similar to IGF2 regulation, myostatin regulation of both IGFBP-3 and IGFBP-5 may 
depend upon fiber type and maturity.  However previous studies which investigate how the loss 
of myostatin affects IGF expression have only considered mice at one age.  Since the expression 
of the IGF family members are differentially regulated over time it is crucial to gain an 
understanding of how the loss of myostatin changes expression throughout varying stages of 
development. 
 The expression of IGF1R may also be differentially regulated by myostatin.  IGF1R 
levels are increased in myostatin-null neonates and adult gastrocnemius muscle compared to wild 
type mice (Table 1.4) (Williams et al., 2011). Increased IGF1R expression may lead to an 
increased number of receptors that may be activated, thereby increasing downstream signaling 
and growth.  Over expression of follistatin, an inhibiting binding protein of myostatin results in 
approximately 37% larger skeletal muscles compared to non-transgenic mice.  However, this 
increase in skeletal muscles size is considerably blunted in mice that have a dominant-negative 
form of IGF1R (Kalista et al., 2012); thereby, implying that IGF1R activation is required for 
follistatin-induced skeletal muscle hypertrophy. 
Current research would suggest that myostatin impedes growth by stimulating the 
expression of IGF1R, IGFBP-3 and IGFBP-5, and inhibiting the expression of IGF2.  Altered 
expression of IGF family members decreases IGF1R stimulation leading to a decrease in AKT 
activation.  Decreased AKT activation then leads to decreased mTOR activation and may lead to 
increased FoxO family member transcription activation, thereby increasing muscle specific 
ubiquitin ligases Murf and Mafbx.  FoxO family members may also increase microRNA-1 
(miRNA-1), which inhibits IGF-1 translation (Elia et al., 2009).  However, most studies indicate 
either unaltered or slightly decreased IGF1 expression in myostatin-null mice compared to wild-
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type mice (Table 1.4) (Kocamis et al., 2002; Gilson et al., 2007; Williams et al., 2011).  Further 
studies are needed to understand how in vivo changes in myostatin expression alters levels of 
IGF1 and IGF2.  Activation of IGF1R by IGF1 and IGF2 is known to inhibit the activity of 
FoxO-3; thereby, ultimately inhibiting the expression of Murf and Mafbx. Myostatin is believed 
to activate FoxO-3; however, the mechanism is not understood.  Two possible explanations are 
that increased myostatin activates downstream targets which directly activate FoxO-3 in an IGF 
independent mechanism (Figure 1.3).  However, another possible explanation is that myostatin 
activity results in decreased IGF transcription thereby decreasing AKT activity and ultimately 
decreasing the IGF/AKT inhibition of FoxO-3 in an IGF dependent mechanism (Figure 1.3).  
Additionally, a better understanding of the expression of IGF family members in response to the 
presence or absence of myostatin is needed.    Research is also needed to identify myostatin 
regulated transcription factors that are ultimately inhibiting or promoting IGF family member 
transcription. 
IGF2 QTL 
 A quantitative trait locus (QTL) is a chromosomal region that contributes to variability of 
a phenotypic trait or traits controlled by multiple genes.  In 1999, two studies intercrossing 
European Wild Boar with Large White domestic pig (Jeon et al.) and Large White with Piétran 
(Nezer et al.) identified a QTL associated with IGF2, which had a major impact on leanness and 
fat deposition.  By comparing a wild-type, Meishan allele to a Large White mutant allele, the 
mutation was determined to be a single nucleotide polymorphism (G to A transition) in intron3 
of the IGF2 gene (IGF2-intron3-3072) (Van Laere et al., 2003).  The mutation improved lean 
meat yield and decreased fatness.  Twenty-four to 30% of the variation in lean percentage in the 
ham and 15% of the variation in loin eye area could be attributed to the G to A transition.  
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Approximately, 10% of the variation in back fat thickness could also be attributed to the 
mutation (Jeon et al., 1999).  The increase in lean meat yield has led to a strong selection for the 
mutation.  Of 46 boars representing eight breeds heavily selected for lean meat production, 72% 
were either heterozygous or homozygous for the A allele.  On the other hand, 32 boars 
representing 6 breeds that had minimal selection pressure for lean meat production were 
homozygous for the wild-type G allele (Van Laere et al., 2003).   The prominent prevalence of 
the mutant allele in the breeds that have been strongly selected for leanness, efficiency, and 
growth implies that the QTL has had a strong impact on the swine industry. 
IGF2 QTL Effect on Body Weight and Lean Meat Yield 
The effect of the IGF2-intron3-G3072A mutation on birth weight is not well understood.  
A study published in 1999 indicated that the mutation had negligible impact on birth weight 
(Jeon et al.).  This was supported by Van Laere et al. (2003) when they indicated that the IGF2 
QTL does not alter pre-natal IGF-2 expression.  However, a more recent study obsereved an 8%  
increase in birth weight for piglets that carry the paternal A allele (Table 1.5) (Van Den 
Maagdenberg et al., 2008).  Increased birth weights have been associated with increased growth 
and feed efficiency at later stages of development (Schinckel et al., 2010).   
Both back fat thickness and muscle accretion are altered by the IGF2 mutation.  In five 
studies, a 7-21% reduction in back-fat thickness was reported in pigs carrying the paternal A 
allele (Table 1.5) (Jeon et al., 1999; Jungerius et al., 2004; Gardan et al., 2008; Van Den 
Maagdenberg et al., 2008; Burgos et al., 2012).  Additionally, a 4-5% increase in loin eye area 
and an 8% increase in estimated carcass lean yield were associated with animals carrying the 
paternal A allele (Jeon et al., 1999; Van Den Maagdenberg et al., 2008; Gardan et al., 2008).  
Reduced fat deposition and increased skeletal muscle accretion did not alter average daily gain 
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(Gardan et al., 2008; Van Den Maagdenberg et al., 2008; Burgos et al., 2012).  However, the 
increased lean deposition and decreased fat deposition did alter feed efficiency.  Pigs carrying 
the paternal A allele had a 0.19 decreased feed to gain ratio compared to pigs which carried the 
paternal G allele (Burgos et al., 2012). 
IGF2 QTL Effect on Meat Quality 
Increased skeletal muscle accretion often is associated with an alteration in meat quality.  
While few studies have investigated how the IGF2 mutation may have altered meat quality, the 
limited available data would suggest that the mutation has little impact on fresh meat quality 
characteristics.  Drip loss, cooking loss, and ultimate pH were not different between carcasses 
that possess a paternal G compared with a paternal A allele (Table 1.6) (Van Den Maagdenberg 
et al., 2008; Burgos et al., 2012).  Color of the longissimus dorsi as measured by L* (Table 1.6) 
(increasing values indicate a whiter color) indicate that paternal A allele may result in paler meat 
(Van Den Maagdenberg et al., 2008; Burgos et al., 2012).  However, the average difference 
between the two studies is less than 1 L* unit, and therefore is likely not meaningful to 
consumers.  Surprisingly, Burgos et al. (2012) noted an increase in intramuscular fat percentage 
within the longissimus dorsi muscle in pigs that carry the paternal A allele.  However, others 
report either a decrease or no change in intramuscular fat deposition in the ham or shoulder due 
to the paternal A allele (Reina et al., 2012; Sánchez del Pulgar et al., 2013).  Furthermore, the G 
to A mutation did not affect tenderness of the longissimus dorsi as measured by Warner-Bratzler 
shear force (A, 33.82 N; G, 33.58 N) (Van Den Maagdenberg et al., 2008).  However, to date no 
studies have been completed in the United States which determines how the IGF2 mutation has 
impacted meat quality.   
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IGF2 QTL Mechanism of Action 
 Pigs carrying a paternal wild-type IGF2 allele have reduced IGF2 expression compared 
to pigs carrying the paternal mutant allele from 3 weeks of age to 6 months.  However, there is 
no difference in IGF2 expression during prenatal time points (Van Laere et al., 2003).   It is 
hypothesized that this increase in IGF2 expression increases skeletal muscle growth and 
decreases fat accumulation.  The mutation which alters IGF2 expression was determined to be a 
G to A transition that occurs in a CpG island with very little methylation in adult skeletal muscle; 
however, in liver approximately 26% of the CpGs were methylated in both genotypes (Van 
Laere et al., 2003).  A CpG island is a segment of DNA with high incidence of cytosine, guanine 
repeats that are susceptible to methylation.  An electrophoretic mobility shift assay (EMSA) 
demonstrated a nuclear factor interacted with unmethylated wild type sequences but not the 
mutant sequence.  Both mutation (G to A) and methylation at the mutation site inhibited this 
interaction (Van Laere et al., 2003). The allele (A) which did not interact with the nuclear factor 
has increased IGF2 levels while the allele that did interact has decreased IGF2 levels, indicating 
that the nuclear factor that interacts with the wild-type quantitative trait nucleotide (QTN), is a 
repressor.  Because IGF2 is unaltered before birth, this suggests that the nuclear transcriptional 
repressor is only interacting with the QTN reducing postnatal IGF2 expression in pigs carrying 
the G allele.  Furthermore, because the expression of IGF2 is unaltered during gestation, the 
increase in growth is likely due to an increase in cross-sectional area rather than an increase in 
myofiber number.   
 With the use of EMSA and transient transfection luciferase reporter analysis, the 
repressor that binds the wild-type allele was determined to be ZBED6, an intronless, alternative 
splice form of Zc3h11a (Markljung et al., 2009).  The ZBED6 protein contains two BED 
19 
 
domains and these domains are encoded 100% homologous in 21 of the 26 mammalian species 
tested (Markljung et al., 2009; Andersson et al., 2010).  Primarily, ZBED6 is expressed in 
skeletal muscle; however, low levels of expression can be detected in other tissues. A promoter 
region, which is thought to initiate transcription of both ZBED6 and ZC3H11A, was found using 
a ChIP analysis.  The promoter region also contains binding sites for many other growth 
promoting transcription factors such as Myc, Jun, Fos, Max, and NF-E2 (Markljung et al., 2009).  
Binding domains for ZBED6 are present in approximately 1,200 annotated genes.  ZBED6 
binding sites were enriched within genes involved in the regulation of biological processes, 
development, transcriptional regulation, neurogenesis, cell-cell signaling, muscle cell 
differentiation, morphogenesis, and muscle development (Markljung et al., 2009) Therefore, 
ZBED6 may have a great impact on muscle development and growth by altering many signaling 
pathways.  However, further research is needed to fully understand the expression ontogeny of 
ZBED6 and how its expression alters growth of livestock species.   
OBJECTIVES 
 The IGF2-intron3-G3072A mutation is prevalent in the pork industry and increases lean 
growth.  However, there are limited data that fully characterize how this mutation alters the 
growth of pigs over time, and how this change may affect meat quality such as Warner-Bratzler 
shear force, ultimate pH and objective color.  In addition, there is little information about how 
the mutation affects expression of other growth factors such as myostatin, IGF1 and other IGF 
family members in skeletal muscle from gestation to market weight.  Therefore, our first 
objective is to fully characterize the effect of the mutation on skeletal muscle growth, meat 
quality and the expression of other growth factors.   
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 Our second objective is to identify how myostatin and IGF family members regulate each 
other to ultimately regulate skeletal muscle growth.  The hypothesis that myostatin inhibits 
skeletal muscle growth by reducing expression of IGF2 and IGF1R and promoting the 
expression of IGF binding proteins will be tested by using myostatin-null mice.  This model will 
allow us to determine how the expression of IGF family members is changed in the absence of 
endogenous myostatin.  
 By gaining a greater understanding of both the IGF2-intron3-G3072A and the myostatin 
loss-of-function mutations, which increase skeletal muscle growth, we may be able to predict if 
the mutations together are additive or if they are ultimately altering the same pathway at different 
points to elicit the same growth response.   
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TABLES 
  
Table 1.1 Comparison of binding affinities of insulin and insulin-like growth factor (IGF) ligands to receptors. 
  Affinities 
IGF1R IGF1 >> IGF2 >> Insulin 
IGF2R IGF2 >> IGF1 
IR-A Insulin > IGF2 
IR-B Insulin >> IGF1 
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Table 1.2  Weight at birth for mice lacking functional IGF2, IGF1R and/or 
IGF2R 
Genotype 
Average 
Weight Percentage of Wild Type 
Normal 1.22 
 Lacking IGF2 0.75 61.5% 
Lacking IGF1R
a
 0.56 45.9% 
Lacking IGF2R
b
 1.71 140.0% 
Lacking IGF2 and IGF1R 0.41 33.6% 
Lacking IGF2 and IGF2R 0.9 73.8% 
Lacking IGF1R and IGF2R 1.28 104.9% 
Lacking IGF2, IGF1R and IGF2R 0.42 34.4% 
a
Neonatal Lethality 
  bPerinatal Lethality 
  Adapted from Ludwig et al., 1996 
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Table 1.3 Binding affinity of IGF signaling proteins to IGF binding 
proteins. 
ka x 10
5
M
-1
s
-1
 IGF-1 
 
IGF-2 
        
IGFBP-1 0.12 ± 0.01 
 
0.32 ± 0.04 
IGFBP-2 0.55 ± 0.12 
 
1.04 ± 0.22 
IGFBP-3 9.12 ± 1.65 
 
17.0 ± 3.79 
IGFBP-4 2.15 ± 0.29 
 
2.20 ± 0.46 
IGFBP-5 5.82 ± 1.03 
 
12.1 ± 1.34 
IGFBP-6 3.02 ± 0.36   3.26 ± 0.71 
Adapted from Wong, Fong, Yang 
(1999) 
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Table 1.4 IGF family member expression in myostatin null vs. wild type mice 
  IGF1   IGF2   IGF1R   
IGFBP-
3   
IGFBP-
5 
                    
Kocamis et al. 
         Adult Heart = 
 
= 
 

    Adult Liver = 
 
ND 
 
= 
    Soleus ND 
 


= 
   Gastrocnemius =a 
 
=
a
 
 
= 
    Pectoralis = 
 
= 
 

    Williams et al. 
         Neonate Heart = 
 




= 
 
= 
Adult Heart = 
   


= 
 
= 
Neonate Liver 

= 
 





Adult Liver 
   
= 
 


= 
Neonatal Skeletal Muscle
b
 = 
 
= 
 




= 
Gastrocnemius 
   


= 
 

Pectoralis =       =     = 
=, No significant differece; ND, mRNA expression not detected 
Upward arrows indicate that myostatin null mice had increased expression 
Downwards arrows indicate that myostatin null mice had decreased expression 
Empty cells indicate that expression was not evaluated 
a
mRNA expression was detected, but at very low levels 
b
Skeletal muscle from hind limb 
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Table 1.5 Summary of IGF2 QTL effect on growth 
Trait     
 
Study; Breed (n = # within genotype) Apat 
 
Gpat P-Value 
            
Birth Weight (kg) 
    
 
Jeon et al., 1999; Large White x Wild Boar (n = 43) NR
d
 
 
NR
d
 >0.05 
 
Van den Maagdenberg et al., 2008; Commercial Cross (n ≥ 62) 1.66 
 
1.53 < 0.05 
      Carcass Length (cm) 
    
 
Van den Maagdenberg et al., 2008; Commercial Cross (n ≥ 62) 83.4 
 
83.5 > 0.1 
      Average Daily Gain (kg/day) 
    
 
Gardan et al., 2008; LargeWhite x Landrace ( n ≥ 5) 0.53 
 
0.56 0.78 
 
Van den Maagdenberg et al., 2008; Commercial Cross (n ≥ 62) 0.57 
 
0.57 > 0.05 
 
Burgos et al., 2012; Large White/Landrace Cross x Duroc (n ≥ 68) 0.8 
 
0.8 > 0.05 
      Backfat Thickness (mm) 
    
 
Gardan et al., 2008; LargeWhite x Landrace ( n ≥ 5)a 30 
 
34 0.08 
 
Van den Maagdenberg et al., 2008; Commercial Cross (n ≥ 62)b 14.9 
 
18.85 < 0.005 
 
Burgos et al., 2012; Large White/Landrace Cross x Duroc (n ≥ 68) 19.09 
 
23.09 < 0.0001 
 
Jeon et al., 1999; Large White x Wild Boar (n = 43) 25.5 
 
27.7 < 0.05 
 
Jungerius et al., 2004; Meishan/Large White/Landrace Cross (n ≥ 344)c 20.8 
 
22.4 NR
d
 
      
Loin Eye Area (cm
2
) 
    
 
Van den Maagdenberg et al., 2008; Commercial Cross (n ≥ 62)b 56.49 
 
53.64 < 0.005 
 
Jeon et al., 1999; Large White x Wild Boar (n = 43) 34.5 
 
33 < 0.05 
      Estimated Carcass Lean Yield (%) 
    
 
Gardan et al., 2008; LargeWhite x Landrace ( n ≥ 5)a 61 
 
56 < 0.01 
  Van den Maagdenberg et al., 2008; Commercial Cross (n ≥ 62)b 58.1   53.6 < 0.005 
a
Measurement was the mean of the estimate taken at the last rib and last lumbar by an optic light probe 
measuring light reflectance 
b
Measurement was taken at the third and fourth last rib by an optic light probe measuring light reflectance 
c
Measurement was taken between the third and fourth rib with a probe. 
d
Not Reported 
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Table 1.6 Summary of IGF2 QTL effect on meat quality 
Trait     
 
Study; Breed (n = # within genotype) Apat 
 
Gpat P-Value 
            
pH - Longissimus Dorsi 24 hours after exsanguination 
    
 
Burgos et al., 2012; Large White/Landrace Cross x Duroc (n ≥ 68) 5.62 
 
5.64 > 0.05 
 
Van den Maagdenberg et al., 2008; Commercial Cross (n ≥ 62) 5.54 
 
5.54 > 0.1 
      
Longissimus Dorsi L*
a
 
    
 
Burgos et al., 2012; Large White/Landrace Cross x Duroc (n ≥ 68) 50.77 
 
49.65 < 0.05 
 
Van den Maagdenberg et al., 2008; Commercial Cross (n ≥ 62) 54.87 
 
54 0.065 
      
Longissimus Dorsi a*
b
 
    
 
Burgos et al., 2012; Large White/Landrace Cross x Duroc (n ≥ 68) 6.3 
 
6.45 > 0.05 
 
Van den Maagdenberg et al., 2008; Commercial Cross (n ≥ 62) 5.29 
 
5.79 < 0.05 
      
Longissimus Dorsi b*
c
 
    
 
Burgos et al., 2012; Large White/Landrace Cross x Duroc (n ≥ 68) 1.59 
 
1.43 > 0.05 
 
Van den Maagdenberg et al., 2008; Commercial Cross (n ≥ 62) 14.91 
 
15.22 > 0.1 
      Longissimus Dorsi Intramuscular Fat (%) 
    
 
Burgos et al., 2012; Large White/Landrace Cross x Duroc (n ≥ 68) 3.08 
 
2.77 < 0.05 
      Drip Loss (%) 
    
 
Burgos et al., 2012; Large White/Landrace Cross x Duroc (n ≥ 68)
d
 8.96 
 
8.38 > 0.05 
 
Van den Maagdenberg et al., 2008; Commercial Cross (n ≥ 62) 4.04 
 
3.79 > 0.1 
      Cooking Loss (%) 
    
 
Burgos et al., 2012; Large White/Landrace Cross x Duroc (n ≥ 68) 34.79 
 
34.42 > 0.05 
  Van den Maagdenberg et al., 2008; Commercial Cross (n ≥ 62) 21.12   21.73 > 0.1 
a
Black to White 
b
Green to Red 
c
Blue to Yellow 
d
6 Day drip loss 
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FIGURES 
Figure 1.1 
 
  IGF1 binds to IGF1R to elicit a response.  IGF1R activates both IRS-1, 
and GRB2.  While redundant responses have been noted from both active 
pathways, IRS-1 activation is primarily responsible for increasing myogenic 
markers, myogenin and MRF4, and decreasing protein degradation.  GRB2 
activation is responsible for satellite cell activation.  Both pathways converge to 
increase protein synthesis by inhibiting the TSC complex, an mTOR inhibitor.   
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Figure 1.2 
 
   Activation of mTORC1 leads to the inhibition of 4E-BP1.  Eukaryotic 
translation initiation factors then bind to the 5’ untranslated region of the mRNA 
strand.  After binding the elongation process will begin. (Figure from Ma and Blenis, 
2009) 
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A. 
 
B. 
 
 
 Previous studies provide evidence that suggests, IGF1 
activates AKT, which inhibits FoxO-3.  FoxO-3 increases the 
expression of Murf and Mafbx1, two muscle specific ubiquitin 
ligases.  It is currently not known if myostatin signaling may be 
responsible for (A) directly activating FoxO-3 or (B) if myostatin 
indirectly acts on FoxO-3 by altering expression of IGF family 
members. 
Figure1.3 
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Chapter 2 
EFFECTS OF THE PORCINE IGF2 INTRON3-G3072A MUTATION ON CARCASS 
CUTABILITY, MEAT QUALITY AND BACON PROCESSING 
 
ABSTRACT 
A SNP in a regulatory region of intron 3 within the porcine IGF2 gene (IGF2- G3072A) is 
associated with increased lean deposition and decreased fat deposition in pigs with paternal A 
alleles (A
Pat
) compared with pigs with paternal G alleles (G
Pat
). However, data regarding fresh 
and processed meat quality characteristics of pigs with different alleles for this polymorphism 
are limited. A single heterozygote (AG) boar was bred to homozygous (AA) commercial 
Yorkshire-cross sows producing F1 barrows and gilts with either G
Pat
 or A
Pat
. Two farrowing 
groups of barrows and gilts were group housed, provided ad libitum access to a diet that met or 
exceeded NRC nutrient recommendations throughout production, and were slaughtered at 176 d 
(+/- 4 d) of age. Fresh LM quality and estimated percent fat-free lean measurements were taken 
on the left-side of carcasses, while carcass cutouts were completed with right-sides.  Fresh belly 
and bacon processing traits were characterized for only block 1 pigs. Pig was treated as the 
experimental unit for all analyses. Ending live weight and HCW were not affected by IGF2 
allele; however, tenth rib back fat thickness was 0.41 cm less (P = 0.01), loin eye area was 4.0 
cm
2
 greater (P = 0.01), and predicted fat free lean was over 2 percentage units greater (P < 0.01) 
in A
Pat
 pigs compared with G
Pat
 pigs. Furthermore, boneless lean cuts from the shoulder, loin and 
ham were heavier (P < 0.05) in A
Pat
 pigs compared with G
Pat
 pigs. Minolta L* value was 2.36 
units greater (P = 0.03), but cooking loss was 1.82 percentage units greater (P < 0.01) in A
Pat
 
pigs compared with G
Pat
 pigs. Additionally, despite reductions in subcutaneous fat, extractable 
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intramuscular lipid from the LM was 0.64 percentage units greater (P = 0.02) in A
Pat
 pigs 
compared with G
Pat
 pigs. Bellies were 7.17 mm thinner (P = 0.01), had 7.27 cm less flop distance 
(P = 0.05), and tended to have 1.34 units greater iodine value (P = 0.09) in A
Pat
 pigs compared 
with G
Pat
 pigs. While not statistically different (P = 0.30), the magnitude of difference in slicing 
yield as a percentage of green weight was 1.57 percentage units between bellies from A
Pat
 pigs 
(85.83%) and bellies from G
Pat
 pigs (87.40%). Pigs with G
Pat
 alleles had superior belly quality 
that may positively impact commercial bacon production. However, pigs with A
Pat
 alleles 
yielded a greater amount of lean product at the expense of producing lighter LM color and 
increased cooking loss. 
Key Words:  belly quality, carcass cutout, IGF2-G3072A, insulin-like growth factor, pig, single 
nucleotide polymorphism  
 
INTRODUCTION 
Mutations that improve carcass lean yield are often associated with reduced meat quality.  
Two such examples are the ryanodine receptor mutation and the Rendement Napole mutation 
that increase loin eye area and reduce back fat depth but reduce loin quality by reducing water 
holding capacity (Oliver et al., 1993; Rosenvold and Andersen, 2003).  As a result of the poor 
meat quality resulting from these mutations, their prevalence has been reduced in US commercial 
swine.  
A SNP within intron 3 of insulin-like growth factor 2 (IGF2) identified as IGF2-G3072A 
(Van Laere et al., 2003) has a considerable impact on lean yield, accounting for up to 20% of the 
variation in backfat thickness and up to 30% of the variation in muscle mass (Jeon et al., 1999; 
Nezer et al., 1999). This substitution disrupts a ZBED6 repressive binding domain resulting in 
increased postnatal IGF2 expression in pigs with the paternal mutant (A) allele, as IGF2 is 
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maternally imprinted (Markljung et al., 2009).  Back fat was reduced up to 20% and loin eye area 
increased up to 5% in pigs with a paternal A allele (A
Pat
) compared with pigs with a paternal G 
(G
Pat
) allele (Jeon et al., 1999; Burgos et al., 2012; Van Den Maagdenberg et al., 2008). Despite 
these increases in lean yield, unlike other growth-promoting mutations, the limited data available 
suggest the IGF2 mutation has little influence on meat quality (Burgos et al., 2012). 
Lean primal cut yield (loin, ham, and shoulder) increased 1.43 percentage units, but the 
belly primal yield was reduced 0.46 percentage units in A
Pat
 pigs compared with G
Pat
 pigs 
(Burgos et al., 2012). Furthermore, PUFA content was greater in dry-cured hams and shoulders 
from A
Pat
 pigs compared with G
Pat
 pigs (Reina et al., 2012). This suggests that G
Pat
 pigs may 
have thicker and firmer bellies and may be selected as a means to improve bacon slicability and 
processing yields. Selection of G
Pat
 alleles however would be expected to reduce lean meat yield 
from carcasses. Therefore, the objectives of this study were to characterize carcass cutability of 
pigs with differential IGF2 alleles and determine how the mutation affects fresh meat quality and 
bacon processing. 
MATERIALS AND METHODS 
 All experimental animal procedures were approved by the University of Illinois 
Institutional Animal Care and Use Committee.    
Animals 
A single IGF2-G3072A heterozygous (AG) Berkshire boar was bred to homozygous 
(AA) commercial Yorkshire cross females.  Therefore, offspring that were heterozygous for the 
IGF2 mutation received and expressed the G
pat
 allele, while homozygous AA offspring 
expressed the A
pat
 allele.  Pigs were weighed at birth, given 200 mg of iron dextran, and 0.2 ml 
40 
 
of a broad spectrum antibiotic.  Additionally, ears were notched, needle teeth snipped, tails 
removed, and males were castrated following typical industry practices (FASS, 2010).   
A skin sample from the ear notch was placed in DNA extraction buffer (Miller et al., 
1988) for genotyping after birth.  Isolation of DNA was completed with a Quick-gDNA isolation 
kit (Zymo Research, Irvine, CA) following manufacturer procedures.  Animals were genotyped 
by either direct Sanger sequencing or by addition of a restriction enzyme, ApeK1 (New England 
BioLabs Inc., Ipswich, MA), after PCR amplification.  Genotyping by PCR was completed with 
the HotStarTaq Plus DNA Polymerase (Qiagen, Valencia, CA) in accordance to manufacturer’s 
instructions with the addition of the optional Q buffer.  Primer sequences were: Forward IGF2 
Primer 5’-CGGACCGAGCCAGGGACGA-3’; Reverse IGF2 Primer 5’- GCCGGCTGGAA 
GGGAGGAA-3’.  Thermocycler (BioRad, Hercules, CA or ABI-Life Technologies, Grand 
Island, NY) program conditions were:  95°C for 5 min followed by 34 cycles of 94°C for 45s, 
64°C for 45s, 72°C for 1 min followed with a termination schedule: 72°C for 5 min and 10°C for 
5 min.  The products were then digested with ApeK1 at 75°C for 30 min.   
Diets are presented in supplementary Table 2.7.  Piglets were supplemented with a milk 
based creep diet at 10 days of age (phase 1).  Piglets were weaned at 21 days of age and 
continued on the phase 1 diet.  Piglets were switched to phase 2 and phase 3 diets, respectively at 
30 and 40 days of age.  Ad libitum access to nursery diets were provided in a multi-hole stainless 
steel feeder and water was provided through a nipple system.  Pigs were moved to the finishing 
barn at 90 days of age and were switched to the first grower ration (grower 1).  Pigs were 
switched to the second grower (grower 2) ration when the average weight of the pigs in the barn 
reached 50 kg.  When the average weight of the pigs in the barn reached 80 kg, the ration was 
switched to the finishing diet for the remaining feeding period.  Ad libitum access to the feed in 
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the finishing barn was provided through a 5-hole pig feeders and water was provided with a 
nipple system. 
Pigs were slaughtered at 176 days (+/- 4) of age by head to heart electrical stunning and 
exsanguination under federal inspection at the University of Illinois Meat Science Laboratory.  
Industry-typical slaughtering procedures were used.  A total of 49 pigs were slaughtered in two 
blocks, the first block of 35 pigs was slaughtered in August and the second block of 14 pigs was 
slaughtered in December.  Carcasses were chilled at 4°C for at least 24 h before quality and yield 
measurements were recorded.  In total, there were 15 male G
Pat
 pigs, 14 male A
Pat
 pigs, 5 female 
G
Pat
 pigs and 15 female A
Pat
 pigs slaughtered.  
Estimated Percent Fat-Free Lean 
 Left-side carcasses were split between the 10
th
 and 11
th
 rib to expose the LM twenty-four 
hours after slaughter.  Back fat was measured at a point ¾ the length of the exposed LM from the 
midline on the left side of the carcass.  Perimeter of the LM was traced with a black fine tip 
marker onto double-matted acetate paper and traced with an Intuos 4 Wacom tablet (PTK-840; 
Tokyo, Japan) and the area was determined in Adobe Photoshop (CS6; Adobe Systems Inc., San 
Jose, CA).  Hot carcass weight, back fat thickness and LM area were used in the following 
equation to determine estimated percent fat-free lean (AMSA, 2001). 
 Pounds of Fat-Free Lean = 8.588 – (21.896   10th Rib Fat Depth, in) + (.465   hot 
Carcass Weight, lb) + (3.005   Loin Eye Area, sq. in.) 
 Lean Percentage = Pounds of Fat-Free Lean / Hot Carcass Weight, lb 
Pork Quality Analyses 
 In accordance to the National Pork Producers Council guidelines, subjective color 
(NPPC, 1999), marbling (NPPC, 1999) and firmness (NPPC, 1991) scores were assigned to the 
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LM.  Objective L*, a* and b* color scores were determined using a Minolta CR-400 with a D65 
light source, 0° observer and 8mm aperture (Minolta Camera Co., Osaka, Japan).  The pH was 
measured in the center of the exposed LM with a glass electrode fitted to a pH-star probe (SFK 
Technologies Inc., Cedar Rapids, IA).  An approximately 20 cm loin section posterior to the split 
surface was removed from the carcass.  First, a 2.54 cm chop was removed from the loin section 
for proximate analysis determination and frozen at -20°C for further analysis.  Next, an 
approximately 0.64 cm slice was removed for drip loss determination.  Five 2.54 cm chops were 
then removed for Warner-Bratzler shear force analysis.   
All subcutaneous fat was trimmed from chops for proximate analysis and then 
homogenized with a food processor.  Moisture and lipid content was quantified with the use of 
chloroform-methanol as described by Novakofski et al. (1989).  Drip loss slices were weighed, 
suspended from a hook in a whirl-pak bag for 24 h and then weighed again to determine percent 
moisture loss.  Chops for Warner-Bratzler shear force were held at 4°C for 1, 3, 7, 14, or 21 days 
and then frozen and held at -30°C.  Warner-Bratzler analysis was then completed as described by 
Dilger et al. (2010).   
Carcass Fabrication 
 Right sides of the carcasses were fabricated approximately 24 h after slaughter.  Sides 
were weighed immediately before fabrication.  Excess leaf fat and other internal adipose tissue 
were removed, weighed and subtracted from the entire side weight to determine chilled side 
weight.  All primals and subprimals were fabricated in accordance to the North American Meat 
Processor’s Meat Buying Guide (NAMP, 2010).  Carcasses were then split into bone-in primals:  
ham, whole belly, loin, shoulder, and jowl to determine bone-in primal yield.   
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Ham.  Bone-in hams were then skinned and trimmed to 0.6 cm of external fat (NAMP 
#402) and weighed.  Trimmed hams were then fabricated into five piece boneless hams: inside 
(NAMP #402F), outside (NAMP #402E), knuckle (NAMP #402H), shank, and lite butt.  
External fat was denuded from the insides, outsides, and knuckles.  Each piece was then weighed 
individually.   
Belly.  Whole sparerib-in bellies were fabricated to separate the spareribs (NAMP #416) 
and natural fall bellies.   
Loin.  Skin-on, bone-in loins were skinned and trimmed to 0.6 cm of external fat to meet 
the specifications for a trimmed, bone-in loin (NAMP #410).  Trimmed loins were weighed and 
cut into back ribs (NAMP #422), Canadian back loins (NAMP #414), sirloins (gluteus medius/ 
gluteus accessorius), and tenderloins (NAMP #415A).   
Shoulder.  The whole shoulders were split into bone-in boston butts and picnic 
shoulders.  Boston butts were trimmed to expose the trapezious muscle (NAMP #406) and then 
the bone was removed to yield a boneless Boston butt (NAMP #406A).  Lastly, bones were 
removed from the bone-in picnic shoulder to yield a boneless picnic shoulder (NAMP #405A).   
Cutting Yields 
The weights of the bone-in, trimmed loins, hams, Boston butts, and picnic shoulders were 
summed to determine bone-in lean cutting yield as a percentage of chilled side weight.  The 
same bone-in cuts with the addition of the whole belly were summed to determine bone-in 
carcass cutting yield.  The weights of the five boneless ham pieces, boneless Canadian loin, 
sirloin, tenderloin, boneless Boston butt and boneless picnic shoulder were summed to determine 
boneless lean cutting yield as a percent of the chilled side weight.  The same boneless cuts with 
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addition of the natural fall belly were summed to determine boneless carcass cutting yield as a 
percent of the chilled side weight.   
Fresh Belly Characteristics 
 Fresh belly and bacon characteristics were only obtained on bellies from pigs included in 
block 1.  Natural fall bellies from the right side of the carcass were placed on a table, covered, 
and allowed to equilibrate overnight at 4°C.  Fresh belly characteristic data were collected in a 
similar manner to Boler et al. (2012).  Belly measurements (length, width, thickness at eight 
points, skin-on untrimmed weight, and flop distance) were obtained.  After fresh evaluation, 
bellies were vacuumed packaged (two bellies per bag), boxed, and stored frozen at -30°C for 
later bacon production. 
 Fatty acid samples containing three layers of fat were collected from the dorsal anterior 
edge of the belly before freezing.  Samples were frozen in liquid nitrogen before being 
pulverized in a blender (Warin Products, Torrington, CT).  The resulting powder was collected 
and used to obtain fatty acid methyl esters (FAME) according to the methodology described by 
AOCS official method Ce 2-66 (1998).  Subsequently, FAME were analyzed using a gas 
chromatograph (Hewlett Packard 5890 series II) equipped with an auto-sampler and a DB-wax 
capillary column (30 m × 0.25mm × 0. 25 µm film coating,  Agilent Technologies, Santa Clara, 
CA).  The equipment was operated under a constant pressure at 1.30 Kg/cm2 using helium as the 
carrier gas and a 99:1 split ratio.  Temperatures of the injector and of the flame-ionization 
detector were held constant at 250°C and 260°C, respectively.  The oven was operated at 170°C 
for 2 min (programmed temperature to increase 4° C /min up to 240°C and then held constant for 
12.5 min).  Chromatographs from FAME were integrated using Agilent Chemstation software 
for gas chromatograph systems (Version B.01.02, ®Agilent Technologies, Inc.).  Peaks were 
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identified using a gas chromatograph reference standard (GLC 68 from Nu-check-prep, Elysian, 
Mn).  Fatty acids were normalized so that the area of each peak was represented as a percentage 
of the total area.  Iodine values (IV) were calculated with the following equation:    
     (    )       (    )       (     )       (     )       (      
     (     ) (AOCS, 1998). 
Bacon Processing 
 Bellies (n = 35) were allowed to thaw for 72 h at approximately 4°C.  Bellies were 
skinned using a hand-held skinner (S-1011 Best and Donovan; Cincinnati, OH).  A durometer 
(Electromatic Equipment Co., Inc. Cedarhurts, NY) was used to measure belly firmness on the 
middle of the fat side of the belly (internal temperature 4°C) after the skin was removed.  Bellies 
were transported to a commercial bacon processing facility and were processed at the facility in 
the same manner as described by Tavárez et al. (2014).  Bellies were processed using standard 
operating protocols of the commercial bacon processing facility.  In short, bellies were pumped 
using a cure solution that delivered a target of 1.50% sodium chloride at a 13% pump uptake.  
Bellies were then cooked using a step-up cooking cycle for approximately 4 h with bellies 
reaching an internal temperature of 53°C.  Bellies were frozen to -6°C, sliced and pressed.  
Unusable ends and incomplete slices were sorted and removed by trained plant personnel.  Ends 
and pieces were calculated as the difference between trimmed, cooked weight and sliced weight.  
Sliced bellies were boxed individually maintaining anatomical orientation (blade to flank end) 
and transported back to the Meat Science Laboratory at the University of Illinois for further 
evaluation. 
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Bacon Slice Characteristics 
 Bacon slice characteristic data were collected in a similar manner to Tavárez et al. 
(2014).  Sliced weights were collected to determine a bacon slicing yield.  Three slicing yield 
equations were used:  one was based on green weight, which accounted for variability due to raw 
materials and variability due to the manufacturing process; one was based on cooked weight, 
which removed the variability due to the manufacturing process; one was based on trimmed, 
cooked weight, which only accounted for the variability in slices not meeting trained plant 
personnel criteria as usable slices.   
 Slices were counted to determine the number of saleable slices.  Slices were then 
separated into five equal portions based on anatomical orientation (zone A, B, C, D, and E) with 
zone A representing the anterior (blade) end and zone E representing the posterior (flank) end , 
as described in Kyle et al. (2014) and Tavárez et al. (2014).  Moisture and lipid content on the 
collection of one slice from each of the five zones were determined in the same manner as 
described by Boler et al. (2011).  Image analysis on one slice from zone A, C, and E was 
determined in the same manner as described by Boler et al. (2011) and Tavárez et al. (2014). 
Statistical Analysis 
 Data were analyzed using pig as the experimental unit in the mixed procedure of SAS 
(SAS Inst., Cary, NC) as a randomized complete block design.  Pig served as the experimental 
unit because treatment (genotype) was applied to the pig.  The fixed effects were genotype and 
sex and their interaction.  Waner-Bratzler shear force was analyzed with the fixed effects of 
genotype, sex, and aging time.  Data were blocked by litter to account for variation attributable 
to the dam.  Due to variation in litter size and distribution of sex and genotype within litter, the 
representation of genotype and sex were not balanced.  A total of 49 pigs were used in the 
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carcass and fresh loin portion of the study, of those, 29 carried A
Pat
 and 20 carried G
Pat
 and 20 
pigs were gilts and 29 were barrows.  A total of 35 pigs were used in the fresh belly and bacon 
processing characteristic portion of the study, of those 19 carried A
Pat
 and 16 carried G
Pat
 and 17 
pigs were gilts and 18 were barrows.  The probability of difference option (PDIFF) was used to 
determine differences in least square means.  Differences were considered statistically different 
at the level of P < 0.05 and considered trends at 0.05 ≤ P < 0.10.   
RESULTS AND DISCUSSION 
Carcass Characteristics 
Ending live weights, HCW, and dressing percentages were not different (P ≥ 0.29) 
between pigs with A
Pat
 alleles and G
Pat
 alleles (Table 2.1).  Tenth rib back fat thickness was 14% 
less in (P = 0.01) in A
Pat
 pigs compared with G
Pat
 pigs.  Loin eye area was 10% greater (P = 
0.01) in A
Pat
 pigs compared with G
Pat
 pigs.  Previous studies (Jeon et al., 1999; Van Den 
Maagdenberg et al., 2008) reported loin eye area was 4-5% greater in A
Pat
 pigs compared with 
G
Pat
 pigs.  The population of pigs in the current study had a greater magnitude of difference in 
loin eye area compared with previous reports.  This may be attributable to the differences in 
international genetics and management practices.  Reduced tenth rib back fat thickness and 
greater loin eye area resulted in a 2.5 percentage unit greater (P < 0.01) estimated fat-free lean in 
A
Pat
 pigs compared with G
Pat
 pigs.  Although different prediction equations were used, previous 
studies (Gardan et al., 2008; Van Den Maagdenberg et al., 2008) also reported estimated carcass 
lean yield was greater in A
Pat
 pigs compared with G
Pat
 pigs.  These data suggest this IGF2 
polymorphism did not alter weight gain but instead shifted nutrient partitioning from fat depots 
into lean muscle.  
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Fresh Loin Quality 
Ultimate pH, drip loss, subjective color, subjective marbling, and subjective firmness 
scores were not different (P ≥ 0.25) in APat pigs and GPat pigs (Table 2.2).  Previous studies (Van 
Den Maagdenberg et al., 2008; Burgos et al., 2012) also reported ultimate pH and drip loss were 
not different between A
Pat
 pigs and G
Pat
 pigs.  Minolta L* was 2.36 greater (P = 0.03; lighter) in 
A
Pat
 pigs compared with G
Pat
 pigs.  A 2 unit differential in Minolta L* score was determined as 
identifiable by consumer panelists (Zhu and Brewer, 1999).  Albeit, in the current population of 
pigs, A
Pat
 pigs (51.1 Minolta L* score is typically associated with a NPPC score between 2 and 
3; NPPC, 1999) had acceptable quality.  Greater challenges with color could become apparent in 
genetic lines and management programs more susceptible to quality issues.  Cooking loss was 
1.8 percentage units greater (P < 0.01)  in chops from A
Pat
 pigs compared with G
Pat
 pigs.  This 
contradicts previous studies (Van Den Maagdenberg et al., 2008; Burgos et al., 2012) that have 
reported no differences in cooking loss between genotypes. 
Moisture percentage of the LM, as determined by proximate composition analysis tended 
to be less (P = 0.09) in A
Pat
 pigs compared with G
Pat
 pigs.  Despite reduced tenth rib back fat 
thickness, extractable lipid in the LM was 0.64 percentage units greater (P = 0.02) in A
Pat
 pigs 
compared with G
Pat 
pigs.  In agreement, previous studies (Burgos et al., 2012; Oczkowicz et al., 
2012) reported greater intramuscular fat in the LM.  This suggests that IGF2 may be a candidate 
gene for differential regulation of subcutaneous and intramuscular fat deposition.  Gardan et. al. 
(2006) indicated intramuscular adipocytes from pigs had 2.3 fold greater IGF2 expression 
compared with subcutaneous adipocytes.  Additionally, IGF2 was greater in adipocytes from 
pigs that had a greater percentage of extractable intramuscular lipid (Aslan et al., 2012). 
Together this suggested IGF2 promotes intramuscular fat deposition.  It can be further 
hypothesized, the IGF2-G3072A SNP resulted in greater intramuscular adipocyte IGF2 
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expression.  Concurrently, IGF2 expression was not increased in subcutaneous adipocytes.  
Alternatively, IGF2 was increased in both intramuscular and subcutaneous adipocytes; however, 
the increased IGF2 expression did not affect subcutaneous adipocytes in the same manner that it 
affects intramuscular adipocytes.  Burgos et. al. (2012) reported reduced intermuscular fat in the 
ham of A
Pat
 pigs compared with G
Pat 
pigs, thereby suggesting that intermuscular adipose may be 
regulated by IGF2 similar to subcutaneous depots.  Additional research is needed to fully 
understand how IGF2 differentially affects the adipose depots.   
 There were few differences in fresh pork quality parameters between barrows and gilts.  
Marbling scores and extractable lipid were reduced (P < 0.01) in gilts compared with barrows.  
Previous studies had reported less marbling and extractable lipid in gilts compared with barrows 
(Uttaro et al., 1993; Cisneros et al., 1996; Fernandez-Duenas et al., 2008).  Additionally, 
moisture was greater (P = 0.01) in gilts compared with barrows. 
 As expected, Warner-Bratzler shear force decreased over time for both genotypes (P < 
0.01); however, was unaffected by genotype at all aging time points (P ≥ 0.11; Fig 1A).  In 
agreement, Van den Maagdenberg et al. (2008) reported tenderness was unaffected by 
IGF2genotype.  Additionally, the majority of the chops in the current study would be considered 
very tender.  Shear force was less than 3.0 kg in 86% of the chops evaluated at 21 days of aging.  
Warner-Bratzler shear force of chops from gilt carcasses were not different (P > 0.18) from 
chops from barrow carcasses with the exception at 14 d of postmortem aging (figure 1B).  At 14 
d of postmortem aging, shear force was greater (P = 0.05) in chops from gilt carcasses compared 
with chops from barrow carcasses.  
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Carcass Cutout 
 There was no affect (P = 0.23) on standardized chilled side weight from either genotype 
or sex (Table 2.8).  Whole loin weights and whole loin percentage of chilled side weight were 
not different (P ≥ 0.27) between genotype.  Likewise loin weight was unaffected by sex, 
however, when expressed as a percentage of chilled side weight, whole loin percentage was 
reduced (P < 0.01) by 1.5 percentage units in gilts compared with barrows.  Trimmed loin 
weights of A
Pat
 pigs were nearly 1 kg (9.8%) heavier (P = 0.01) than G
Pat
 pigs.  This resulted in a 
1.38 percentage unit increase (P < 0.01) in trimmed loin percent of chilled side weight in A
Pat
 
pigs compared with G
Pat
 pigs.  Boneless Canadian back loins from A
Pat
 pigs were 12.8% (0.44 
kg) heavier (P < 0.01) and were 0.69 percentage units greater (P < 0.01) as a percentage of 
chilled side weight compared with G
Pat
 pigs.  Tenderloin weights were greater (P = 0.05) in A
Pat
 
pigs compared with G
Pat
 pigs.  However, when expressed as a percentage of chilled side weight 
there was no effect (P = 0.17) of genotype.  Sirloin weights and sirloin weights as percentage of 
chilled side weight were unaffected (P ≥ 0.25) by genotype.  Back rib weights and back rib 
percentages expressed as a percentage of chilled side weight were greater (P = 0.05) in A
Pat
 pigs 
compared with G
Pat
 pigs.  
 Untrimmed, whole shoulder weights were unaffected by genotype (P = 0.24) or sex (P = 
0.23).  On the other hand, upon fabrication, the jowl, a fattier cut, weighed 12.8% less (P = 0.01) 
in carcasses from A
Pat
 pigs compared with G
Pat
 pigs.  Additionally, this reduction in jowl weight 
resulted in a 0.49 percentage unit reduction (P < 0.01) in jowl as a percentage of chilled side 
weight in A
Pat
 pigs compared with G
Pat
 pigs.  Both bone-in Boston butt and boneless Boston butt 
weights were greater (10.0% and 10.5%, respectively; P < 0.01) in A
Pat
 pigs compared with G
Pat
 
pigs.  Bone-in Boston percentages and boneless Boston percentages when expressed as a 
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percentage of chilled side weight were both 0.56 percentage units greater (P < 0.01) in A
Pat
 pigs 
compared with G
Pat
 pigs.  Bone-in, untrimmed picnic shoulder weights were unaffected by 
genotype (P < 0.18); however, boneless picnic shoulder weights were 8.5% greater (P = 0.01) in 
carcasses from A
Pat
 pigs compared with G
Pat
 pigs.  Similarly, when expressed as a percentage of 
chilled side weight, boneless picnic shoulder was 0.47 percentage units greater (P = 0.03) in 
carcasses from A
Pat
 pigs compared with G
Pat
 pigs.  None of the cuts fabricated from the shoulder 
were affected by sex (P ≥ 0.10).   
 Canadian back weights as a percentage of chilled side weight were nearly 0.5 percentage 
units heavier (P = 0.02) in gilts compared with barrows.  Tenderloin (P = 0.05) and sirloin (P = 
0.07) percentages expressed as a percentage of chilled side weight tended to be greater in gilts 
compared with barrows.  However, this increase was only 0.06 and 0.12 percentage-units 
respectively, and therefore, may be of little practical importance.  Back rib weights were 
unaffected (P ≥ 0.19) by sex.   
 Whole ham (P = 0.02) and trimmed ham (P < 0.01) weights were 6.1% and 10.1% 
heavier respectively in A
Pat
 pigs compared with G
Pat
 pigs (Table 2.9).  Both whole ham (P = 
0.04) and trimmed ham (P < 0.01) as a percentage of chilled side weight were greater in A
Pat
 pigs 
compared with G
Pat
 pigs.  Seam fat often masked the differences in trimmed primal weights.  As 
seam fat was removed during further fabrication of the hams, differences between genotype were 
more apparent.  Boneless ham pieces, inside, outside, knuckle, lite butt, and shank weights were 
at least 8.5% heavier (P ≤ 0.03) in APat pigs compared with GPat pigs. 
 Whole sparerib-in belly weight was unaffected by genotype (P = 1.00); however, when 
expressed as a percentage of chilled side weight, whole sparerib-in belly percentage was reduced 
by 0.67 percentage units (P = 0.02) in A
Pat
 pigs compared with G
Pat
 pigs.  Sparerib weights were 
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not affected by genotype (P ≥ 0.16).  Additionally, natural fall belly weights were unaffected by 
genotype (P = 0.68); however, when expressed as a percentage of chilled side weight belly 
percentages were 0.76 percentage units less (P = 0.01) in A
Pat
 pigs compared with G
Pat
 pigs.  
Belly (with and without spareribs) weights were unaffected by sex (P ≥ 0.26).  Sparerib weights 
were also unaffected by sex (P = 0.51); however, when expressed as a percentage of chilled side 
weight sparerib percentages tended to be heavier (P = 0.06) in gilt carcasses compared with 
barrow carcasses.   
 Whole ham weights and trimmed ham weights were not affected (P ≥ 0.45) by sex.  
However when expressed as a percentage of chilled side weight, whole hams tended to be 
heavier (P = 0.06) and trimmed hams were 1.1 percentage units greater (P = 0.01) in gilts 
compared with barrows.  Boneless ham pieces were not different (P ≥ 0.13) between sexes.  But, 
when expressed as a percentage of chilled side weight, inside, knuckle, and shank percentages 
were all greater (P ≤ 0.01) in gilts compared with barrows.  Furthermore outside weights 
expressed as a percentage of chilled side weight tended to be heavier (P = 0.05) in gilts 
compared with barrows.   
 Bone-in, trimmed sub-primals excluding whole sparerib-in belly weights were summed 
and expressed as a percentage of chilled side weight to calculate bone-in lean yield (Table 2.3).  
Bone-in lean yields were increased (P < 0.01) 3.43 percentage units in carcasses from A
Pat
 pigs 
compared with G
Pat
 pigs.  When whole sparerib-in belly weights were included to calculate bone-
in carcass cutting yields, the magnitude of the difference between genotypes was reduced to 2.68 
percentage units. This can be attributed to the belly.  The belly contains a greater amount of fat; 
therefore, pigs with the A
Pat
 allele have decreased fat accumulation and decreased belly weights 
ultimately decreasing the magnitude of the difference between the lean and carcass cutting 
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yields.  Boneless lean cutting yields included all boneless subprimals excluding bellies and were 
increased (P < 0.01) 3.08 percentage units in carcasses from A
Pat
 pigs compared with G
Pat
 pigs.  
Boneless carcass cutting yields included bellies and were increased (P < 0.01) 2.34 percentage 
units in carcasses from A
Pat
 pigs compared with G
Pat
 pigs. 
Fresh Belly Characteristics 
 Fresh belly characteristics are presented in Table 2.4.  Belly length and belly width were 
not affected (P ≥ 0.20) by genotype.  Bellies were 7.17 mm thinner (P = 0.01) in APat pigs 
compared with G
Pat
 pigs.  Flop distance (P = 0.05) and durometer measurements (P = 0.07), both 
objective measurements for belly firmness, tended to be less in bellies from A
Pat
 pigs compared 
with bellies from G
Pat
 pigs.  Iodine value tended to be greater (P = 0.09) in bellies from A
Pat
 pigs 
compared with bellies from G
Pat
 pigs.  Full fatty acid profiles are presented in Supplementary 
Table 2.10.  While limited data exists on fresh belly characteristics of pigs with different IGF2 
alleles; Reina et al. (2012) reported greater SFA percentages and reduced PUFA in dry-cured 
hams and dry-cured shoulders from A
Pat 
pigs compared with G
Pat
 pigs.  Although, Reina et al. 
(2012) did not report iodine value, using the AOCS (1998) equation and the average percentages 
reported, the iodine value of dry cure hams from the A
Pat 
pigs was 1.47 units greater than the G
Pat
 
pigs.  Additionally, the iodine value of dry-cure shoulders was 2.60 units greater in A
Pat 
pigs 
compared with G
Pat
 pigs.  It has been well established lighter and thinner bellies with greater 
unsaturated fats are more difficult to slice than heavier and thicker bellies with greater saturated 
fats (Seman et al., 2013). 
Bacon Processing Characteristics 
 Bacon processing characteristics are presented in Table 2.5.  There were no statistical 
differences (P ≥ 0.10) in processing weights and yields for genotype, sex, or the interaction of 
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genotype and sex.  Because the main objective when designing this study was to quantify the 
changes in carcass cutability between genotypes, the population of 35 bellies was likely not large 
enough to determine the statistical differences in processing yields associated with the 
genotypes.  Therefore, while not statistically different (P = 0.30), the magnitude of difference in 
slicing yield as a percentage of green weight was 1.57 percentage units between bellies from 
bellies from A
Pat
 pigs (85.83%) and G
Pat
 pigs (87.40%).  The average green weight of the 35 
bellies used in this study was 5.27 kg, thus bellies from A
Pat
 pigs yielded 0.08 kg less bacon 
compared with bellies from G
Pat
 pigs. 
Bacon Slice Characteristics 
 Bacon slice characteristics are presented in Table 2.6.  The number of saleable slices was 
not different (P = 0.70) between bellies from A
Pat
 pigs and bellies from G
Pat
 pigs.  Bacon slice 
moisture percentage was 4.73 percentage units greater (P < 0.01) in bellies from A
Pat
 pigs 
compared with bellies from G
Pat
 pigs.  While, bacon slice fat percentage was 6.67 percentage 
units less (P < 0.01) in bellies from A
Pat
 pigs compared with bellies from G
Pat
 pigs.  Furthermore, 
blade lean percentage was greater (P < 0.01) in bellies from A
Pat
 pigs compared with bellies from 
G
Pat
 pigs.  Middle and flank lean percentages were not different (P ≥ 0.17) between bellies from 
A
Pat
 pigs and bellies from G
Pat
 pigs.  Even so, average lean percentage (P = 0.02) and average 
lean:fat (P = 0.04) were greater in bellies from A
Pat
 pigs and bellies from G
Pat
 pigs.  Thus, greater 
lean deposition and reduced fat deposition in carcasses from A
Pat
 pigs compared with G
Pat
 pigs, 
was also apparent in bacon slices.  Person et al. (2005) reported consumers viewed bacon from 
thin bellies (47.9% moisture; 36.2% fat) and average bellies (40.5% moisture; 46.4% fat) had 
greater consumer sensory attributes compared with bacon from thick bellies (40.4% moisture; 
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46.3% fat).  Thus, bacon from A
Pat
 pigs (47.9% moisture; 36.1% fat) would likely have similar 
sensory attributes compared to bacon from G
Pat
 pigs (43.1% moisture; 42.7% fat). 
IMPLICATIONS 
 Pigs with a paternal A allele have greater carcass cutting yields compared with G
Pat 
pigs.  
Based on current prices (Weekly National Carlot Meat Report, July 12, 2014), the 2.34-
percentage unit increase in boneless carcass cutting yield results in a potential $0.18/kg greater 
total revenue of boneless retail cuts and on a per carcass basis would increase the total potential 
revenue from boneless cuts (125 kg) by $22.50.  In 2013, 107.5 million barrows and gilts were 
harvested in the United States with an average HCW of 125 kg (USDA, 2013).  Therefore, if this 
$0.18/kg increase in carcass value were applied to the entire population the increase in value 
would be substantial. 
 Despite the greater increase in boneless lean cutting yields, bacon slicing yields as a 
percentage of green weight were reduced 1.57-percentage units.  The May 2014 average 
consumer price of sliced bacon was $13.33/kg with a 40% retail mark-up, the packer value of 
bacon would be approximately $8.00/kg.  Simplistically, based on a $4.19/kg derind belly price 
(USDA, 2013) and the data from this study, the average return on investment from improved 
bacon processing yield would be $1.47/belly and $2.94/pig for G
Pat
 pigs compared with A
Pat
 
pigs. 
CONCLUSIONS 
Selection pressure for leaner and more efficient pigs has resulted in the G to A 
substitution to become nearly fixed in the commercial crossbred pig population.  This mutation 
produces a remarkable increase in lean meat yield as a result of increased lean deposition and 
decreased subcutaneous fat accumulation. Additionally, unlike the Halothane and Rendement 
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Napole mutations, the IGF2 SNP has minimal effect on fresh meat quality. Pigs with A
Pat
 alleles 
had lighter LM color but ultimate pH was not different in pigs with G
Pat
 alleles. Increased cutting 
yields however, may be at the expense of bacon processing, particularly from thinner, more 
unsaturated bellies.  As the demand for pork continues to increase, increased selection pressure 
for more efficient, higher yielding pigs will remain.  Therefore, differential selection may 
provide a means to meet the demand for both fresh lean meat and bacon.  Pigs with A
Pat
 alleles 
may be bred to improve lean meat yield with minimal implications upon fresh meat quality, 
while pigs with G
Pat
 alleles may be selected for superior belly quality and bacon processing. 
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TABLES 
Table 2.1  Effects of IGF2-G3072A and sex on carcass characteristics of finishing gilts and 
barrows. 
  Genotype
1
   Sex 
SEM
2
 
P-Value 
  A
Pat
 G
Pat 
  Gilts Barrows G
3
 Sex G x S
4 
Pigs, n 29 20  20 29     
Live Weight, kg 130.54 127.25 
 
125.62 132.17 2.97 0.29 0.05 0.73 
HCW, kg 104.91 102.51 
 
101.21 106.21 2.57 0.37 0.09 0.66 
Dressing Percent, % 80.35 80.6 
 
80.6 80.35 0.32 0.43 0.48 0.44 
10
th
 Rib Fat, cm 2.41 2.82 
 
2.29 2.94 0.15 0.01 < 0.01 0.58 
LM Area, sq. cm. 55.65 50.56 
 
53.73 52.47 1.70 0.01 0.51 0.63 
Predicted FFL
5
, % 52.79 50.27   53.09 49.97 0.77 < 0.01 < 0.01 0.92 
1
A
Pat
 = Pigs with a paternal A allele; G
Pat
 = Pigs with a paternal G allele. 
2
Maximum standard error of the mean for the fixed effects.
 
3
G = Genotype. 
4
 G x S = Interaction of Genotype and Sex. 
5
FFL = Fat Free Lean. 
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Table 2.2  Effects of IGF2-G3072A and sex on fresh meat quality characteristics of the 
longissimus muscle (LM) of finishing gilts and barrows. 
   Genotype
1 
  Sex 
SEM
2
 
P-Value 
   A
Pat 
G
Pat 
  Gilts Barrows Geno
3 
Sex G x S
4 
Pigs, n 29 20  20 29     
Ultimate pH 5.45 5.47 
 
5.47 5.45 0.02 0.45 0.45 0.46 
Drip Loss, % 5.73 4.96 
 
5.59 5.09 0.67 0.27 0.50 0.56 
Subjective Color 2.90 3.06 
 
2.90 3.06 0.18 0.39 0.44 0.28 
Subjective Marbling 1.47 1.56 
 
1.26 1.77 0.15 0.55 < 0.01 0.75 
Subjective Firmness 2.34 2.57 
 
2.26 2.65 0.19 0.25 0.07 0.50 
Objective Color          
 
L* 51.12 48.76 
 
50.03 49.85 1.01 0.03 0.87 0.41 
 a* 11.18 10.97 
 
11.13 11.01 0.45 0.66 0.81 0.75 
 b* 6.10 5.35 
 
5.95 5.50 0.49 0.14 0.40 0.49 
Cooking Loss, % 21.80  19.98 
 
20.80 21.00 0.54 < 0.01 0.73 0.20 
Moisture, % 73.26 73.71 
 
73.85 73.12 0.25 0.09 0.01 0.54 
Fat, % 3.01 2.37   2.26 3.12 0.26 0.02 < 0.01 0.66 
1
A
Pat
 = Pigs with a paternal A allele; G
Pat
 = Pigs with a paternal G allele. 
2
Maximum standard error of the mean for the fixed effects.
 
3
Geno = Genotype. 
4
 G x S = Interaction of Genotype and Sex. 
 
62 
 
Table 2.3  Effects of IGF2-G3072A and sex on carcass cutting yields of finishing gilts and barrows. 
    Genotype
1
   Sex 
SEM
2
 
P-Value 
Item A
Pat
 G
Pat
   Gilts Barrows Geno
3
 Sex G x S
4
 
Pigs, n 29 20 
 
20 29 
    Bone-in Lean Cutting Yield, %
5
 61.89 58.46 
 
61.07 59.28 0.63 < 0.01 0.01 0.25 
Bone-in Carcass Cutting Yield, %
6
 76.11 73.43 
 
75.70 73.85 0.50 < 0.01 < 0.01 0.64 
Boneless Lean Cutting Yield, %
7
 42.57 39.49 
 
42.20 39.86 0.61 < 0.01 < 0.01 1.00 
Boneless Carcass Cutting Yield, %
8
 56.80 54.46   56.83 54.43 0.50 < 0.01 < 0.01 0.31 
1
A
Pat 
= Pigs with paternal A allele; G
Pat
 = Pigs with a paternal G allele. 
2
Maximum standard error of the mean for the fixed effects. 
3
Geno = Genotype. 
4
 G x S = Interaction of Genotype and Sex. 
5
Bone-in Lean Cutting Yield = (Trimmed Loin + Trimmed Ham + Bone-in Boston Butt + Bone-in Picnic Shoulder) / Chilled 
Side Weight 
6
Bone-in Carcass Cutting Yield = (Trimmed Loin + Trimmed Ham + Bone-in Boston Butt + Bone-in Picnic Shoulder + 
Whole Belly) / Chilled Side Weight 
7
Boneless Lean Cutting Yield = (Canadian Back + Tenderloin + Sirloin + Inside + Outside + Knuckle + Lite Butt + Shank + 
Boneless Boston Butt + Boneless Picnic Shoulder) / Chilled Side Weight 
8
Boneless Carcass Cutting Yield = (Canadian Back + Tenderloin + Sirloin + Inside + Outside + Knuckle + Lite Butt + Shank 
+ Boneless Boston Butt + Boneless Picnic Shoulder + Natural Fall Belly) / Chilled Side Weight 
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Table 2.4  Effects of IGF2-G3072A and sex on fresh belly quality of finishing gilts and barrows. 
    Genotype
1 
  Sex 
SEM
2
 
P-Value 
Item A
Pat 
G
Pat 
  Gilts Barrows Geno
3 
Sex G x S
4 
Pigs, n 19 16 
 
17 18 
    Length, cm 62.96 61.38 
 
61.66 62.68 0.90 0.20 0.41 0.82 
Width, cm 25.13 24.62 
 
25.17 24.59 0.38 0.32 0.27 0.74 
Thickness
5
, mm 42.59 49.76 
 
46.04 46.31 1.92 0.01 0.91 0.36 
Flop distance, cm 28.91 36.18 
 
28.04 37.05 2.73 0.05 0.02 0.75 
Durometer
6
 67.92 73.90 
 
68.61 73.22 2.41 0.07 0.16 0.12 
Iodine value
7
  65.05 63.71   65.94 62.82 0.57 0.09 < 0.01 0.14 
1
A
Pat
 = Pigs with paternal A allele; G
Pat
 = Pigs with a paternal G allele.
 
2
Maximum standard error of the mean for the fixed effects.
 
3
Geno = Genotype.
 
4
 G x S = Interaction of Genotype and Sex. 
5
Thickness was determined by taking the average of measurements at 8 locations; 4 on the 
ventral side of the belly and 4 on the dorsal side of the belly. 
6
Durometer measured belly firmness on the middle of the fat side of the belly.  Higher durometer 
values indicate greater firmness. 
7
 AOCS (1998); Iodine value = 16:1 (0.95) + 18:1 (0.86) + 18:2 (1.732) + 18:3 (2.616) + 20:1 
(0.785) + 22:1 (0.723). 
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Table 2.5. Effects of IGF2-G3072A and sex on bacon processing characteristics of finishing gilts and barrows. 
    Genotype
1
   Sex 
SEM
2
 
P-Value 
Item A
Pat
 G
Pat
   Gilts Barrows Geno
3
 Sex G x S
4
 
Pigs, n 19 16 
 
17 18 
    Green wt, kg 5.16 5.46 
 
5.16 5.45 0.19 0.26 0.27 0.53 
Pumped wt, kg 5.80 6.10 
 
5.78 6.12 0.22 0.32 0.24 0.55 
Pump uptake, % 12.41 11.75 
 
11.83 12.32 0.30 0.11 0.23 0.66 
Cooked wt, kg 5.32 5.66 
 
5.33 5.66 0.21 0.23 0.25 0.51 
Cooked yield, % 102.95 103.71 
 
103.01 103.65 0.33 0.10 0.16 0.29 
Trimmed cooked wt, kg 4.88 5.22 
 
4.90 5.20 0.19 0.20 0.25 0.49 
Ends and pieces wt
5
, kg 0.44 0.44 
 
0.43 0.45 0.02 0.98 0.57 0.88 
Sliced wt, kg 4.44 4.78 
 
4.48 4.74 0.20 0.22 0.33 0.53 
Slicing yield 
         
 
6
As a pct. of green wt, % 85.83 87.40 
 
86.40 86.83 1.11 0.30 0.77 0.56 
 
7
As a pct. of cooked wt, % 83.35 84.26 
 
83.85 83.76 0.91 0.46 0.94 0.70 
  
8
As a pct. of trimmed, cooked wt, % 90.83 91.33   91.10 91.06 0.74 0.62 0.97 0.73 
1
A
Pat
 = Pigs with paternal A allele; G
Pat
 = Pigs with a paternal G allele.
 
2
Maximum standard error of the mean for the fixed effects.
 
3
Geno = Genotype.
 
4
 G x S = Interaction of Genotype and Sex.
 
5                                                       
6
Slicing yield as a percent of green wt = (Sliced wt / Green wt) × 100. 
7
Slicing yield as a percent of green wt = (Sliced wt / Cooked wt) × 100. 
8
Slicing yield as a percent of green wt = (Sliced wt / Trimmed, Cooked wt) × 100. 
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Table 2.6. Effects of IGF2-G3072A and sex on bacon slice characteristics. 
    Genotype
1
   Sex 
SEM
2
 
P-Value 
Item A
Pat 
G
Pat 
  Gilts Barrows Geno
3 
Sex G x S
4 
Pigs, n 19 16 
 
17 18 
    Number of slices, # 138 136 
 
133 140 3 0.70 0.14 0.61 
Bacon composition 
         
 
Moisture, % 47.87 43.14 
 
47.05 43.96 0.95 < 0.01 0.02 0.51 
 
Fat, % 36.07 42.74 
 
37.30 41.51 1.33 < 0.01 0.02 0.49 
Image analysis 
         
 
Blade percent lean, % 61.23 54.00 
 
59.91 55.32 1.80 < 0.01 0.07 0.50 
 
Middle percent lean, % 49.00 45.27 
 
48.77 45.50 2.00 0.17 0.23 0.25 
 
Flank percent lean, % 57.82 54.55 
 
54.61 57.76 1.73 0.17 0.18 0.55 
 
Average percent lean, % 56.02 51.27 
 
54.43 52.86 1.47 0.02 0.43 0.30 
  Average lean:fat, ratio 1.32 1.09   1.26 1.15 0.08 0.04 0.31 0.35 
1
A
Pat
 = Pigs with paternal A allele; G
Pat
 = Pigs with a paternal G allele.
 
2
Maximum standard error of the mean for the fixed effects.
 
3
Geno = Genotype.
 
4
 G x S = Interaction of Genotype and Sex.
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Figure 2.1  Warner-Bratzler shear force (kg) of chops from the longissiumus dorsi aged 1, 3, 7, 
14, 21 days.  A.)  Chops from A
Pat (●) pigs compared with (▪) GPat pigs.   B.) Chops from gilts (●) 
pigs compared with (▪) barrows.  
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SUPPLEMENTAL TABLES 
Table 2.7.  Experimental diet composition and calculated analysis. 
Ingredient Phase 1
1
 Phase 2
2
 Phase 3
3
 Grower 1
4
 Grower 2
5
 Finisher
6
 
Corn, % 30.51 46.59 56.90 69.46 81.12 83.12 
SBM, % 20.24 23.69 31.18 27.21 15.70 14.00 
Blood Plasma, % 7.50 3.00 - - - - 
Whey, dried, % 25.00 20.00 5.00 - - - 
Milk, Lactose, % 10.00 - - 0.00 - - 
Choice white grease, % 3.00 3.00 3.00 1.00 1.00 1.00 
Limestone, % 1.14 1.09 0.90 0.96 0.80 0.70 
DCP, % 0.63 0.85 1.35 0.92 0.85 0.78 
Lysine HCL, % 0.04 0.05 0.02 - 0.13 0.05 
DL-Met, % 0.14 0.07 0.02 - - - 
Salt, % 0.10 0.10 - - - - 
Cu sulfate, % - - 0.08 - - - 
ZnO, % 0.40 0.26 - - - - 
Pulmotil 18, % 0.75 0.75 - - - - 
Mecadox 2.5, % - - 1.00 - - - 
Swine TM, % 0.35 0.35 0.35 0.35 0.30 0.30 
Vit. ADEK, % 0.20 0.20 0.20 0.10 0.10 0.05 
       Total ME (kcal/kg) 3462 3418 3382 3338 3355 3367 
CP, % 20.90 19.79 20.15 18.71 14.18 13.53 
Total lysine, % 1.45 1.24 1.13 0.98 0.77 0.66 
SID lysine, % 1.29 1.10 0.99 0.85 0.67 0.56 
Available P, % 0.48 0.44 0.40 0.30 0.26 0.24 
Ca, % 0.81 0.82 0.81 0.68 0.57 0.51 
SID Met:Lys 0.30 0.30 0.30 0.31 0.32 0.37 
SID Thr:Lys 0.63 0.64 0.66 0.69 0.64 0.71 
SID Trp:Lys 0.22 0.22 0.23 0.23 0.20 0.22 
SID Ile:Lys 0.61 0.68 0.77 0.80 0.73 0.81 
SID Val:Lys 0.74 0.77 0.82 0.88 0.84 0.94 
1
Ad libitum access to the Phase 1 diet was provided from 10d of age to 30d of age.  
2
Ad libitum access to the Phase 2 diet was provided from 30d of age to 40d of age. 
3
Ad libitum access to the Phase 3 diet was provided from 40d of age to 90d of age. 
4
Ad libitum access to the Grower 1 diet was provided from 90d until the average weight of the pigs within the barn 
reached 50 kg.
 
5
 Ad libitum access to Grower 2 diet was provided when the average weight of the pigs within the barn reached 50 kg 
until the average weight of the pigs reached 80kg.
 
6
 Ad libitum access to Finisher diet was provided when the average weight of the pigs reached 80 kg until slaughter.
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Table 2.8.   Effects of IGF2-G3072A and sex on carcass cutting yield of the loin and shoulder primals. 
    Genotype
1
   Sex 
SEM
2
 
P-Value 
Item A
Pat
 G
Pat
   Gilts Barrows Geno
3
 Sex G x S
4
 
Pigs, n 29 20 
 
20 29 
    Standardized Side 50.31 48.70 
 
48.33 50.68 1.30 0.23 0.11 0.50 
Loin 13.38 12.83 
 
12.44 13.78 0.47 0.27 0.14 0.83 
 
% chilled side weight 26.45 26.15 
 
25.54 27.06 0.40 0.47 < .01 0.05 
Trimmed Loin 10.67 9.71 
 
9.99 10.39 0.36 0.01 0.32 0.78 
 
% chilled side weight 21.16 19.78 
 
20.55 20.40 0.34 < .01 0.69 0.04 
Canadian Back 3.86 3.42 
 
3.66 3.62 0.13 < .01 0.77 0.83 
 
% chilled side weight 7.72 7.03 
 
7.59 7.16 0.17 < .01 0.02 0.55 
Tenderloin 0.50 0.46 
 
0.49 0.48 0.02 0.05 0.60 0.85 
 
% chilled side weight 0.99 0.95 
 
1.00 0.94 0.03 0.17 0.05 0.31 
Sirloin 0.93 0.89 
 
0.92 0.90 0.04 0.25 0.74 0.76 
 
% chilled side weight 1.85 1.82 
 
1.89 1.77 0.06 0.61 0.07 0.29 
Backribs 0.78 0.70 
 
0.71 0.77 0.03 0.05 0.19 0.31 
 
% chilled side weight 1.54 1.43 
 
1.48 1.50 0.05 0.05 0.66 0.03 
Shoulder 13.92 13.49 
 
13.47 13.94 0.35 0.24 0.23 0.11 
 
% chilled side weight
 
 27.62 27.66 
 
27.83 27.45 0.27 0.90 0.21 0.01 
Jowl 1.29 1.48 
 
1.33 1.45 0.07 0.01 0.10 0.32 
 
% chilled side weight 2.58 3.07 
 
2.76 2.89 0.11 < .01 0.30 0.15 
Bone-in Boston Butt 4.33 3.94 
 
4.08 4.19 0.12 < .01 0.42 0.22 
 
% chilled side weight 8.67 8.11 
 
8.49 8.30 0.14 < .01 0.20 0.27 
Boneless Boston Butt 3.99 3.61 
 
3.74 3.84 0.12 < .01 0.42 0.21 
 
% chilled side weight 7.99 7.43 
 
7.79 7.63 0.15 < .01 0.32 0.26 
Bone-in Picnic Shoulder 5.31 5.09 
 
5.15 5.24 0.15 0.18 0.60 0.11 
 
% chilled side weight 10.58 10.51 
 
10.71 10.37 0.21 0.75 0.15 0.10 
Boneless Picnic Shoulder 4.33 3.99 
 
4.14 4.18 0.13 0.01 0.78 0.21 
  % chilled side weight 8.61 8.14   8.54 8.21 0.20 0.03 0.14 0.37 
1
A
Pat
 = Pigs with paternal A allele; G
Pat
 = Pigs with a paternal G allele.
 
2
Maximum standard error of the mean for the fixed effects.
 
3
Geno = Genotype.
 
4
 G x S = Interaction of Genotype and Sex. 
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Table 2.9.   Effects of IGF2-G3072A and sex on carcass cutting yield of the ham and belly primals. 
    Genotype
1
   Sex 
SEM
2
 
P-Value 
Item A
Pat
 G
Pat
   Gilts Barrows Geno
3
 Sex G x S
4
 
N 29 20 
 
20 29 
    Whole Ham 12.81 12.07 
 
12.32 12.56 0.29 0.02 0.45 0.65 
 
Whole Ham, % 25.64 24.90 
 
25.64 24.90 0.34 0.04 0.06 0.47 
Trimmed Ham 10.71 9.73 
 
10.24 10.20 0.26 < .01 0.89 0.94 
 
Trimmed Ham, % 21.48 20.05 
 
21.31 20.22 0.38 < .01 0.01 0.18 
Inside 2.04 1.76 
 
1.95 1.85 0.05 < .01 0.13 0.45 
 
Inside, % 4.12 3.61 
 
4.06 3.67 0.11 < .01 < .01 0.89 
Outside 2.80 2.58 
 
2.70 2.68 0.10 0.03 0.81 0.90 
 
Outside, % 5.59 5.32 
 
5.62 5.29 0.15 0.10 0.05 0.26 
Semitendinosus 0.64 0.59 
 
0.62 0.61 0.02 0.02 0.57 0.83 
 
Semitendinosus, % 1.27 1.21 
 
1.29 1.20 0.03 0.07 0.01 0.24 
Lite Butt 0.38 0.28 
 
0.34 0.32 0.03 < .01 0.56 0.80 
 
Lite Butt, % 0.77 0.59 
 
0.72 0.64 0.06 0.01 0.24 0.80 
Knuckle 1.58 1.44 
 
1.54 1.48 0.05 0.01 0.19 0.53 
 
Knuckle, % 3.16 2.97 
 
3.21 2.92 0.09 0.05 0.01 0.96 
Shank 0.89 0.79 
 
0.85 0.83 0.03 < .01 0.48 0.33 
 
Shank, % 1.79 1.62 
 
1.77 1.64 0.04 < .01 0.01 0.68 
Whole Belly 8.82 8.82 
 
8.69 8.94 0.28 1.00 0.44 0.24 
 
Whole Belly, % 17.47 18.14 
 
17.97 17.64 0.28 0.02 0.29 0.09 
Spareribs 1.64 1.54 
 
1.62 1.56 0.07 0.16 0.51 0.77 
 
Spareribs, % 3.25 3.16 
 
3.33 3.08 0.12 0.45 0.06 0.85 
Natural Fall Belly 7.18 7.28 
 
7.08 7.37 0.23 0.68 0.26 0.19 
 
Natural Fally Belly, % 14.22 14.98 
 
14.63 14.57 0.25 0.01 0.82 0.05 
1
A
Pat
 = Pigs with paternal A allele; G
Pat
 = Pigs with a paternal G allele.
 
2
Maximum standard error of the mean for the fixed effects.
 
3
Geno = Genotype.
 
4
 G x S = Interaction of Genotype and Sex
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Table 2.10.   Effects of IGF2-G3072A and sex on fatty acid composition of the belly. 
    Genotype
1
   Sex 
SEM
2
 
P-Value 
Item A
Pat
 G
Pat
   Gilts 
Barrow
s Geno
3
 Sex G x S
4
 
n 19 16 
 
17 18 
    C14:0, % 1.40 1.41 
 
1.37 1.44 0.03 0.94 0.07 0.22 
 
C14:1, % 0.03 0.03 
 
0.03 0.03 0.00 0.03 0.58 0.81 
 
C15:0, % 0.07 0.05 
 
0.07 0.05 0.02 0.47 0.50 0.39 
C16:0, % 24.47 24.91 
 
24.02 25.36 0.29 0.26 < 0.01 0.26 
 
C16:1, % 3.79 3.59 
 
3.72 3.66 0.06 0.02 0.43 0.39 
C17:0, % 0.26 0.29 
 
0.26 0.30 0.03 0.46 0.24 0.09 
 
C17:1, % 0.01 0.01 
 
0.00 0.02 0.00 0.83 < 0.01 0.36 
C18:0, % 9.86 10.12 
 
9.65 10.33 0.19 0.30 0.01 0.41 
 
C18:1n9, % 46.12 46.50 
 
46.52 46.10 0.35 0.42 0.36 0.78 
 
C18:2n6, % 11.47 10.64 
 
11.78 10.33 0.28 0.03 < 0.01 0.06 
 
C18:3n6, % 0.03 0.04 
 
0.03 0.04 0.01 0.63 0.61 0.40 
 
C18:3n3, % 0.45 0.42 
 
0.47 0.40 0.01 0.18 < 0.01 0.48 
C20:0, % 0.16 0.16 
 
0.15 0.17 0.00 0.98 < 0.01 0.42 
 
C20:1n9, % 0.84 0.84 
 
0.83 0.85 0.03 0.94 0.50 0.59 
 
C20:2n6, % 0.45 0.42 
 
0.47 0.41 0.02 0.26 0.01 0.37 
 
C20:3n3, % 0.07 0.06 
 
0.07 0.06 0.00 0.18 0.01 0.53 
 
C20:3n6, % 0.08 0.08 
 
0.09 0.07 0.00 0.04 0.01 0.49 
 
C20:4n6, % 0.25 0.22 
 
0.26 0.21 0.01 0.06 < 0.01 0.50 
 
C20:5n3, % 0.01 0.01 
 
0.01 0.01 0.00 0.34 0.38 0.23 
C22:0, % 0.01 0.01 
 
0.01 0.01 0.00 0.28 0.06 0.30 
 
C22:1n9, % 0.02 0.05 
 
0.05 0.02 0.01 0.07 0.03 0.04 
 
C22:2n6, % 0.00 0.00 
 
0.00 0.00 0.00 0.87 0.87 0.33 
 
C22:4n6, % 0.09 0.11 
 
0.09 0.11 0.03 0.62 0.69 0.46 
 
C22:5n3, % 0.04 0.05 
 
0.05 0.04 0.01 0.47 0.21 0.33 
 
C22:6n3, % 0.02 0.02 
 
0.02 0.01 0.01 0.76 0.16 0.47 
5
Total SFA, % 36.16 36.89 
 
35.45 37.60 0.47 0.25 < 0.01 0.31 
6
Total MUFA, % 50.81 51.01 
 
51.15 50.67 0.36 0.68 0.32 0.66 
7
Total PUFA, % 12.96 12.05 
 
13.34 11.68 0.32 0.04 < 0.01 0.06 
8
UFA:SFA, ratio 1.78 1.71 
 
1.83 1.66 0.04 0.19 < 0.01 0.28 
1
A
Pat
 = Pigs with a paternal A allele; G
Pat
 = Pigs with a paternal G allele.
 
2
Maximum standard error of the mean for the fixed effects.
 
3
Geno = Genotype.
 
4
 G x S = Interaction of Genotype and Sex.
 
5
Total SFA = + (C14:0) + (C16:0) + (C17:0) + (C18:0) +(C20:0) + (C22:0). 
6
Total MUFA = (C14:1) + (C16:1) + (C17:1) + (C18:1t) + (C18:1c) + (C20:1) + (C22:1). 
7
Total PUFA = (C18:2) + (C18:3) + (C20:2) + (C20:3 n3) + (C20:3 n6) + (C20:4) + (C20:5) + 
(22:2 n6) + (22:4 n6) + (22:5 n3) + (22:6 n3). 
8
UFA: SFA ratio = (total MUFA + total PUFA) / total SFA. 
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Chapter 3 
INCREASED PRENATAL IGF2 EXPRESSION DUE TO THE PORCINE IGF2 
INTRON3-G3072A MUTATION MAY BE RESPONSIBLE FOR INCREASED MUSCLE 
MASS   
 
ABSTRACT 
A SNP (IGF2 G3072A) within intron 3 of insulin-like growth factor 2 (IGF2) disrupts a binding 
site for the repressor ZBED6. As a result, loin eye area is increased up to 5%. However, the 
contributions of prenatal alterations in IGF2 as opposed to increased postnatal IGF2 expression 
are unclear. As muscle fiber number is set at birth, prenatal and neonate skeletal muscle 
development is critical in determining mature growth potential. Therefore, objectives of this 
study were to determine the contributions of hyperplasia and hypertrophy to increased muscle 
mass and delineate the effect of the IGF2 mutation on the expression of myogenic genes during 
prenatal and postnatal growth. Sows (IGF2 A/A) were bred to a single, heterozygous (IGF2 A/G) 
boar. For fetal samples, sows were euthanized at 60 and 90 d of gestation to obtain fetuses. Male 
and female offspring were also euthanized at birth (0d), weaning (21d), and at market weight of 
approximately 130 kg (176d). At each time point, the LM, psoas major (PM), and 
semitendinosus (ST) muscles were weighed. Samples of the LM were used to quantify the 
expression of IGF family members, myogenic regulatory factors (MRF), myosin heavy chain 
isoforms, and growth factors, myostatin and ZBED6. Liver samples were used to quantify IGF1 
and IGF2 expression. At 176d, weights of LM, PM, and ST muscles were all increased 
approximately 8-14% (P < 0.01) in pigs with paternal A (A
Pat
) alleles compared with those with 
paternal G (G
Pat
) alleles. Additionally, total muscle fiber number in the ST at 176d tended to be 
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greater (P = 0.10), while muscle fiber cross sectional area tended to be reduced (P = 0.08) in A
Pat
 
pigs compared with G
Pat
 pigs. In addition to the expected 2.7 – 4.5 fold increase (P ≤ 0.02) in 
IGF2 expression in the LM in A
Pat
 compared to G
Pat
 pigs at postnatal time points (21d and 176d), 
IGF2 expression was also increased (P ≤ 0.06) 1.4-1.5 fold at d90 of gestation and at birth. At 
d90, expression of MYF5, a MRF expressed in proliferating myoblasts, in the LM was greater (P 
=0.01) in A
Pat
 pigs compared with G
Pat
 pigs. These data suggest that prenatal hyperplasia of 
muscle fibers stimulated by increased IGF2 expression may contribute to increased muscle mass 
of A
Pat
 pigs. Interestingly, at 21d hepatic IGF2 expression was greater (P = 0.01), while IGF1 
expression decreased (P =0.01) in A
Pat
 pigs compared with G
Pat
 pigs; however there were no 
differences (P ≥ 0.18) in hepatic expression between genotypes at 0d and 176d.  
Key Words:  IGF2 G3072A, insulin-like growth factor, muscle fiber number, muscle fiber cross 
sectional area, pig, single nucleotide polymorphism  
 
INTRODUCTION 
Insulin-like growth factor 2 (IGF2) is a maternally imprinted growth factor that 
positively regulates skeletal muscle growth (Ferguson-Smith et al., 1991) by activating the 
insulin-like growth factor 1 receptor (IGF1R) (Florini et al., 1996).  Mice lacking functional Igf2 
are born approximately 60% smaller than wild type littermates; however, postnatal growth rate is 
not different (DeChiara et al., 1992). Additionally, prenatal IGF2 expression is substantially 
greater compared with postnatal IGF2 expression in skeletal muscle and liver (Van Laere et al., 
2003).  Because of these data, IGF2 is primarily thought to regulate the expression of prenatal 
skeletal muscle development.  However, in 2003 a G to A SNP (IGF2-inron3-G3072A) within 
intron 3 of IGF2 was identified and determined to increase postnatal IGF2 expression (Van Laere 
et al., 2003).  Back fat was reduced up to 20% and loin eye area was increased up to 5% in pigs 
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with paternal A (A
Pat
) alleles compared to pigs with paternal G (G
Pat
) alleles (Jeon et al., 1999; 
Van Den Maagdenberg et al., 2008b).  Therefore, IGF2 expression may also play a significant 
role in postnatal skeletal muscle growth. 
Because skeletal muscle fiber number is determined during late gestation, alterations that 
impact prenatal myogenesis especially at a time of myoblast proliferation, could greatly impact 
postnatal growth potential (Rehfeldt et al., 2000).  There is currently no data that suggests the 
SNP alters prenatal IGF2 expression; however only one prenatal time point has been 
investigated.  Additionally, despite the elevated postnatal IGF2 expression and greater muscle 
mass, Van den Maagdenberg et al. (2008) found no difference in the cross sectional area of 
muscle fibers within LM muscles of A
Pat
 pigs and G
Pat
 pigs.  Therefore, further research is 
needed to elucidate the mechanism by which the IGF2 SNP alters growth.  The objectives of this 
study were to determine the contributions of hyperplasia and hypertrophy to increased muscle 
mass and delineate the effect of the IGF2 mutation on the expression of myogenic genes during 
prenatal and postnatal growth. 
MATERIALS AND METHODS 
 All live phase experimental animal procedures were approved by the University of 
Illinois Institutional Animal Care and Use Committee. 
Animals 
A single IGF2-intron3-G3072A heterozygote (AG) Berkshire boar was bred to 
homozygote (AA) commercial Yorkshire-cross females.  Therefore, offspring that were 
heterozygous for the IGF2 mutation received and expressed the G
pat
 allele, while homozygous 
AA offspring expressed the A
pat
 allele.  Offspring were euthanized at two prenatal time points: d 
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60 (d60) and 90 (d90), and three postnatal time points: birth (0d), weaning (21d), and market 
(176d ± 4d).   
Sows were bred and maintained on a gestation diet (Table 3.4).  Sows were slaughtered 
under federal inspection at the University of Illinois Meat Science Laboratory by head-to-heart 
electrical stunning followed by exsanguination to obtain fetuses.  Fetuses were collected from 
sows at two points, d60 and d90 (± 2d) of gestation.   Three sows each were slaughtered for both 
d60 and d90 samples and 36 and 32 fetuses were collected for each time point, respectively 
(Table 3.1).  Fetuses were weighed and measured to determine body weight and crown-to-rump 
length.  
All piglets were weighed within twenty-four hours of birth to determine birth weight.  
Piglets destined for 0d sample collection were euthanized within twenty-four hours of birth, 
before castration and typical processing procedures.  Pigs that were euthanized for 21d and 176d 
sample collection were given 200 mg of iron dextran and 0.2 ml of a broad spectrum antibiotic at 
birth.  Additionally, ears were notched, needle teeth snipped, tails removed, and males were 
castrated following typical industry practices (FASS, 2010). 
Diets are presented in supplementary table 3.4.  Piglets were supplemented with a milk 
based creep diet at 10 days of age (phase 1).  Piglets were weaned at 21 days of age and 
continued on the phase 1 diet.  Piglets were switched to phase 2 and phase 3 diets at 30 and 40 
days of age, respectively.  Ad libitum access to nursery diets were provided in multi-hole 
stainless steel feeders and water was provided through a nipple system.  Pigs were moved to the 
finishing barn at 90 days of age and were switched to the first grower ration (grower 1).  Pigs 
were switched to the second grower (grower 2) ration when the average pig weight in the barn 
reached 50 kg.  When the average pig weight in the barn reached 80 kg, the ration was switched 
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to the finishing diet for the remaining feeding period.  Ad libitum access to feed in the finishing 
barn was provided through 5-hole pig feeders and water was provided with a nipple system. 
Piglets were anesthetized at 0d and 21d by an intramuscular injection of a 
telazol:ketamine:xylazine solution [50.0 mg of tiletamine HCl and 50.0 mg of zolazepam  HCl 
(Zoetis, Florham Park, NJ) reconstituted with 2.5 ml ketamine (100g/L; Zoetis, Florham Park, 
NJ) and 2.5 ml xylazine (100g/L; Lloyd Inc. of Iowa, Shenadoah, IA) administered at 0.1 ml/10 
kg]. Piglets were euthanized with an intracardiac fatal dose injection of Fatal-Plus® (1ml/10kg; 
Vortech Pharmaceuticals Ltd., Dearborn, MI ).  After euthanasia, all piglets were weighed and 
measured to determine body weight, and crown-to-rump length.  At 0d, a total of 30 piglets 
representing 5 litters were euthanized.  At 21d, a total of 32 piglets representing 4 litters were 
euthanized (Table 3.1). 
Market weight pigs (176d) were weighed immediately before slaughter.  Pigs were 
slaughtered by head-to-heart electrical stunning followed by exsanguination under federal 
inspection at the University of Illinois Meat Science Lab.  Skeletal muscle and liver samples 
were taken after carcasses passed federal inspection, no more than 45 minutes after 
exsanguination.  Carcasses were chilled at 4°C for at least 24 h before LM, psoas major (PM), 
and semitendinosus (ST) muscles were removed and weighed.  Carcass length was determined 
by measuring the distance between the most anterior point of the first rib and the most anterior 
point of the aitch bone.  A total of 49 pigs representing 7 litters were slaughtered in two blocks, 
the first block of 35 pigs were slaughtered in August and the second block of 14 pigs were 
slaughtered in December.   
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Sample Collection 
 At each time point, LM and spinalis dorsi were removed as a unit and weighed.  Samples 
of LM were collected at a point directly posterior to the spinalis dorsi.  After dissection, fetal and 
market weight samples were immediately stored at -80º C or in liquid nitrogen.  Birth and 
weaning samples were immediately placed in RNAlater (Ambion-Life Technologies, Grand 
Island, NY) and then stored at -80º C within 12 hours.  Liver samples of approximately 100 mg 
were obtained from postnatal time points for gene expression analysis and stored at -80º C.  
Additionally, ST muscles, at all time points and PM muscles, at postnatal time points, were 
removed and weighed.  The ST muscles collected from pigs at 176d were cut in half, 
perpendicular to muscle fibers.  Cut surfaces of ST muscles were traced on acetate paper.  
Tracings were retraced using an Intuos 4 Wacom tablet (PTK-840; Tokyo, Japan) into Adobe 
Photoshop Cs5 Extended (Adobe Systems Incorporated, San Jose, CA) to determine cross 
sectional area (CSA).  Samples were obtained from both dark and light areas of ST muscles.  
Approximately 1.0 cm
3
 samples from each area were frozen in liquid nitrogen-chilled 3-
methylbutane and held at -80° C until further analysis.   
Genotyping 
A skin sample from the ear was placed in DNA extraction buffer (Miller et al., 1988) for 
genotyping.  Isolation of DNA was completed with a Quick-gDNA isolation kit (Zymo 
Research, Irvine, CA) following manufacturer procedures.  Animals were genotyped by either 
direct Sanger sequencing or PCR amplification followed by digestion with restriction enzyme, 
ApeK1 (New England BioLabs, Inc., Ipswich, MA).  Genotyping by PCR was completed with 
HotStarTaq Plus DNA Polymerase (Qiagen, Valencia, CA) with addition of optional Q buffer.  
Primer sequences for reactions were: forward IGF2 Primer: 5’-CGGACCGAGCCAGGGA 
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CGA-3’; reverse IGF2 Primer: 5’-GCCGGCTGGAAGGGAGGAA-3’.  Thermocycler (BioRad, 
Hercules, CA or ABI-Life Technologies, Grand Island, NY) program conditions were:  95° C for 
5 min followed by 34 cycles of 94° C for 45 s, 64° C for 45 s, 72° C for 1 min followed with a 
termination schedule: 72° C for 5 min and 10° C for 5 min.  Products were then digested with 
ApeK1 at 75° C for 30 min.  Products were visualized on a 4% agarose gel.  The Apek1 
restriction site was on the G allele (A: 130bp fragment; G: 100bp and 30bp fragments).    
RNA Isolation and cDNA preparation 
 Tri-Reagent method (Sigma-Aldrich, St. Louis, MO) was used to isolate total RNA from 
tissue samples as described by Jones et al. (2014).  Total RNA concentration was determined 
with a Nanodrop spectrophotometer (Nanodrop, Wilmington, DE).   
 Synthesis of cDNA was carried out with qScript cDNA SuperMix (Quanta Biosciences, 
Gaithersburg, MD) following manufacturer procedures.  In short, 1µg of RNA was added to 
qScript cDNA SuperMix  and incubated at 25° C for 5 min, 42° C for 30 min, 85° C for 5 min 
and stored at -20° C for further analysis. 
Quantitative Polymerase Chain Reaction 
 Quantitative polymerase chain reaction (qPCR) was carried out with qScript PerfeCTa 
FastMix II, Rox (Quanta Biosciences, Gaithersburg, MD) following manufacturer procedures.  
Beta-2-microglobulin (B2M) was chosen as an endogenous control as B2M had an efficiency 
between 90 and 100% and was unaffected by genotype, sex, and age.  All primers were 
purchased from Life Technologies (Grand Island, NY). Accession numbers along with either 
stock numbers or custom designed primer sequences are listed in supplemental tables 3.5 and 
3.6.  Primer efficiencies were evaluated and determined to be between 90 and 100%. 
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 Quantitative PCR was performed in duplicate on a 96 well plate.  A Step One Plus qPCR 
machine (Applied Biosystems by Life Technologies; Grand Island, NY) was used to amplify and 
quantify cDNA synthesis.  The gene of interest for each sample was normalized to B2M to obtain 
ΔCT values.  The ΔCT values were then normalized to the average expression of 176d male APat 
pigs to determine ΔΔCT values.  The ΔΔCT values were statistically analyzed.  Means and 95% 
confidence intervals were converted to reported fold changes. 
Myosin Heavy Chain Fiber Type Determination 
 Frozen dark and light ST samples were cut to 7 µm thick sections on a cryostat (Reichert-
Jung Cryocut 1800, Leica Microsystems Inc., Buffalo Grove, IL).  Sections were placed on a 
glass side and held at -80º C for further analysis.  Immunofluorescence was used to distinguish 
skeletal muscle fiber types.  Slides were fixed in -20º C chilled acetone for 2 mins before 
blocking with 10% normal goat serum.  Primary antibodies (Developmental Hybridoma Bank, 
Iowa City, IA) of unique antibody isoform structure, targeted Myosin Heavy Chain (MHC) 
isoforms 1 (BA-F8, IgG2b, 1/50), 2A (SC-71, IgG1, 1/200) and 2B (BF-F3, IgM, 1/10). 
Secondary antibodies conjugated to three distinct Alexa Fluor® (Life Technologies, Grand 
Island, NY) dyes differentiated fiber types (A-21140, Alexa Flour® 350, 1/1000; A-21121, Alexa 
Flour® 488, 1/1500; A-21421, Alexa Flour® 555, 1/500).  Slides were rinsed in three 1X PBS 
(BioWittaker Phosphate Buffered Saline 10X, Lonza, Switzerland) washes after each incubation 
step.  An Advanced Microscopy Group Evos Florescent Microscope (model AMF-4306-US, Life 
Technologies, Grand Island, NY) with total magnification of 259X was used to visualize 
florescence and capture three representative images that were used to determine fiber type 
composition and fiber type CSA.   Cells were traced on Adobe Photoshop (Adobe Systems 
Incorporated, San Jose, CA) to determine average CSA for each fiber type.  A minimum of 470 
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cells per animal were analyzed.  A length of 511 pixels was set equal to the 400 µm scale bar for 
each picture. Total fiber number within ST was estimated by dividing the CSA of the ST muscle 
by the average muscle fiber CSA from both the dark and light sections.   
Statistical Analysis 
 Data were analyzed using pig as the experimental unit in the MIXED procedure of SAS 
(SAS Inst., Cary, NC).  Pig served as experimental unit because treatment (genotype) was 
applied to the pig.  Data were analyzed as a randomized complete block design in a factorial 
arrangement of treatments.  For anthropomorphic measurements, fixed effects were genotype 
and sex and their interaction at each age.  For gene expression analysis, fixed effects were 
genotype, sex, age and their interactions.  For fiber type determination, only samples from the 
first 176d slaughter date were analyzed; and the model included the main effects of genotype, 
sex, and their interaction.  Data were blocked by litter to account for variation attributable to the 
random effect of sows.  Gene expression analysis were reported as mean fold changes (± 95% 
confidence interval) compared to the average expression of male G
Pat
 pigs at 176d.  All other 
data are presented as age and genotype interaction means (± standard error of the mean).  
Additionally, while the main effect of sex was analyzed, results and discussion were focused on 
effects of genotype and age as these more appropriately represented the objective of the study.   
RESULTS 
Anthropomorphic Measurements   
At prenatal time points, anthropomorphic measurements were not different between 
genotypes (Table 3.2) with the exception that at d60, A
Pat
 fetuses tended to be heavier (P = 0.06) 
compared with G
Pat 
fetuses.  Body length and weights were also not different (P ≥ 0.13) between 
genotypes at postnatal time points. Muscle weights (LM, PM, and ST) were not different (P ≥ 
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0.26) between A
Pat
 and G
Pat
 pigs at 0d and 21d.  At 176d, however, LM, PM, and ST weights 
were 32.4%, 8.2%, 8.2% heavier (P ≤ 0.05), respectively, in APat pigs compared with GPat pigs.   
Muscle Fiber Cross Sectional Area, Number and Type 
 To determine muscle fiber number and cross sectional area, ST muscles were divided into 
a dark region and a light region.  By immunofluorescence (Fig. 3.1), fiber type composition and 
muscle fiber CSA for both dark and light regions were quantified (Table 3.3).  In the dark region 
of ST muscles, there was an interaction (P = 0.04) between genotype and sex for CSA of type 1 
muscle fibers. Type 1 fibers were larger in G
Pat
 females compared with G
Pat
 males (4053 vs. 
3320 µm
2
; P = 0.05) but CSA of type 1 fibers were not different (P ≥ 0.31) between sexes of APat 
pigs.  Additionally in the dark region of the ST, type 2a fibers tended to be smaller in A
Pat
 pigs 
compared with G
Pat
 pigs.  There were no differences (P ≥ 0.33) in the CSA of type 2x and type 
2b between A
Pat
 pigs and G
Pat
 pigs in the dark region of the ST.  Furthermore, proportions of type 
1, type 2a, type 2x, and type 2b fibers were not different (P ≤ 0.61) between APat pigs and GPat 
pigs in dark regions of ST muscles. 
In light regions of ST muscles, CSA of type 1 fibers were not different (P = 0.77) 
between A
Pat
 pigs and G
Pat
 pigs.  However, type 2a (P = 0.09) and type 2x (P = 0.06) fiber CSA 
tended to be smaller in the light regions of A
Pat
 pigs compared with G
Pat
 pigs.  Type 2b fibers 
were not different (P ≥ 0.14) between APat pigs and GPat pigs.  Additionally, in light regions, type 
2a fibers tended to make up a lesser (P = 0.06) proportion of fibers in A
Pat
 pigs compared with 
G
Pat
 pigs.  There were no differences (P ≥ 0.39) in proportions of type 1, type 2x, and type 2b 
fibers in light regions of A
Pat
 pigs and G
Pat
 pigs.  In total, average fiber CSA tended to be smaller 
(P = 0.08) in ST muscles from A
Pat
 pigs compared with G
Pat
 pigs.  On the other hand, A
Pat
 pigs 
tended to have a greater (P = 0.10) number of fibers in ST muscles compared with G
Pat
 pigs. 
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IGF Family Members Expression 
  At gestational d60, IGF2 expression was not different (P = 0.70) between A
Pat
 and G
Pat
 
pigs (Fig. 3.2A).  However, at d90, IGF2 expression tended to be 1.4-fold greater (P = 0.06) in 
A
Pat
 pigs compared with G
Pat
 pigs.  This is particularly important as fiber number is determined 
before birth, and any minor changes in expression during this period could have significant 
effects on mature skeletal muscle growth potential.  In general, postnatal IGF2 expression in LM 
decreased with time and IGF2 expression was greater in A
Pat
 pigs compared with G
Pat
 pigs.  At 
0d, IGF2 expression was 1.5-fold greater (P = 0.02) in A
Pat
 pigs compared with G
Pat
 pigs.  The 
magnitude of difference between G
pat
 and A
pat
 pigs increased with time; at 21d and 176d, IGF2 
expression was 2.7 and 4.1-fold greater (P < 0.01) respectively, in A
Pat
 pigs compared with G
Pat
 
pigs.  
 Similar to IGF2, insulin-like growth factor 1 (IGF1) expression decreased after birth 
(5.8-fold from 90d to 176d), however the reduction was markedly less than the decrease in IGF2 
expression (Fig. 3.2B).  Furthermore, IGF1 expression was not different (P ≥ 0.14) between APat 
and G
Pat
 pigs at any age.  At d60, IGF1R expression was greatest (P < 0.01) and, on average, 
decreased 53.6-fold from d60 compared to 21d (Fig. 3.2C).  Additionally, IGF1R increased (P < 
0.01) 4.4-fold from 21d to 176d.  At d60 IGF1R expression was 1.4-fold greater (P = 0.02) in 
A
Pat
 pigs compared with G
Pat
 pigs.  There were no other differences (P ≥ 0.29) in IGF1R 
expression between A
Pat
 pigs and G
Pat
 pigs at any other age.  Prenatal IGF 2 receptor (IGF2R) 
expression was greater than postnatal expression; however there was only a 4.3 fold decrease (P 
< 0.01) in expression from the maximum amount of prenatal expression at d90 and the minimum 
amount of postnatal expression at 0d (Fig. 3.2D).  There were no differences (P ≥ 0.27) in 
IGF2R expression between A
Pat
 pigs and G
Pat
 pigs at any age.   
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At prenatal d60, IGF binding protein 3 (IGFBP3) expression was greatest and decreased 
(P < 0.01) 33.3-fold by 21d (Fig. 3.2E).  Additionally by 176d, IGFBP3 expression increased (P 
< 0.01) 6-fold from 21d.  Unexpectedly, at d60 IGFBP3 expression was reduced 1.6-fold (P = 
0.03) in A
Pat
 pigs compared with G
Pat
 pigs.  Conversely, IGFBP3 expression at d90 tended to be 
1.5-fold greater (P < 0.07) in A
Pat
 pigs compared with G
Pat 
pigs.  There were no other differences 
(P ≥ 0.24) in IGFBP3 expression between APat pigs and GPat pigs at any postnatal age.  Similar to 
IGFBP3, IGF binding protein 5 (IGFBP5) expression decreased with increasing age (Fig. 3.2F).  
Expression of IGFBP5 decreased (P < 0.01) 6.3-fold from d60 to 176d.  At 176d, IGFBP5 
expression was 1.3-fold greater (P = 0.03) in A
Pat
 pigs compared with G
Pat
 pigs; however, the 
magnitude of difference was small and may be of little biological importance.  There were no 
differences (P ≥ 0.23) in expression of IGFBP5 between APat pigs and GPat pigs at any other age. 
Hepatic IGF1 and IGF2 Expression 
 The liver is the primary source of circulating IGF1 and IGF2; therefore, hepatic IGF1 and 
IGF2 expression was quantified at 0d, 21d, and 176d.  Hepatic IGF1 expression was reduced (P 
< 0.01) 2.0-fold in A
Pat
 pigs compared with G
Pat
 pigs at 21d (Fig. 3.3A).  However, there were no 
differences (P ≥ 0.18) between APat pigs and GPat pigs at 0d or 176d.   
 Hepatic IGF2 expression, unlike IGF1, decreased markedly with age, as IGF2 expression 
decreased (P < 0.01) 147-fold from 0d to 176d (Fig. 3.3B).   Additionally, at 21d hepatic IGF2 
expression was 1.9-fold greater (P = 0.01) in A
Pat
 pigs compared with G
Pat
 pigs.  There were no 
differences (P ≥ 0.46) in IGF2 expression at 0d and 176d between APat pigs and  GPat pigs.   
Myostatin and ZBED6 Expression 
 Myostatin (MSTN) and zinc finger BED-type containing 6 (ZBED6) inhibit the growth 
of skeletal muscle.  Expression of MSTN was reduced (P < 0.01) 17-fold from prenatal d90 to 
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birth (Fig. 3.4A).   Additionally, MSTN expression was not different (P ≥ 0.12) between APat pigs 
and G
Pat
 pigs at any age.  At d60, ZBED6 expression was greatest and declined (P < 0.01) in 
expression through 0d and 21d (Fig. 3.4B). Expression of ZBED6 increased (P < 0.01) 1.9-fold 
from 21d to 176d.  At d90, ZBED6 expression was 1.4-fold greater (P = 0.01) in A
Pat
 pigs 
compared with G
Pat
 pigs.  
Myogenic Regulatory Factor Expression 
 In general, expression of myogenic regulatory factors including myogenic factor 5 
(MYF5), myogenic differentiation 1 (MYOD1), and myogenin (MYOG) decreased with 
increasing age (Fig. 3.5).  Few myogenic regulatory factor expression differences (P ≥ 0.16) 
occurred between genotypes.  However, at d90 MYF5 expression was 1.4-fold greater (P = 0.01) 
and MYOG was 1.3-fold greater in A
Pat
 pigs compared with G
Pat
 pigs.  Additionally, MYOG 
expression at birth was 1.3-fold greater (P = 0.05) in A
Pat
 pigs compared with G
Pat
 pigs.   
Myosin Heavy Chain Expression 
 Myosin heavy chain isoform 1 (MHC1) expression was greatest at d60 and 176d (Fig. 
3.6A).  At d90, MHC1 expression was 1.7-fold greater (P < 0.01) in A
Pat
 pigs compared with G
Pat
 
pigs.  There were no differences (P ≥ 0.62) in MHC1 expression at any other age between APat 
pigs and G
Pat
 pigs.  Myosin heavy chain isoform 2a (MHC2A) expression was greatest (P < 0.01) 
at 0d; however, MHC2A expression was decreased by 21d and remained constant at 176d (Fig. 
3.6B).  At all ages, MHC2A expression was not different (P ≥ 0.51) between APat pigs and GPat 
pigs.  Myosin heavy chain isoform 2x (MHC2X) was minimally expressed prenatally, and 
expression increased (P < 0.01) over 12-fold from d90 to 0d (Fig. 3.6C).  Additionally, MHC2X 
expression was 1.7-fold greater (P = 0.05) at 0d and tended to be greater (P = 0.07) at d90 in A
Pat
 
pigs compared with G
Pat
 pigs; however, there were no other differences (P ≥ 0.59) in MHC2X 
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expression between genotypes at any other age.  Lastly, prenatal Myosin Heavy Chain isoform 2b 
(MHC2B) expression was minimal at prenatal time points and at 0d, MHC2B expression 
increased (P < 0.01) over 100-fold from 0d to 21d (Fig. 3.6D).  Similar to MHC2X, MHC2B 
expression at 0d was 1.7-fold greater (P = 0.04) and at d60 tended to be greater (P = 0.07) in A
Pat
 
pigs compared with G
Pat
 pigs; however, the biological significance of this was likely minimal as 
MHC2B expression at d60 and 0d was negligible compared to its expression at later postnatal 
time points.  Expression of MHC2B was not different (P ≥ 0.51) between genotypes at d60, 21d, 
or 176d.     
DISCUSSION 
 Similar to the results of the current study, Van Laere et al. (2003) found that IGF2 
expression was greater in A
Pat
 pigs compared with G
Pat
 pigs at 3 weeks of age and older.  
Additionally, at d60 of gestation IGF2 expression was not different between A
Pat
 and G
Pat
 pigs.  
However, in addition to the elevated postnatal IGF2 expression, IGF2 expression tended to be 
greater in the LM of d90 fetuses and was greater in the LM of neonates at birth.  Greater IGF2 
expression in fetal and neonatal skeletal muscle of A
Pat 
pigs compared with G
Pat 
pigs may have 
increased growth potential by increasing muscle cell number.  Myogenesis is a biphasic event, 
from which fibers are formed in two waves that give rise to primary and secondary muscle 
fibers.  In pigs, the second wave of fiber formation is completed at approximately 85-100 days of 
gestation (Wigmore and Stickland, 1983).  Therefore, elevated IGF2 expression during this time 
could result in greater myoblast recruitment and proliferation.  However, more recent studies 
would also suggest that there is a third wave of fibers known as tertiary fibers that are formed 
during very late gestation through the 2
nd
 or 3
rd
 week after birth (Bérard et al., 2011).  
Consequently, total fiber number in ST muscles tended to be greater in A
Pat 
pigs compared with 
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G
Pat 
pigs.  Furthermore, similar to ST, MYF5 expression was greater at d90 in the LM of A
pat
 pigs 
compared with G
Pat
 pigs, suggestive of myoblast proliferation again leading to additional muscle 
fiber formation. Therefore, it is probable that greater prenatal and neonatal IGF2 expression in 
A
Pat
 pigs compared with G
Pat
 pigs, increases myoblast recruitment and proliferation.  Greater 
fiber number is then responsible for increased muscle weights and reduced fat accumulation in 
A
Pat
 pigs compared with G
Pat
 pigs.   
Despite greater IGF2 expression at 176d, ST fiber CSA tended to be smaller in A
Pat 
pigs 
compared with G
Pat
 pigs.  Similarly, Van den Maagdenberg et al. (2008a) reported a 5 percentage 
unit increase in predicted lean meat content and a 10% increase in LM weight in A
Pat 
pigs 
compared with G
Pat
 pigs but no difference in LM fiber CSA between genotypes.  Additionally, 
while Van den Maagdenberg et al. (2008b) noted no statistical difference between total fiber 
number in the LM of A
Pat 
pigs compared with G
Pat
 pigs; however, similar to the current study, 
muscle fiber number was 10% greater for A
Pat 
pigs compared with G
Pat
 pigs.  Therefore, together 
these data would suggest that greater prenatal and neonatal IGF2 expression in A
Pat 
pigs 
compared with G
Pat
 pigs was perhaps more critical for growth and increased muscle mass 
compared with elevated IGF2 expression at later time points.  Additionally, at 176d A
Pat
 pigs 
appear to be later maturing than G
Pat
 pigs, as A
Pat
 pigs have less subcutaneous fat and greater 
muscle weights.  
In the current study, minimal differences in MHC isoform composition within light and 
dark regions of ST muscles were observed.  Nonetheless, proportion of MHC2A fibers tended to 
be reduced in light regions of ST muscles in A
Pat 
pigs compared with G
Pat
 pigs.  Additionally, 
MHC2A and MHC2X fibers tended to be smaller in light regions and MHC2A fibers tended to 
be smaller in dark regions in A
Pat 
pigs compared with G
Pat
 pigs. Therefore, this overall tendency 
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would result in a slightly lighter, more glycolytic muscle profile.  This was consistent with 
Burgos et al. (2012) and Clark et al. (2014) who reported a slight increase in Minolta L* units, 
indicative of a whiter color for the LM in A
Pat 
pigs compared with G
Pat
 pigs.  However, Van den 
Maagdenberg et al (2008b) found no differences in MHC fiber type composition in the LM of 
A
Pat 
pigs and G
Pat
 pigs.  Additionally, stimulation of growth in pigs by treatment with exogenous 
growth hormone, was mediated by both IGF1 and IGF2 and also did not alter MHC fiber type 
proportions in the LM (Lafaucheur et al., 1992).  It should also be noted that MHC expression 
was not different in the LM at 176d.  Therefore, these data would suggest that LM MHC 
composition was minimally impacted by genotype; while the ST may tend to be more glycolytic 
in nature in A
Pat 
pigs compared with G
Pat
 pigs.   
The liver is the primary source of circulating IGF family members.  However, the 
significance of circulating IGF family members is under significant scrutiny.  Mice lacking 
hepatic Igf1 have normal skeletal muscle growth, despite a 75% reduction in circulating Igf1 
levels (Roith et al., 2001).  While this implies that circulating Igf1 was not required for skeletal 
muscle growth, upon second look, in mice lacking hepatic IGF1 there was also a 75% reduction 
in circulating IGF binding proteins.  Therefore, circulating unbound Igf1 in hepatic Igf1 
knockout mice were similar to wild type animals.  Without further research, the result of normal 
skeletal muscle growth in hepatic Igf1 knockout mice cannot be exclusively attributed to the 
unchanged levels of circulating unbound Igf1 or to the unaltered levels of autocrine/paracrine 
signaling from skeletal muscle.  Regardless, in the current study there was greater hepatic IGF2 
expression at 21d in A
Pat 
pigs compared with G
Pat
 pigs and a concomitant decrease in hepatic 
IGF1. In contrast, Van Laere et al. (2003) reported no difference at 21d in hepatic IGF2 
expression in A
Pat 
pigs compared with G
Pat
 pigs.  Because of the complementary shift in IGF1 
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and IGF2 expression, the effect on skeletal muscle growth was likely minimal.  Nonetheless, it 
would be interesting to determine temporal hepatic changes in methylation status of the wild type 
allele.  Van Laere et al. (2003), reported greater methylation near the SNP within liver tissue 
compared to skeletal muscle tissue of four month old pigs.  However, if methylation status of this 
site was temporally regulated, IGF2 expression should be increased in A
Pat
 pigs whenever the 
G
Pat
 allele is unmethylated, as ZBED6 is unable to bind to a methylated allele. 
Our final objective was to determine if elevated IGF2 expression in A
Pat 
pigs compared 
with G
Pat
 pigs, changed the expression of other negative growth factors such as MSTN and 
ZBED6.  An interaction of MSTN and IGF2 has been previously reported.  Mice subjected to a 
microgravity environment had greater Mstn expression and reduced Igf2 expression in skeletal 
muscle (Lalani et al., 2000) compared with controls.  Conversely, follistatin overexpression 
reduced Mstn and increased Igf2 expression in skeletal muscle of mice (Gilson et al., 2007; 
Gilson et al., 2009).  However, increased IGF2 expression in A
Pat
 pigs compared with G
Pat
 pigs 
did not alter MSTN expression at any time point.  These data imply that MSTN is upstream of 
IGF2 in respect to skeletal muscle growth regulation.  Postnatal ZBED6 expression was not 
different between A
Pat 
pigs and G
Pat
 pigs; however, greater ZBED6 expression at d90 may be a 
prenatal negative feedback loop caused by excess IGF2.  It was also interesting that ZBED6 
expression was greatest at d60, a time point at which IGF2 expression was unresponsive to 
ZBED6 repression.  Further research is needed to fully understand why IGF2 expression is 
unresponsive to ZBED6 at early prenatal time points. 
CONCLUSIONS 
 As expected, the IGF2-G3072A mutation resulted in greater muscle weights at 176d and 
greater postnatal IGF2 expression.   However, prenatal IGF2 expression also tended to be greater 
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at d90 of gestation in A
Pat
 pigs compared with G
Pat
 pigs.  Altered IGF2 expression during late 
gestation tended to result in a greater number of muscle fibers within the ST, and evidence for 
greater muscle fiber number within the LD.  Mechanisms that enhance growth by increasing 
muscle cell number rather than cell size ultimately increases growth potential of mature animals.  
As individual fiber growth plateaus, nutrients are repartitioned towards fat cell growth.  
Therefore, pigs with A
Pat
 alleles may be later maturing and can be marketed at heavier weights 
but with similar subcutaneous fat depth than pigs with G
Pat
 alleles.   
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TABLES 
Table 3.1  Number of prenatal fetuses and postnatal pigs per 
genotype and sex.
3
 
  
Male Female Total 
    G
Pat
 A
Pat
 G
Pat
 A
Pat
   
Prenatal
1
 
     
 
d60 7 9 8 12 36 
 
d90 7 9 8 8 32 
Postnatal
2
 
     
 
0d 8 5 5 12 30 
 
21d 6 9 6 11 32 
  176d 15 14 5 15 49 
1
d60 = fetuses obtained at day 60 of gestation; d90 = fetuses 
obtained at day 90 of gestation. 
2
0d = Piglets obtained at birth; 21d = piglets obtained at weaning; 
176d = pigs slaughtered at a market weight (130 kg Average). 
3
A
Pat
 = Pigs with paternal A alleles; G
Pat
 = pigs with paternal G 
alleles.  
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Table 3.2  Effects of IGF2 G3072A and sex on anthropomorphic measurements at prenatal day 60 and 90 of 
gestation and postnatal days 0, 21, and 176.
1
 
   
Genotype3 
 
Sex 
 
  P Values   
    n2 G
Pat APat   Female Male SEM4 Geno
5 Sex G x S6 
Body weight 
          
 
d60, g 7-12 156.33 164.29 
 
158.38 162.24 3.40 0.06 0.36 0.25 
 
d90, g 7-9 768.88 749.06 
 
756.07 761.87 35.83 0.62 0.88 0.71 
 
0d, kg 16-38 1.46 1.50 
 
1.47 1.49 0.59 0.36 0.65 0.16 
 
21d, kg 6-11 6.22 6.07 
 
6.11 6.18 0.36 0.65 0.85 0.58 
 
176d, kg 5-15 124.45 127.62 
 
121.33 130.73 7.58 0.34 0.01 0.97 
Longissimus Dorsi weight 
          
 
d60, g 2-4 2.17 2.47 
 
2.16 2.47 0.15 0.17 0.16 0.76 
 
d90, g 7-9 11.45 11.30 
 
11.02 11.73 0.99 0.87 0.41 0.59 
 
0d, g 5-12 20.23 19.80 
 
19.97 20.06 1.72 0.76 0.96 0.65 
 
21d, g 6-11 118.44 108.19 
 
111.86 114.77 7.35 0.26 0.75 0.58 
 
176d, kg 5-15 16.13 18.35 
 
17.14 17.34 0.90 < 0.01 0.78 0.97 
Psoas Major weight 
          
 
0d, g 5-12 4.18 4.24 
 
4.21 4.21 0.42 0.89 0.99 0.62 
 
21d, g 5-9 17.30 16.16 
 
17.41 16.06 1.99 0.53 0.46 0.42 
 
176d, kg 5-15 2.19 2.37 
 
2.28 2.29 0.17 0.05 0.97 0.71 
Semitendinosus weight 
          
 
d60, g 2-4 0.40 0.37 
 
0.37 0.40 0.05 0.62 0.71 0.90 
 
d90, g 7-9 2.32 1.94 
 
2.04 2.22 0.30 0.26 0.56 0.31 
 
0d, g 5-12 3.29 3.20 
 
3.32 3.17 0.39 0.77 0.67 0.58 
 
21d, g 6-11 22.35 20.94 
 
21.69 21.60 1.67 0.36 0.96 0.78 
 
176d, kg 5-15 2.82 3.05 
 
2.94 2.93 0.19 0.02 0.93 0.69 
Length7 
          
 
d60, cm 7-12 14.09 14.25 
 
14.07 14.27 0.43 0.34 0.23 0.63 
 
d90, cm 7-9 24.48 24.17 
 
24.22 24.44 0.40 0.44 0.55 0.89 
 
0d, cm 5-12 26.66 27.30 
 
26.61 27.35 0.66 0.40 0.37 0.23 
 
21d, cm 6-11 42.37 41.02 
 
41.72 41.66 0.70 0.16 0.95 0.50 
  176d, cm 5-15 80.79 81.90   81.13 81.56 1.02 0.13 0.57 0.70 
1d60 = fetuses obtained at day 60 of gestation;  d90 = fetuses obtained at day 90 of gestation; 0d = Piglets obtained at birth; 21d = 
piglets obtained at weaning; 176d = pigs slaughtered at a market weight (130 kg Average). 
2Represents the range for n of each Genotype and Sex combination.  
3APat = Pigs with paternal A alleles; GPat = Pigs with paternal G alleles. 
4Maximum standard error of the mean for the fixed effects. 
5Geno = Genotype. 
6G x S = Interaction of Genotype and Sex. 
7At 176d, carcass length was measured from the most anterior point of the first rib to the most anterior point of the aitch bone; at all 
other time points, crown to rump length was measured from the posterior point of the crown to the most anterior point of the tail.   
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Table 3.3  Effects of IGF2 G3072A and sex on fiber type cross sectional area and fiber type proportion in the dark 
and light regions of the ST and total fiber number in the ST at 176d pigs.
1
 
   
Genotype3 
 
Sex 
 
  P Values   
    n2 G
Pat APat   Female Male SEM4 Geno
5 Sex G x S6 
n, pigs 
 
15 19 
 
17 17 
 
   
Dark Region of the ST 
          
 
CSA of MHC1, µm2 5-12 3,687 3,543 
 
3,763 3,466 236.4 0.48 0.17 0.04 
 
CSA of MHC2A, µm2 5-12 3,722 3,337 
 
3,855 3,203 294.7 0.08 < 0.01 0.22 
 
CSA of MHC2X, µm2 5-12 4,165 4,004 
 
4,250 3,919 197.3 0.55 0.23 0.36 
 
CSA of MHC2B, µm2 5-12 2,682 1,978 
 
3,007 1,653 516.8 0.33 0.06 0.53 
 
MHC1, % 5-12 41.8 40.6 
 
41.8 40.7 1.8 0.61 0.66 0.78 
 
MHC2A, % 5-12 27.0 27.6 
 
26.7 27.9 1.0 0.65 0.36 0.51 
 
MHC2X, % 5-12 29.7 30.2 
 
29.1 30.8 1.6 0.44 0.83 0.61 
 
MHC2B, % 5-12 1.5 1.6 
 
2.5 0.6 0.6 0.85 0.03 0.66 
Light Region of the ST 
          
 
CSA of MHC1, µm2 4-10 3,797 4,035 
 
3,809 4,022 610.0 0.77 0.79 0.56 
 
CSA of MHC2A, µm2 4-10 4,501 3,670 
 
4,152 4,019 369.1 0.09 0.82 0.79 
 
CSA of MHC2X, µm2 4-10 5,477 4,459 
 
5,192 4,744 382.6 0.06 0.38 0.89 
 
CSA of MHC2B, µm2 4-10 4,983 4,147 
 
4,832 4,298 413.3 0.14 0.37 0.60 
 
MHC1, % 4-10 4.5 4.8 
 
4.8 4.4 1.2 0.85 0.82 0.04 
 
MHC2A, % 4-10 15.6 12.8 
 
13.3 15.0 1.1 0.06 0.25 0.26 
 
MHC2X, % 4-10 35.2 34.3 
 
33.3 36.2 2.5 0.78 0.44 0.58 
 
MHC2B, % 4-10 44.7 48.2 
 
48.6 44.4 3.1 0.39 0.30 0.46 
Total 
          
 
ST Cross Sectional Area, 
cm2 
4-10 32.6 32.9 
 
33.9 31.6 1.1 0.85 0.14 0.68 
 
Average Fiber CSA, µm2 4-10 4,417 3,894 
 
4,378 3,933 263.6 0.08 0.15 0.81 
 
Total Fiber Number7 4-10 773,462 860,517 
 
803,991 829,988 48,770 0.10 0.63 0.51 
1176d = pigs slaughtered at a market weight (130 kg Average); ST = Semitendinosus; CSA = cross sectional area 
2Represents the range for n of each Genotype and Sex combination.  
3APat = Pigs with paternal A alleles; GPat = Pigs with paternal G alleles. 
4Maximum standard error of the mean for the fixed effects. 
5Geno = Genotype. 
6G x S = Interaction of Genotype and Sex. 
7Total Fiber Number = (ST CSA / Average Fiber CSA) 
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FIGURES 
 
Figure 3.1  Representative images of cross section immunofluorescent analysis of dark (A, B) 
and light (C, D) regions of the semitendinosus muscle from pigs with paternal G alleles (A, C) or  
paternal A alleles (B, D).  Blue fibers correspond to type 1 fibers, green fibers correspond to type 
2a fibers, red fibers correspond to type 2b fibers and the unstained fibers correspond to type 2x 
fibers.  
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Figure 3.2  Interaction means of genotype and age for (A) insulin-like growth factor 2 (IGF2), 
(B) insulin-like growth factor 1 (IGF1), (C) insulin-like growth factor 1 receptor (IGF1R), (D) 
Insulin-like growth factor 2 receptor (IGF2R), (E) Insulin-like growth factor binding protein 3 
(IGFBP3), and (F) Insulin-like growth factor binding protein 5 (IGFBP5), expression in the LM 
at prenatal time points, d60 and d90 of gestation and postnatal time points, birth (0d), weaning 
(21d), and at a market weight of approximately 130 kg (176d) for pigs with paternal A (A
Pat
) 
alleles or paternal G (G
Pat
) alleles.  Gene expression was determined in duplicate quantitative 
polymerase chain reactions (qPCR).  There were no less than 30 animals represented within each 
age.  Gene expression was normalized to the endogenous control, Beta-2-microglobulin.  Least 
square means (± 95% confidence interval) were reported as fold change compared to the average 
male with paternal G alleles.   Bars without a common letter are considered different (P < 0.05).    
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Figure 3.3  Interaction means of genotype and age for hepatic (A) Insulin-like growth factor 1 
(IGF1), and (B) Insulin-like growth factor 2 (IGF2), expression at postnatal time points, birth 
(0d), weaning (21d), and at a market weight of approximately 130 kg (176d) for pigs with 
paternal A (A
Pat
) alleles or paternal G (G
Pat
) alleles.  Gene expression was determined in 
duplicate quantitative polymerase chain reactions (qPCR).  There were no less than 30 animals 
represented within each age.  Gene expression was normalized to the endogenous control, Beta-
2-microglobulin.  Least square means (± 95% confidence interval) were reported as fold change 
compared to the average male with paternal G alleles.   Bars without a common letter are 
considered different (P < 0.05).    
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Figure 3.4  Interaction means of genotype and age for (A) myostatin (MSTN), and (B) zinc finger 
BED-type containing 6 (ZBED6), expression in the LM at prenatal time points, d60 and d90 of 
gestation and postnatal time points, birth (0d), weaning (21d), and at a market weight of 
approximately 130 kg (176d) for pigs with paternal A (A
Pat
) alleles or paternal G (G
Pat
) alleles.  
Gene expression was determined in duplicate quantitative polymerase chain reactions (qPCR).  
There were no less than 30 animals represented within each age.  Gene expression was 
normalized to the endogenous control, Beta-2-microglobulin.  Least square means (± 95% 
confidence interval) were reported as fold change compared to the average male with paternal G 
alleles.   Bars without a common letter are considered different (P < 0.05).    
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Figure 3.5  Interaction means of genotype and age for (A) myogenic factor 5 (MYF5), (B) 
myogenic differentiation 1 (MYOD), and (C) Myogenin expression in the LM at prenatal time 
points, d60 and d90 of gestation and postnatal time points, birth (0d), weaning (21d), and at a 
market weight of approximately 130 kg (176d) for pigs with paternal A (A
Pat
) alleles or paternal 
G (G
Pat
) alleles.  Gene expression was determined in duplicate quantitative polymerase chain 
reactions (qPCR).  There were no less than 30 animals represented within each age.  Gene 
expression was normalized to the endogenous control, Beta-2-microglobulin.  Least square 
means (± 95% confidence interval) were reported as fold change compared to the average male 
with paternal G alleles.   Bars without a common letter are considered different (P < 0.05).    
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Figure 3.6  Interaction means of genotype and age for (A) myosin heavy chain isoform 1 
(MHC1), (B) myosin heavy chain isoform 2a (MHC2a), (C) myosin heavy chain isoform 2x 
(MHC2x), and (D) myosin heavy chain isoform 2b (MHC2b) expression in the LM at prenatal 
time points, d60 and d90 of gestation and postnatal time points, birth (0d), weaning (21d), and at 
a market weight of approximately 130 kg (176d) for pigs with paternal A (A
Pat
) alleles or 
paternal G (G
Pat
) alleles.  Gene expression was determined in duplicate quantitative polymerase 
chain reactions (qPCR).  There were no less than 30 animals represented within each age.  Gene 
expression was normalized to the endogenous control, Beta-2-microglobulin.  Least square 
means (± 95% confidence interval) were reported as fold change compared to the average male 
with paternal G alleles.   Bars without a common letter are considered different (P < 0.05).    
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SUPPLEMENTAL TABLES 
Table 3.4  Experimental diet composition and calculated analysis. 
Ingredient Gestation
1
 
Phase 
1
2
 
Phase 
2
3
 
Phase 
3
4
 
Grower 
1
5
 
Grower 
2
6
 
Finisher
7
 
Corn, % 77.15 30.51 46.59 56.9 69.46 81.12 83.12 
SBM, % 11.55 20.24 23.69 31.18 27.21 15.7 14 
Blood Plasma, % - 7.5 3 - - - - 
Whey, dried, % - 25 20 5 - - - 
Milk, Lactose, % - 10 - - 0 - - 
Choice white grease, % - 3 3 3 1 1 1 
Limestone, % 0.75 1.14 1.09 0.9 0.96 0.8 0.7 
DCP, % 1.9 0.63 0.85 1.35 0.92 0.85 0.78 
Lysine HCL, % - 0.04 0.05 0.02 - 0.13 0.05 
DL-Met, % - 0.14 0.07 0.02 - - - 
Salt, % - 0.1 0.1 - - - - 
Cu sulfate, % - - - 0.08 - - - 
ZnO, % - 0.4 0.26 - - - - 
Pulmotil 18, % - 0.75 0.75 - - - - 
Mecadox 2.5, % - - - 1 - - - 
Swine TM, % 0.35 0.35 0.35 0.35 0.35 0.3 0.3 
Vit. ADEK, % 0.2 0.2 0.2 0.2 0.1 0.1 0.05 
Sow Pac, % 0.1 - - - - - - 
 
       Total ME (kcal/kg) 3,280 3,462 3,418 3,382 3,338 3,355 3,367 
CP, % 12.5 20.9 19.79 20.15 18.71 14.18 13.53 
Total lysine, % 0.57 1.45 1.24 1.13 0.98 0.77 0.66 
SID lysine, % 0.47 1.29 1.10 0.99 0.85 0.67 0.56 
Available P, % 0.40 0.48 0.44 0.40 0.30 0.26 0.24 
Ca, % 0.85 0.81 0.82 0.81 0.68 0.57 0.51 
SID Met:Lys 0.40 0.30 0.30 0.30 0.31 0.32 0.37 
SID Thr:Lys 0.76 0.63 0.64 0.66 0.69 0.64 0.71 
SID Trp:Lys 0.23 0.22 0.22 0.23 0.23 0.20 0.22 
SID Ile:Lys 0.88 0.61 0.68 0.77 0.80 0.73 0.81 
SID Val:Lys 1.02 0.74 0.77 0.82 0.88 0.84 0.94 
1
Ad libitum access to the gestation diet was provided from artificial insemination through parturition.  
2
Ad libitum access to the Phase 1 diet was provided from 10d of age to 30d of age.  
3
Ad libitum access to the Phase 2 diet was provided from 30d of age to 40d of age. 
4
Ad libitum access to the Phase 3 diet was provided from 40d of age to 90d of age. 
5
Ad libitum access to the Grower 1 diet was provided from 90d until the average weight of the pigs 
within the barn reached 50 kg. 
6
 Ad libitum access to Grower 2 diet was provided when the average weight of the pigs within the 
barn reached 50 kg until the average weight of the pigs reached 80kg. 
7
 Ad libitum access to Finisher diet was provided when the average weight of the pigs reached 80 kg 
until slaughter. 
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Table 3.5  IGF family member and myogenic regulatory factor Taqman primers and accession 
identification numbers for quantitative gene expression analysis.
1
 
Gene Name 
Accession 
Number Primer Primer/Stock Number 
Insulin-like growth factor 2 
(IGF2) 
 Forward: CCGTGCTTCCGGACAACT 
NM_213883.2 Reverse: AGGTGTCATAGCGGAAGAACTTG 
 Reporter: CCCCAGATACCCCGTGG 
    
Insulin-like growth factor 1 
receptor (IGF1R) 
 Forward: TGGCCAGAACCTGAGAATCCT 
NM_214172.1 Reverse: GGACACACATTCCCGCTGAT 
 Reporter: ATACGGATCACAAGTCGAG 
    
Insulin-like growth factor 2 
receptor (IGF2R) 
 Forward: CCACGCTGGAGCAGTACGA 
NM_001244473.1 Reverse: TGTCCAGGGCGTACCAGTTC 
 Reporter: CTCTCCAGTCTTGCAAAA 
    
Insulin-like growth factor 
binding protien 3 (IGFBP3) 
 Forward: CGCTACAAGGTCGACTACGAGTCT 
NM_001005156.1 Reverse: GCGGCAAGGCCCGTAT 
 Reporter: TCTCCTCTGAGTCCAAGC 
 
 
  
Insulin-like growth factor 
binding protien 5 (IGFBP5) 
 Forward: GACCGCAAGGGATTCTACAAGA 
NM_214099.1 Reverse: TCCACGCACCAGCAGATG 
 Reporter: CCTTCCCGTGGCCG 
    
Myogenic factor 5(MYF5) 
 Forward: GTCCAGAAAGAGCAGCAGTTTTG 
NM_001278775.1 Reverse: AGGAGCTTTTATCCGTGGCATAT 
 Reporter: ATCTACTGTCCGGATGTAC 
    
Myogenin (MYOG) 
 Forward: CCTCCTGCAGTCCAGAATGG 
NM_001012406.1 Reverse: TAGGGTCAGCTGTGAGCAGATG 
 Reporter: TGGAGTTCGGCCCC 
    Insulin-like growth factor 1 
(IGF1) 
NM_214256.1 Stock #: Ss03394499_m1 
Myogenic differentiation 1 
(MYOD) 
NM_001002824.1 Stock #: Ss03378464_u1 
1
All primers are Taqman primers purchased from Life Technologies (Grand Island, NY) and all reporters are 
Fam fluorescently labeled.  
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Table 3.6  Myostatin, ZBED6, myosin heavy chain, and endogenous control Taqman primers and 
accession identification numbers for quantitative gene expression analysis.
1
 
Gene Name 
Accession 
Number Primer Primer/Stock Number 
Myostatin (MSTN) 
 
Forward: CGACGGAAACGATCATTACCA 
NM_214435.2 Reverse: AAGCAGCATTTGGGTTTTCCT 
 
Reporter: TACAGAGTCTGATCTTCTAATG 
    
zinc finger BED-type 
containing 6 (ZBED6) 
 Forward: TTTGACCCAAGTTGCTGTTCAGT 
XM_005656651.1 Reverse: TGAAAGTGGCCATTTGCAGTAA 
 
Reporter: CATGTGTAGTTGGCAATC 
    
Myosin Heavy Chain 1 
(MHC1) 
 Forward: AATGTCCAGCAGGTGATGTATGC 
NM_001104951.1 Reverse: ATCCGTGTCACCATCCAGTTG 
 
Reporter: AGGCCGTGTATGAGAAG 
    
Myosin Heavy Chain 2a 
(MHC2A) 
 Forward: GCAAAAGCGTAATGCTGAAGCT 
NM_214136.1 Reverse: CCTCTTCCGTCTGGTAGGTGAGT 
 
Reporter: TGCGCAAACATGAGAGG 
    
Myosin Heavy Chain 2x 
(MHC2X) 
 Forward: GGGTCTACGCAAACACGAGAGA 
NM_001104951.1 Reverse: CAGATCCTGGAGCCTGAGAATG 
 
Reporter: AAGGAACTCACTTACCAAAC 
    
Myosin Heavy Chain 2b 
(MHC2B) 
 
Forward: GGGTCTTCGGAAACATGAGAGA 
NM_001123141.1 Reverse: TCCTGCAGCCTGAGAACATTC 
 
Reporter: TTACCAGACTGAGGAGGAC 
    
Beta-2 Microglobulin (B2M) 
 Forward: GTGAAGCACGTGACTCTCGATAAG 
NM_213978.1 Reverse: ATAATCTCTGTGATGCCGGTTAGTG 
  Reporter: AAGATAGTTAAGTGGGATCGAGA 
1
All primers are Taqman primers purchased from Life Technologies (Grand Island, NY) and all reporters are 
Fam fluorescently labeled.  
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Chapter 4 
ELEVATED INSULIN-LIKE GROWTH FACTOR 2 EXPRESSION MAY 
CONTRIBUTE TO THE HYPERMUSCULAR PHENOTYPE OF MYOSTATIN NULL 
MICE 
 
ABSTRACT 
Myostatin (Mstn) inhibits while insulin-like growth factors 1 and 2 (Igf1 and Igf2) increase pre- 
and postnatal skeletal muscle growth.  However, there is little known regarding Mstn regulation 
of Igf1 and Igf2 expression during postnatal growth.   Therefore, we quantified expression of IGF 
family members in skeletal muscle and liver during the rapid growth phase of Mstn null (MN) 
mice.  Wild type (WT) and MN mice were euthanized at birth (0d), 7 days (7d), weaning (21d), 
sexual maturity (42d), and 10 weeks of age (70d).  For the neonatal periods, 0d and 7d, all 
muscles from the hind limbs were compiled for RNA extraction.  At 21d, 42d, and 70d, biceps 
femoris (BF), tibialis anterior, triceps brachii (TB), and gastrocnemious-soleus complex were 
collected.   As expected, muscle weights were up to 90% greater in MN mice compared with WT 
mice at 21d, 42d and 70d. However, Igf1 expression was reduced (P ≤ 0.04) at 7d and 21d in 
MN mice compared to WT mice.  Expression of Igf2 did not differ between genotypes at 0d and 
7d.  However, at 21d, 42d and 70d in BF and TB muscles, Igf2 expression was 1.9 – 2.9 fold 
greater (P < 0.01) in MN compared to WT mice.  Likewise, a similar increase was observed in 
three known Igf2 transcript variants at 21d and 70d in BF muscles of MN mice compared with 
WT mice.  Additionally, at 70d Igf2 protein levels in BF muscles were 223% greater (P < 0.01) 
in MN mice compared with WT mice.  Hepatic Igf1 and Igf2 levels were minimally affected by 
genotype; with the exception of, a 1.4-fold reduction (P = 0.04) in Igf1 expression in 21d MN 
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mice compared with WT mice.  Hepatic Igf2 expression tended to greater (P = 0.06) at 21d in 
MN mice compared with WT mice.  Therefore, this study is the first to provide evidence that 
Mstn may negatively regulate Igf2 expression to control postnatal skeletal muscle growth. 
Key Terms:  Myostatin, Insulin-Like Growth Factor, Igf1, Igf2 
 
INTRODUCTION 
 Myostatin (Mstn), a TGF-β superfamily member, is a negative regulator of both prenatal 
and postnatal skeletal muscle growth (McPherron et al., 1997).  Mutations that diminish Mstn 
functionality have been identified in mice (McPherron et al., 1997), cattle (Grobet et al., 1998), 
dogs (Moser et al., 2007), sheep (Clop et al., 2006) and humans (Schuelke et al., 2004).  Such 
mutations result in up to 87% more skeletal muscle fibers and up to a two to three-fold increase 
in body weight (McPherron et al., 1997).  Myostatin inhibits growth by binding to the type II 
activin receptor thereby activating both the Smad protein and MAPK pathways leading to altered 
transcriptional activity (Kollias and McDermott, 2008).   
Insulin-like growth factor 1 and 2 (Igf1 and Igf2) both stimulate growth by activating 
Igf1 receptor (Igf1r) (Florini et al., 1996).  Body weights of mice lacking functional Igf1 or Igf2 
are reduced 40% or 60%, respectively, compared to wild type mice (Baker et al., 1993; DeChiara 
et al., 1990). Insulin-like growth factor 2 is maternally imprinted and primarily regulates prenatal 
growth, as Igf2 expression is reduced over 40-fold in skeletal muscle postnatally compared to 
prenatal levels  (Van Laere et al., 2003).  Additionally, there are 3 known and 2 predicted Igf2 
sequences (Duart-Garcia and Braunschweig, 2014).  However, there is currently minimal 
information about the temporal expression patterns of the variants.  
Despite the greatly reduced expression of Igf2 during postnatal growth, Igf2 may still 
play an important role in regulating postnatal skeletal muscle hypertrophy.  Pigs with a mutation 
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within intron 3 of the paternal Igf2 allele disrupting the binding site of the transcriptional 
repressor Zbed6 had greater postnatal Igf2 expression (Van Laere et al., 2003; Andersson et al., 
2010; Markljung et al., 2009).  At approximately 185 days of age this mutation results in 5-fold 
greater Igf2 expression resulting in greater skeletal muscle mass and reduced subcutaneous fat 
accumulation (Gardan et al., 2008, Van Den Maagdenbeg et al., 2008).   
 Current preliminary research would indicate that Mstn may mediate transcription of IGF 
family members.  In vitro, exogenous Mstn decreases Igf2 but not Igf1 in primary myoblasts 
(Miyake et al., 2010).  Myostatin null (MN) mice have been previously used to determine how 
loss of Mstn affects IGF family member expression (Kocamis 2002, and Williams 2011).  
Kocamis et al. concluded that Mstn acts as an endocrine factor that travels to the liver to reduce 
hepatic Igf1 expression and circulating Igf1 levels.  Additionally, Igf1 expression was decreased 
in the gastrocnemius muscle of MN mice compared with WT mice.  However, IGF family 
members are known to have unique temporal expression patterns in skeletal muscle, and 
previous research has only quantified IGF expression after the mice have reached their mature 
size.  Additionally, due to reduced Igf2 expression in skeletal muscle after birth, its role in 
postnatal growth stimulation has largely been ignored.   Determining how the loss of Mstn alters 
expression of IGF family members is a first step in understanding how these two potent growth 
factor families, Igf and Mstn, cooperate to control growth. 
MATERIALS AND METHODS 
Animals and Sample Collection 
 The University of Illinois Institutional Animal Care and Use Committee approved all 
animal procedures.  Mice from an internal C57BL/6 J colony were provided ad libitum access to 
a chow diet, had ad libitum access to water, were maintained in a 12 hour light/dark cycle, and 
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were individually housed after weaning.  Mice heterozygous for the Mstn mutation described by 
McPherron et al. (1997) were kept in monogamous breeding pairs.  Offspring were euthanized at 
5 timepoints: birth (0d), one week of age (7d), weaning (21d), six weeks of age (42d), and 7 
weeks of age (70d).  Samples were obtained from 5 male and 5 female Mstn null (MN) mice and 
5 male and 5 female wild type (WT) mice at each time point.  Entire litters of mice were 
euthanized by decapitation within twenty-four hours after birth for 0d samples and seven days 
after birth for 7d samples.  Mice were euthanized at 21d, 42d or 70d by asphyxiation with carbon 
dioxide followed by cervical dislocation.  All mice were weighed after euthanasia to determine 
whole body weight.  Skin, head, feet, tail and internal organs were removed to determine empty 
carcass weights.  A portion of tail was used for genotyping.  For 7d and older mice, liver and 
heart were weighed and the liver was stored for further analysis.  For 0d and 7d mice, muscles 
from hind limbs were removed from each side of the carcass, compiled and stored at -80C for 
further analysis.  For mice 21d and older, triceps brachii (TB), tibialis anterior, 
gastrocnemious/soleus complex, and biceps femoris (BF) muscles were removed, weighed, and 
stored at -80° C. 
Genotyping 
 Isolation of DNA was completed with DNA Prep for PCR Extracta Kit (Quanta 
Biosciences; Gaithersburg, MD) according to manufacturer’s instructions.  Genotyping was 
accomplished by PCR using Accustart
TM
 II GelTrack PCR supermix kit (Quanta Biosciences; 
Gaithersburg, MD) in accordance with manufacturer’s protocol with the addition of three Mstn 
primers listed in supplementary table 4.3.  Thermocycler parameters were as follows:  94º C for 
3 min followed by 30 cycles of 94º C for 15 s, 56.5º C for 30s, and 72º for 1 min.  Products were 
visualized on a 2.5% agarose gel.   
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RNA Isolation and cDNA preparation 
 Isolation of RNA and concentration quantification was completed as described by Jones 
et al. (2014).  Synthesis of cDNA was carried out with qScript cDNA SuperMix (Quanta 
Biosciences, Gaithersburg, MD) following manufacturer procedures.  In short, 1µg of RNA was 
added to qScript cDNA SuperMix  and incubated at 25° C for 5 minutes, 42° C for 30 minutes 
and then 85° C for 5 minutes and then stored at -20C for further analysis. 
Quantitative Polymerase Chain Reaction 
 Quantitative polymerase chain reaction (qPCR) was completed with TaqMan Gene 
Expression Master Mix (Life Technologies, Grand Island, NY) in accordance with 
manufacturer’s directions.  For all muscle samples, 18s rRNA was determined to be unaffected 
by genotype and age, and had an efficiency between 0.9 and 1.0 and therefore was used as the 
endogenous control. For liver samples, Gapdh was chosen to be an acceptable endogenous 
control using similar criteria.  On a 96 well plate, duplex reactions were performed in duplicate 
such that each gene of interest was simultaneously quantified with the endogenous control.  
Primer/probe mixes were obtained from Life Technologies for both IGF family members 
(Supplemental Table S4.4) and Igf2 transcript variants (Supplemental Table 4.5).  A Step One 
Plus qPCR machine (Applied Biosystems by Life Technologies; Grand Island, NY) was used to 
amplify and quantify gene expression using the following temperature cycle:  50º C for 2 min, 
95º C for 10 min followed by 40 cycles of 95º C for 15 s, 60º C for 1 min.  The gene of interest 
for each sample was normalized to the reference gene.  For 0d and 7d, gene expression in 
compiled hind limb samples were expressed as a fold change compared to the 7d WT male 
average.  For 21d, 42d and 70d, gene expression in BF and TB muscles were expressed as fold 
change compared to the 70d WT male average for each respective muscle.     
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Skeletal Muscle Igf2 Protein Quantification 
 Protein was extracted from 70d BF muscle in 1X RIPA buffer with Triton-X 100 (Alfa 
Aesar, Ward Hill, MA).  Protein concentration was determined on a 1/20 dilution of protein 
extract solution using Pierce
TM
 BCA Protein Assay Kit (Thermo Scientific, Waltham, MA) 
following manufacturer procedures.  Protein concentrations were standardized to 5µg/ml.  
Following manufacturer procedures, Igf2 levels were quantified in a 1/10 dilution by a Mouse 
IGF-2 ELISA kit (EK0381, Boster Biological Technology Co., Ltd., Fremont, CA) with a 
sensitivity of < 5pg/ml and no detectable cross-reactivity with Igf1.  Wavelength was read with a 
spectrophotometer (Synergy HT; BioTek, Winooski, VT). 
Statistical Analysis 
 Data were analyzed using the mixed procedure in SAS (SAS Institute Inc., Cary, NC) and   
individual mouse was the experimental unit for all traits measured.   Data were analyzed as a 
randomized complete design in a factorial arrangement of treatments.  For body and muscle 
weights, data were analyzed as a 2 x 2 factorial arrangement with the main effects of genotype, 
sex and the interaction of the two at each age.  For skeletal muscle Igf family member gene 
expression, due to differences in muscle samples (compiled hind limb vs. BF or TB), 0d and 7d 
were analyzed separately from 21d, 42d, and 70d samples.  Therefore, early time points were 
analyzed as a 2 x 2 x 2 factorial arrangement while older time points were analyzed as a 2 x 2 x 3 
factorial arrangement with genotype, sex, age and interactions as the main effects.  For hepatic 
gene expression, (21d, 42d, and 70d) data were also analyzed as a 2 x 2 x 3 factorial 
arrangement.  For Igf2 transcript variant analysis, we analyzed 0d, 21d, and 70d samples together 
with the addition of variant expression in the 2 x 2 x 3 x 3 (genotype, sex, age, variant) factorial 
arrangement model.   
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For gene expression, ΔΔCT values were used for analysis and main effect means were 
presented as fold change (± 95% confidence interval).  Body weights and muscle weights were 
presented as main effects means (± standard error of the mean) of genotype and sex.  While sex 
was included in the model, unless otherwise specified there were no genotype and sex or three-
way interactions (P > 0.10). Therefore, for simplicity, gene expression and ELISA data were 
presented as interaction means (± standard error of the mean) of genotype and age (Supplemental 
Figures 4.7-S4.12). Transcript variant data were presented as the interaction means (± 95% 
confidence interval) of genotype, age and variant, as there was no 4-way interaction.  The 
probability of difference option (PDIFF) was used to determine differences in least square 
means.  A Tukey adjustment was used to protect against type 1 error due to multiple 
comparisons. Comparisons of means were considered significant if P ≤ 0.05 and trending 
towards significance if 0.05 ≤ P ≤ 0.10. 
RESULTS 
Body, Organ and Muscle Weights 
 While loss of Mstn is known to result in increased muscle weights in adult mice 
(McPherron et al., 1997) there are limited data that quantify skeletal muscle and organ weights 
specifically during the rapid phase of growth in MN mice.  An interaction between genotype and 
sex was observed at 0d, male MN body weights were at least 19% heavier (P ≤ 0.02) than male 
WT,  female MN, and female WT mice. On the other hand, genotype did not alter (P = 0.81) 
body weights of female mice at 0d, and female mice weights did not differ (P ≥ 0.60) at 0d from 
male WT mice.  At 7d of age, body weight (P = 0.11) and carcass weight (P = 0.94) did not 
differ between genotypes (Table 4.1).  However at 21d, body weight was actually reduced 10% 
(P = 0.04) in MN mice compared with WT mice despite similar carcass weights (P = 0.95) 
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between genotypes.  At 42d, body weight was similar between genotypes (P = 0.87), however, 
the MN hypermuscular phenotype was evident in the 17.9% increase in carcass weight (P < 
0.01) in MN mice compared with WT mice.  Similarly at 70d, whole body weights and carcass 
weights were increased (P < 0.01) 19.6% and 45.3%, respectively, for MN mice compared with 
WT mice.   
The hypermuscular phenotype of MN mice was also quite evident in the weights of 
individual muscles.  At 21d of age, TB and gastroconemius/soleus complex muscles were 45.0% 
and 28.2% heavier, respectively,(P ≤ 0.03), in MN mice compared with WT mice (Table 4.2).  
Additionally at 21d, tibialis anterior muscles tended to be heavier (P = 0.07) in MN mice 
compared with WT mice; however, BF muscles were not different (P = 0.83) between 
genotypes.  At 42d and 70d all muscles collected were between 32-110% heavier (P ≤ 0.04) in 
MN mice compared with WT mice.  
 Liver and heart weights were collected from 7d to 70d to determine the effects of loss of 
Mstn on organ growth.  At 7d, liver weights were not different (P = 0.12) between genotypes; 
though at 21d and 42d, liver weights were reduced (P ≤ 0.01) by 25% and 20% in MN mice 
compared with WT mice.  At 70d, liver weights were not different (P = 0.41) between MN mice 
and WT mice.  Similarly, heart weights were reduced (P = 0.01) 17% at 21d in MN mice 
compared with WT mice. However, heart weights were not different (P ≥ 0.14) between MN 
mice and WT mice at any other time point.   
Skeletal muscle IGF family member expression 
 We hypothesized that increased IGF signaling may be responsible for the greater skeletal 
muscle hypertrophy in MN mice.  To test our hypothesis, we quantified IGF family member 
expression within skeletal muscle of MN and WT mice.   As expected, Igf2 expression decreased 
 111 
 
with age (Figure 4.1).  It should also be noted, Igf2 expression was greater than Igf1 expression 
at all time points excluding 70d.  Expression of Igf1 was reduced (P < 0.01) in compiled hind 
limb muscles at 7d and was reduced (P ≤ 0.04) in both TB and BF muscles at 21d in MN mice 
compared with WT mice. At 0d and 7d, Igf2 was not different (P ≥ 0.41) between MN mice and 
WT mice; however, at 21d, 42d, and 70d, Igf2 expression was 1.9 - 2.9 fold greater (P < 0.01) in 
TB and BF muscles of MN mice compared with WT mice.  During this same period (21d to 
70d), we observed a more dramatic weight gain in muscles of MN mice (400%) compared with 
muscles of WT (264%) mice.  Therefore, increased Igf2 and not Igf1 expression may support the 
greater postnatal skeletal muscle hypertrophy of MN mice.  
At 7d, both Igfr1 and Igfr2 expression was increased compared with 0d, but expression 
did not differ between genotypes (Figure 4.2).  At 21d, Igf1r expression was 1.7-fold greater (P ≤ 
0.04) in TB and BF muscles of MN mice compared with WT mice, but expression was similar 
between genotypes at 42 and 70 d.  Expression of both Igf2r and Igfbp3 were not different (P ≥ 
0.13) between MN mice and WT mice.  Expression of Igfbp5 was greater (P = 0.01) in hind limb 
muscles at 7d in MN mice compared with WT mice (Figure 4.3).  Additionally, Igfbp5 was 
greater (P ≤ 0.01) in TB muscles at 21d and 70d in MN mice compared with WT mice. 
However, in BF muscles Igfbp5 expression was greater (P = 0.02) only at 42d in MN mice 
compared with WT mice. We conclude from this that Igf2 and possibly Igf1r may contribute to 
the postnatal skeletal muscle hypertrophy of MN mice.  
Igf2 Transcript Variant and Opposite Strand Expression 
 These data support the role of Igf2 contributing to the increased muscle hypertrophy 
observed in MN mice. However, it was unknown whether this increased expression of Igf2 was 
variant specific. Therefore, we quantified gene expression of three known (V1, V2, and V3) and 
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two predicted variants (VX1 and VX2) in skeletal muscle (Duart-Garcia and Braunschweig, 
2014) at 0d, 21d, and 70din MN mice and WT mice.  Transcript variant data are presented in 
Figure 4.4.  All Igf2 transcript variants expression decreased with age.  The two predicted 
transcript variants (VX1 and VX2) were only minimally expressed at 0d. At 21d, VX2 was not 
detectable, and at 70d, VX1 and VX2 were not detectable (data not shown).  At 0d there was also 
no difference in transcript variant expression in hind limb muscles between WT and MN mice, 
reiterating are earlier finding that at 0d, Igf2 expression in hind limb muscles is not affected by 
genotype.  At 21d and 70d, Igf2 V1, V2 and V3 expression were all elevated (P < 0.01) in MN 
mice compared with WT mice.  At 21d V1, V2, and V3 expression were 2.8, 2.2, and 2.3-fold 
greater in MN mice compared with WT mice.  Additionally, at d70 V1, V2, and V3 expression 
were 3.4, 2.5, and 3.9-fold greater in MN mice compared with WT mice.   
 In addition to transcript variant analysis, we also quantified the expression of an antisense 
Igf2 transcript (Igf2as), transcribed on the complimentary strand of Igf2.  Elevated Igf2 
expression is often associated with elevated Igf2as expression (Braunschweig, 2004).  Therefore 
as expected, at 0d Igf2as expression in hind limb muscles were not different between MN mice 
and WT mice (data not shown).  However, at 21d Igf2as expression in BF muscles were 2.0-fold 
greater (P < 0.01) in MN mice compared with WT mice.  Interestingly at 70d albeit Igf2 
expression was greater in MN mice compared with WT mice, Igf2as was not different between 
MN mice and WT mice.  However, the practical significance of this is restricted due to the 
limited functional understanding of the Igf2as transcript.  
IGF2 protein quantification 
 To determine if the elevated Igf2 expression were translated into elevated protein levels, 
we quantified Igf2 protein at 70d in BF muscles (Table 4.5).   Similar to above results, Igf2 was 
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increased 223% (P < 0.01) in MN mice (13,817 pg/ml ± 1,377) compared with WT mice (6,205 
pg/ml ± 1,460).  Again this supports our hypothesis that elevated Igf2 may contribute to the 
hypermuscular phenotype in MN mice.   
Liver Expression 
 Myostatin has been demonstrated to have endocrine actions, and specifically act upon the 
liver to increase Igf1 expression. Therefore, we quantified hepatic Igf1 and Igf2 expression at 
21d, 42d, and 70d, as it is the primary source of circulating IGF family members. Expression of 
Igf1 increased with age, while expression of Igf2 declined (Figure 4.6).  Additionally, Igf1 
expression was reduced (P = 0.04) 1.4-fold in liver at 21d in MN mice compared with WT mice; 
however, at 42d and 70d there was no difference in Igf1 expression between MN and WT mice.   
Hepatic Igf2 expression tended to be elevated 1.3-fold (P = 0.06) at 21d for MN mice compared 
with WT mice.  At 42d and 70d Igf2 expression was nearly undetectable, and there was no 
difference (P ≥ 0.43) in expression between genotypes.  
DISCUSSION 
 Mice lacking functional Mstn have larger and approximately 87% more skeletal muscle 
fibers (McPherron et al., 1997).  Therefore, Mstn regulates both prenatal hyperplasia of 
myoblasts and postnatal hypertrophy of myofibers.  While Mstn is known to inhibit skeletal 
muscle growth by activating the Smad pathway, less is known regarding the interaction of Mstn 
and positive growth regulators such as Igf1 and maternally imprinted, Igf2.  With differing 
affinities, both Igf1 and Igf2 can bind and activate Igf1r and insulin receptor isoforms to increase 
skeletal muscle growth.  It has been a contemporary belief that because of the significant decline 
in Igf2, especially circulating Igf2, after birth, Igf2 is primarily responsible for controlling fetal 
skeletal muscle growth while Igf1 is responsible for regulating growth of postnatal skeletal 
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muscle.  However, recently the importance of postnatal skeletal muscle Igf2 expression has come 
to the forefront.  A SNP within intron 3 of the paternal Igf2 allele in pigs has been associated 
with increased leanness and decreased fat accumulation (Van Laere et al., 2003).   Pigs with the 
‘A’ allele have greater postnatal Igf2 expression compared with those with the wild type ‘G’ 
allele.  Given the increase in muscle hypertrophy in IGF2 ‘A’ pigs, we hypothesized that 
increased postnatal muscle hypertrophy in MN mice may also be associated with elevated Igf2 
levels. 
 While, Igf2 expression has been shown to be elevated in bovine MN fetuses during late 
gestation compared to WT fetuses (Gerrard and Grant, 1994), we are first to demonstrate that 
MN mice have elevated postnatal Igf2 expression.  Therefore, we hypothesize that Mstn may 
regulate postnatal skeletal muscle growth by repressing skeletal muscle Igf2 expression, leading 
to reduced postnatal hypertrophic skeletal muscle growth.  This is in agreement with previous 
studies that have also identified Igf2 as a potential target for Mstn.  Lalani et al. (2000) reported 
that mice subjected to microgravity environment during space shuttle flight had elevated Mstn 
expression and decreased Igf2 expression, while Igf1 was unaltered.  Additionally, 
overexpression of follistatin, an inhibitor of Mstn, elevates Igf2 expression (Gilson et al., 2007, 
Kalista et al., 2012).  However, Kalista et al. (2012) concluded that Igf2 does not play a role in 
the greater skeletal muscle hypertrophy of MN mice as inhibition of Mstn by follistatin was 
dependent upon Igf1r and not dependent upon Igf2. However, follistatin also can repress other 
growth inhibitors and, in fact, can induce hypertrophy independent of Mstn inhibition (Winbanks 
et al., 2012).  Therefore, a conclusion cannot be drawn regarding the role of Igf2 in Mstn 
inhibition based on studies designed to evaluate the effects of follistatin.   
 115 
 
Myostatin elicits a growth inhibitory response by binding and activating the cell surface 
receptor, activin receptor IIB (Acvr2b) (Lee and McPherron, 2001).  Upon activation, activin-
like kinase (ALK) phosphorylates Smad 2/3, which initiates the Smad signaling cascade that 
ultimately reduces cell proliferation and hypertrophic growth (Lee and McPherron, 2001).  
Miyake et al. (2010) demonstrated that Igf2 expression is attenuated when myoblasts are treated 
with recombinant myostatin.  However Igf2 expression was restored with the addition of an ALK 
inhibitor.  Therefore, these data provide evidence that myostatin negatively regulates the 
expression of Igf2 in an ALK/Smad dependent manner (Miyake et al., 2010).     
The significance of circulating Igf1 and Igf2 in supporting skeletal muscle hypertrophy 
has been a controversial topic of discussion.  Hepatic Igf1 knockdown models had normal 
skeletal muscle growth, despite 75% less circulating Igf1 (Roith et al., 2001) suggesting that 
autocrine/paracrine Igf1 signaling is more important for regulation of skeletal muscle growth.  
However, in hepatic specific Igf1 knockdown models, a concomitant, approximately 75% 
reduction in IGFBPs also occurred resulting in similar levels of circulating unbound Igf1 (Roith 
et al., 2001).  Therefore, it is unknown if normal growth pattern was a result of 
autocrine/paracrine signaling or from normal levels of unbound Igf1.   
Previous reports have implicated a reduction in circulating Igf1 as one mechanism of the 
inhibitory effects of Mstn (Williams et al., 2011).  However, in our current study, hepatic Igf1 
expression was reduced at 21d in MN mice compared with WT mice, and there were no 
differences in hepatic Igf2 expression at any time point between MN mice and WT. This is in 
contrast to Williams et al. (2011) that detected elevated hepatic Igf1expression and circulating 
Igf1 levels in 7-month old MN mice compared with WT mice.  Thereby, concluding that Mstn is 
released into circulation to decrease hepatic Igf1 expression, leading to decreased circulating Igf1 
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levels. These discrepancies could be explained by the age of mice used in each respective study.  
Our study focused on younger mice when growth is most rapid, whereas, Williams et al. 
evaluated mature, 7-month old mice.  At this mature stage, increased hepatic Igf1 may be needed 
to sustain and maintain greater muscle mass in MN mice compared with WT mice.  However, 
results of our study would imply that Mstn does not regulate hepatic Igf1 expression in growing 
mice.   
 With exception of Igf2, IGF family member expression was similar to previous studies.  
In agreement with Williams et al. (2011) expression of skeletal muscle Igf1 was, in general, 
reduced in MN mice compared with WT mice.  A possible explanation for reduction in Igf1 
expression could be partially explained by a compensatory down regulation caused by elevated 
Igf2 expression.  However, this does not fully explain reduced Igf1 expression at 7d when Igf2 
expression was not elevated in MN mice compared with WT mice.  Therefore, further research is 
needed to fully understand why loss of Mstn results in reduced Igf1 expression.  Additionally, 
similar to our study, inhibition of Mstn by follistatin or loss of functional Mstn elevates Igf1r 
expression (Kalista et al., 2012; Williams et al., 2011).  Elevated Igf1r expression could also 
partially explain increased growth in MN mice compared with WT mice.   
 Using MN mice, we have provided evidence to support our hypothesis that Mstn reduces 
Igf2 to inhibit postnatal skeletal muscle growth.  However, further research is needed to confirm 
if elevated Igf2 expression is necessary for increased skeletal muscle growth in MN mice.  
Understanding the pathways that regulate and control skeletal muscle growth are essential for 
developing therapeutics and growth enhancing technologies needed to mitigate atrophic 
muscular diseases. 
  
 117 
 
LITERATURE CITED 
Andersson, L., G. Andersson, G. Hjälm, L. Jiang, K. Lindblad-Toh, A. M. Lindroth, E. 
Markljung, A. M. Nyström, C. J. Rubin, and E. Sundström. 2010. ZBED6: The birth of a 
new transcription factor in the common ancestor of placental mammals. Transcription. 
1:144-148. 
Baker, J., J. Liu, E. J. Robertson, and A. Efstratiadis. 1993. Role of insulin-like growth factors in 
embryonic and postnatal growth. Cell. 75:73-82. 
Braunschweig, M. H., A. Van Laere, N. Buys, L. Andersson, and G. Andersson.  2004.  IGF2 
antisense transcript expression in porcine postnatal muscle is affected by a quantitative 
trait nucleotide in intron 3.  Genomics.  84: 1021-1029. 
Clop, A., F. Marcq, H. Takeda, D. Pirottin, X. Tordoir, B. Bibé, J. Bouix, F. Caiment, J. Elsen, 
and F. Eychenne. 2006. A mutation creating a potential illegitimate microRNA target site 
in the myostatin gene affects muscularity in sheep. Nat. Genet. 38:813-818. 
DeChiara, T. M., A. Efstratiadis, and E. J. Robertsen. 1990. A growth-deficiency phenotype in 
heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting.  
Nature. 345:78-80. 
Duart-Garcia, C. and M. H. Braunschweig. 2014.  Functional expression study of igf2 antisense 
transcript in mouse.  Int. J. Genomics.  390296. 
Florini, J. R., D. Z. Ewton, and S. A. Coolican. 1996. Growth hormone and the insulin-like 
growth factor system in myogenesis. Endocr. Rev. 17:481-517. 
Gardan, D., F. Gondret, K. Van den Maagdenberg, N. Buys, S. De Smet, and I. Louveau. 2008. 
Lipid metabolism and cellular features of skeletal muscle and subcutaneous adipose 
tissue in pigs differing in IGF-II genotype. Domest. Anim. Endocrin. 34:45-53. 
Gerrard, D. E., and A. L. Grant.  1994.  Insulin-like growth factor-II expression in developing 
muscle of double muscled and normal cattle.  Domest. Anim. Endocrin.  11: 339-347. 
Gilson H, O. Schakman, L. Combaret, P. Lause, L. Grobet, D. Attaix, J. Ketelslegers, and J. 
Thissen. 2007. Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy. 
Endocrinology. 148:452-460 
Gilson, H., O. Schakman, S. Kalista, P. Lause, K. Tsuchida, and J. P. Thissen. 2009.  Follistatin 
induces muscle hypertrophy through satellite cell proliferation and inhibition of both 
myostatin and activin. Am. J. Physiol. Endocrinol. Metab. 297:E157-64. 
Grobet, L., D. Poncelet, L. J. Royo, B. Brouwers, D. Pirottin, C. Michaux, F. Ménissier, M. 
Zanotti, S. Dunner, and M. Georges. 1998. Molecular definition of an allelic series of 
 118 
 
mutations disrupting the myostatin function and causing double-muscling in cattle. 
Mamm. genome. 9:210-213. 
Jones, J. C., K. A. Kroscher, and A. C. Dilger.  2014. Reductions in expression of growth 
regulating genes in skeletal muscle with age in wild type and myostatin null mice.  BMC 
Physiology.  14: 3. 
Kalista, S., O. Schakman, H. Gilson, P. Lause, B. Demeulder, L. Bertrand, M. Pende, and J. 
Thissen. 2012. The type 1 insulin-like growth factor receptor (IGF-IR) pathway is 
mandatory for the follistatin-induced skeletal muscle hypertrophy. Endocrinology. 
153:241-253. 
Kocamis, H., S. A. Gahr, L. Batelli, A. F. Hubbs, and J. Killefer.  2002.  IGF-1, IGF-II, and IGF-
receptor-1 transcript and IGF-II protein expression I myostatin knockout mice tissues.  
Muscle Nerve. 26: 55-63. 
Kollias, H. D. and J. C. McDermott. 2008. Transforming growth factor-β and myostatin 
signaling in skeletal muscle. J. Appl. Physiol. 104:579-587. 
Lalani, R., S. Bhasin, F. Byhower, R. Tarnuzzer, M. Grant, R. Shen, S. Asa, S. Ezzat, and N. F. 
Gonzalez-Cadavid. 2000.  Myostatin and insulin-like growth factor-I and -II expression 
in the muscle of rats exposed to the microgravity environment of the NeuroLab space 
shuttle flight.  J. Endocrinol. 167:417-428. 
Lee, S., and A. C. McPherron.  2001.  Regulation of myostatin activity and muscle growth.  
PNAS.  98:  9306-9311. 
Markljung, E., L. Jiang, J. D. Jaffe, T. S. Mikkelsen, O. Wallerman, M. Larhammar, X. Zhang, 
L. Wang, V. Saenz-Vash, and A. Gnirke. 2009. ZBED6, a novel transcription factor 
derived from a domesticated DNA transposon regulates IGF2 expression and muscle 
growth. PLoS biology. 7:e1000256. 
McPherron, A. C., A. M.  Lawler, and S. Lee. 1997. Regulation of skeletal muscle mass in mice 
by a new TGF-p superfamily member.  Nature. 387:83-90. 
Miyake, M., S. Hayashi, Y. Taketa, S. Iwasaki, K. Watanabe, S. Ohwada, H. Aso, and T. 
Yamaguchi. 2010. Myostatin down‐regulates the IGF‐2 expression via ALK‐Smad 
signaling during myogenesis in cattle. Animal Science Journal. 81:223-229. 
Mosher, D. S., P. Quignon, C. D. Bustamante, N. B. Sutter, C. S. Mellersh, H. G. Parker, and E. 
A. Ostrander. 2007. A mutation in the myostatin gene increases muscle mass and 
enhances racing performance in heterozygote dogs. PLoS genetics. 3:e79. 
Roith, D. L., L. Scavo, and A. Butler.  2001. What is the role of circulating IGF-I? Trends in 
Endocrinology & Metabolism. 12:48-52. 
 119 
 
Schuelke, M., K. R. Wagner, L. E. Stolz, C. Hübner, T. Riebel, W. Kömen, T. Braun, J. F. 
Tobin, and S. Lee. 2004. Myostatin mutation associated with gross muscle hypertrophy in 
a child. N. Engl. J. Med. 350:2682-2688. 
Van Den Maagdenberg, K., A. Stinckens, E. Claeys, N. Buys, and S. De Smet. 2008. Effect of 
the insulin-like growth factor-II and RYR1 genotype in pigs on carcass and meat quality 
traits. Meat Sci. 80:293-303. 
Van Laere, A. S., M. Nguyen, M. Braunschweig, C. Nezer, C. Collette, L. Moreau, A. L. 
Archibald, C. S. Haley, N. Buys, and M. Tally.  2003.  A regulatory mutation in IGF2 
causes a major QTL effect on muscle growth in the pig. Nature. 425:832-836. 
Williams, N. G., J. P. Interlichia, M. F. Jackson, D. Hwang, P. Cohen, and B. D. Rodgers.  2011.  
Endocrine actions of myostatin: systemic regulation of the IGF and IGF binding protein 
axis. Endocrinology. 152:172-180. 
Winbanks, C. E., K. L. Weeks, R. E. Thomson, P. V. Sepulveda, C. Beyer, H. Qian, J. L. Chen, 
J. M. Allen, G. I. Lancaster, M. A. Febbraio, C. A. Harrison, J. R. McMullen, J. S. 
Chamberlain, and P. Gregorevic. 2012. Follistatin-mediated skeletal muscle hypertrophy 
is regulated by Smad3 and mTOR independently of myostatin. J. Cell Biol. 197:997-1008 
  
  
 120 
 
TABLES 
Table 4.1  Body and carcass weights of wild type and myostatin null mice from 0d to 
70d of age.  
Trait Genotype 
 
Sex 
 
P-Value 
 
Age WT MN   F M SEM G Sex G x S 
n, at each age 10 10 
 
10 10 
    Whole Weight, g 
         
 
0d 1.30 1.44 
 
1.32 1.43 0.05 0.06 0.13 0.03 
 
7d 3.30 3.31 
 
3.51 3.10 0.35 0.10 0.04 0.27 
 
21d 8.00 7.22 
 
7.27 7.95 0.27 0.04 0.08 0.82 
 
42d 17.91 18.01 
 
16.92 18.99 0.40 0.87 < 0.01 0.33 
 
70d 20.57 24.61 
 
21.01 24.17 0.54 < 0.01 < 0.01 0.56 
Carcass Weight, g 
         
 
0d 0.45 0.52 
 
0.46 0.51 0.02 0.03 0.16 0.03 
 
7d 1.03 1.02 
 
1.01 1.03 0.09 0.94 0.89 0.51 
 
21d 2.82 2.83 
 
2.68 2.97 0.12 0.95 0.09 0.89 
 
42d 6.92 8.16 
 
7.06 8.03 0.26 < 0.01 0.02 0.13 
  70d 8.64 12.55   9.69 11.49 0.26 < 0.01 < 0.01 0.89 
WT, Wildtype mice; MN, Myostatin null mice; F, Female; M, Male; SEM, Standard 
error of the mean; G, Genotype; G x S, Interaction of genotype and sex. 
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Table 4.2 Muscle and organ weights of wild type and myostatin null mice from 21d to 70d of 
age. 
Trait Genotype 
 
Sex 
 
P-Value 
  Age WT MN   F M SEM G Sex G x S 
n, at each age 10 10 
 
10 10 
    Biceps Femoris, mg                   
  21d 54.1 52.8   50.2 56.8 4.2 0.83 0.28 0.44 
  42d 145.6 192.7   156.0 182.3 13.1 0.02 0.17 0.74 
  70d 219.0 311.6   245.1 285.5 18.7 < 0.01 0.15 0.60 
Triceps Brachii, mg                   
  21d 22.2 32.2   25.3 29.2 1.5 < 0.01 0.08 0.40 
  42d 52.0 98.6   71.4 79.1 4.7 < 0.01 0.27 0.90 
  70d 80.4 152.9   95.7 137.5 5.9 < 0.01 < 0.01 < 0.01 
Tibialis Anterior, mg                  
  21d 13.4 16.7   14.0 16.1 1.3 0.07 0.25 0.50 
  42d 34.0 53.3   35.6 517.4 6.1 0.04 0.08 0.09 
  70d 40.3 63.7   50.2 53.8 4.4 < 0.01 0.57 0.07 
Gastroc/Soleus, mg                   
  21d 25.2 32.3   27.8 29.7 2.2 0.03 0.56 0.57 
  42d 71.1 100.7   83.1 886.7 5.4 < 0.01 0.48 0.37 
  70d 100.0 178.3   114.9 163.5 15.9 0.02 0.05 0.26 
Liver Weight, mg                   
  7d 105.0 87.2   97.9 94.3 7.7 0.12 0.74 0.89 
  21d 381.3 285.7   322.5 344.5 22.8 0.01 0.50 0.61 
  42d 1070.7 860.8   845.3 1086.2 43.8 < 0.01 < 0.01 0.74 
  70d 1020.9 1084.9   1007.4 1098.5 53.1 0.41 0.24 0.38 
Heart Weight, mg                   
  7d 24.4 21.1   23.4 22.1 1.6 0.14 0.56 0.92 
  21d 63.6 52.9   56.0 60.5 2.8 0.01 0.26 0.41 
  42d 109.3 104.7   99.6 114.4 4.3 0.46 0.03 0.17 
  70d 126.4 126.1   122.5 130.0 4.3 0.96 0.23 0.96 
WT, Wildtype mice; MN, Myostatin null mice; F, Female; M, Male; SEM, Standard error of the 
mean; G, Genotype; G x S, Interaction of genotype and sex. 
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FIGURES 
 
 
Figure 4.1  Igf1 (A,B, C) and Igf2 (D, E, F) expression in compiled hind limb muscles of 0d and 
7d mice (A, D), and  triceps brachii (B, E) and biceps femoris muscles (C, F)  of 21d, 42d, and 
70d mice. Skeletal muscle gene expression of Igf1 and Igf2 in wildtype (WT) and myostatin null 
(MN) mice was determined in duplicate, duplex quantitative polymerase chain reactions (qPCR; 
n = 10 per genotype at each age).  All gene expression was normalized to the endogenous 
control, 18s-rRNA.  Least square means (± 95% confidence interval) were reported as fold 
change compared to the average male WT mice at 7d or 70d within each respective muscle.  Bars 
without a common letter are different (P < 0.05).    
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Figure 4.2  Igf1r (A,B, C) and Igf2r (D, E, F) expression in compiled hind limb muscles of 0d 
and 7d mice (A, D), and  triceps brachii (B, E) and biceps femoris muscles (C, F)  of 21d, 42d, 
and 70d mice. Skeletal muscle gene expression of Igf1r and Igf2r in wildtype (WT) and 
myostatin null (MN) mice was determined in duplicate, duplex quantitative polymerase chain 
reactions (qPCR; n = 10 per genotype at each age).  All gene expression was normalized to the 
endogenous control, 18s-rRNA.  Least square means (± 95% confidence interval) were reported 
as fold change compared to the average male WT mice at 7d or 70d within each respective 
muscle.  Bars without a common letter are different (P < 0.05).    
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Figure 4.3  Igfbp3 (A,B, C) and Igfbp5 (D, E, F) expression in compiled hind limb muscles of 0d 
and 7d mice (A, D), and  triceps brachii (B, E) and biceps femoris muscles (C, F)  of 21d, 42d, 
and 70d mice. Skeletal muscle gene expression of Igfbp3 and Igfbp5 in wildtype (WT) and 
myostatin null (MN) mice was determined in duplicate, duplex quantitative polymerase chain 
reactions (qPCR; n = 10 per genotype at each age).  All gene expression was normalized to the 
endogenous control, 18s-rRNA.  Least square means (± 95% confidence interval) were reported 
as fold change compared to the average male WT mice at 7d or 70d within each respective 
muscle.  Bars without a common letter are different (P < 0.05).    
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Figure 4.4  Igf2 transcript variant (A) expression in compiled hind limb muscles at 0d, and from 
biceps femoris muscles of 21d and 70d mice.  Igf2antisense (Igf2as) (B) expression in biceps 
femoris muscles at 21d and 70d mice.  Skeletal muscle gene expression of Igf2 transcript variants 
(V1, V2 and V3) and Igf2as transcript in wildtype (WT) and myostatin null (MN) mice was 
determined in duplicate, duplex quantitative polymerase chain reactions (qPCR; n = 10 per 
genotype at each age).  All gene expression was normalized to the endogenous control, 18s-
rRNA.  Transcript variant least square means (± 95% confidence interval) were reported as fold 
change compared to the average V1 expression of male WT mice at 70d.  IGF2as least square 
means (± 95% confidence interval) were reported as fold change compared to the average male 
WT mice at 70d. Bars without a common letter are different (P < 0.05).     
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Figure 4.5  Igf2 protein levels in biceps femoris muscles of wildtype (WT) and myostatin null 
(MN) mice at 70d. Igf2 protein levels were determined in duplicate by a sandwich ELISA kit 
with a sensitivity of < 5pg/ml. The ELISA had no detectable cross reactivity with IGF-1.   Least 
square means are reported as means ± standard error of the mean.  Bars without a common letter 
are different (P < 0.05).   
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Figure 4.6  Interaction means of genotype and age for hepatic Igf1 (A) and Igf2 (B) expression at 
21d, 42d, and 70d mice.  Hepatic Igf1 and Igf2 expression in wildtype (WT) and myostatin null 
(MN) mice was determined in duplicate, duplex quantitative polymerase chain reactions (qPCR; 
n = 10 per genotype at each age).  All gene expression was normalized to the endogenous 
control, Gapd.  Means (± 95% confidence interval) are reported as fold change compared to the 
average male WT mice at 70d for each gene.  Bars without a common letter are considered 
different (P < 0.05).   
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SUPPLEMENTAL TABLES 
 
  
Supplemental table 4.3  Primer sequences for genotyping 
myostatin null mice 
Primer Sequence 
Forward (KO-2) GTGCGATAATCCAGTCCCAT 
Reverse (KO-1) GGCATCTGTTCTGCTATTACGTGC 
Neomycin (KO-3) GTGGATGTGGAATGTGTGCGAGG 
KO-2 + KO-1 = WT Amplicon, 416 bp. 
KO-3 + KO-1 = MN Amplicon, 260 bp.. 
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Supplemental table 4.4 Insulin-like growth factor family members and endogenous control accession 
numbers and quantitative PCR assay identification numbers 
Gene 
Symbol Gene Name 
Accession 
Number Assay ID 
Igf1
1
 insulin-like growth factor 1 NM_184052.3 Mm00439560_m1 
Igf2
1
 insulin-like growth factor 2 NM_001122736.1 Mm00439564_m1 
Igf1r
1
 insulin-like growth factor I receptor NM_010513.2 Mm00802831_m1 
Igf2r
1
 insulin-like growth factor 2 receptor NM_010515.2 Mm00439576_m1 
Igfbp3
1
 insulin-like growth factor binding protein 3 NM_008343.2 Mm01187817_m1 
Igfbp5
1
 insulin-like growth factor binding protein 5 NM_010518.2 Mm00516037_m1 
18s rRNA
2
 18S ribosomal RNA NR_003278.3 4310893E 
Gapdh
2
 Glyceraldeyhyde-3-phosphate dehydrogenase NM_001289726.1 4352932E 
All primers are Taqman primers purchased from Life Technologies (Grand Island, NY). 
1
Fam fluorescently labeled reporters. 
2
Vic fluorescently labeled reporters. 
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Supplemental table 4.5 Custom designed Igf2 transcript variant and Igf2 antisense primer and reporter sequences. 
Gene Symbol 
Accession 
Number Primer/Reporter Primer/Reporter Sequence 
    
  
Forward: CCCCACCAAAAAAGCCATCT 
Igf2 Variant 1 (V1) NM_010514.3 Reverse: CGCAGAGGCCGAATGTG 
  
Reporter: Fam-CCCGTTCTGTCCCGTC 
    
  
Forward: TTCGGCCTTGTGGTACCAAT 
Igf2 Variant 2 (V2) NM_001122736 Reverse: GGCGAAGGCCAAAGAGATG 
  
Reporter: Fam-AAGTCGATGTTGGTGCTT 
    
  
Forward: TTTCCTGTCTTCATCCTCTTCCA 
Igf2 Variant 3 (V3) NM_001122737 Reverse: TCCCCATTGGTACCTGAAGTTG 
  
Reporter: Fam-CCAGCGGCCTCCT 
    
  
Forward: TGTGGACTCTGCCGAGGAA 
Igf2 Variant X1 (VX1) XM_006508486 Reverse: CATTGGTACCTGACCAGTGAACTG 
  
Reporter: Fam-CTCTGCTGTTTGGTGGC 
    
  
Forward: CACATTTAGACAGCATTTCCTCATTC 
Igf2 Variant X2 (VX2) XM_006508487 Reverse: CCCCATTGGTACCTCTAATTTCTG 
  
Reporter: Fam-CTAGAGGACTTCTCTGAAGC 
    
  
Forward: CTCACACCCCGGAGATGAAC 
Igf2antisense (Igf2as) NR_002855 Reverse: CCAGCACAGGCATGAGGAA 
  
Reporter: Fam-ACTTTGCCAGGGTCC 
      
All primers are Taqman primers purchased from Life Technologies (Grand Island, NY). 
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SUPPLEMENTAL FIGURES 
 
Supplemental figure 4.7  Igf1 (A,B, C) and Igf2 (D, E, F) expression in compiled hind limb 
muscles of 0d and 7d mice (A, D), and  triceps brachii (B, E) and biceps femoris muscles (C, F)  
of 21d, 42d, and 70d mice. Skeletal muscle gene expression of Igf1 and Igf2 in female and male 
mice was determined in duplicate, duplex quantitative polymerase chain reactions (qPCR; n = 10 
per genotype at each age).  All gene expression was normalized to the endogenous control, 18s-
rRNA.  Least square means (± 95% confidence interval) were reported as fold change compared 
to the average male wild type mice at 7d or 70d within each respective muscle.  Bars without a 
common letter are different (P < 0.05).    
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Supplemental figure 4.8  Igf1r (A,B, C) and Igf2r (D, E, F) expression in compiled hind limb 
muscles of 0d and 7d mice (A, D), and  triceps brachii (B, E) and biceps femoris muscles (C, F)  
of 21d, 42d, and 70d mice. Skeletal muscle gene expression of Igf1r and Igf2r in female and 
male mice was determined in duplicate, duplex quantitative polymerase chain reactions (qPCR; n 
= 10 per genotype at each age).  All gene expression was normalized to the endogenous control, 
18s-rRNA.  Least square means (± 95% confidence interval) were reported as fold change 
compared to the average male wild type mice at 7d or 70d within each respective muscle.  Bars 
without a common letter are different (P < 0.05).    
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Supplemental figure 4.9  Igfbp3 (A,B, C) and Igfbp5 (D, E, F) expression in compiled hind 
limb muscles of 0d and 7d mice (A, D), and  triceps brachii (B, E) and biceps femoris muscles 
(C, F)  of 21d, 42d, and 70d mice. Skeletal muscle gene expression of Igfbp3 and Igfbp5 in 
female and male mice was determined in duplicate, duplex quantitative polymerase chain 
reactions (qPCR; n = 10 per genotype at each age).  All gene expression was normalized to the 
endogenous control, 18s-rRNA.  Least square means (± 95% confidence interval) were reported 
as fold change compared to the average male wild type mice at 7d or 70d within each respective 
muscle.  Bars without a common letter are different (P < 0.05).    
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Supplemental figure 4.10  Igf2 transcript variant (A) expression in compiled hind limb muscles 
at 0d, and from biceps femoris muscles of 21d and 70d mice.  Igf2antisense (Igf2as) (B) 
expression in biceps femoris muscles at 21d and 70d mice.  Skeletal muscle gene expression of 
Igf2 transcript variants (V1, V2 and V3) and Igf2as transcript in female and male mice was 
determined in duplicate, duplex quantitative polymerase chain reactions (qPCR; n = 10 per 
genotype at each age).  All gene expression was normalized to the endogenous control, 18s-
rRNA.  Transcript variant least square means (± 95% confidence interval) were reported as fold 
change compared to the average V1 expression of male wild type mice at 70d.  IGF2as least 
square means (± 95% confidence interval) were reported as fold change compared to the average 
male wild type mice at 70d. Bars without a common letter are different (P < 0.05).    
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Supplemental figure 4.11  Igf2 protein levels in biceps femoris muscles of female and male 
mice at 70d. Igf2 protein levels were determined in duplicate by a sandwich ELISA kit with a 
sensitivity of < 5pg/ml. The ELISA had no detectable cross reactivity with IGF-1.   Least square 
means are reported as means ± standard error of the mean.  Bars without a common letter are 
different (P < 0.05).   
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Supplemental figure 4.12  Interaction means of genotype and age for hepatic Igf1 (A) and Igf2 
(B) expression at 21d, 42d, and 70d mice.  Hepatic Igf1 and Igf2 expression in female and male 
mice was determined in duplicate, duplex quantitative polymerase chain reactions (qPCR; n = 10 
per genotype at each age).  All gene expression was normalized to the endogenous control, Gapd.  
Means (± 95% confidence interval) are reported as fold change compared to the average male 
wild type mice at 70d for each gene.  Bars without a common letter are considered different (P < 
0.05).   
 
